Days At A Glance Speakers Session Type Search
Type

    07:00 - 20:00 
    Registration Open
    ACC Cityside Galleria
    07:30 - 08:00 
    Breakfast for Working Group Attendees
    Exhibition Hall
    08:00 - 09:30 
    ESPE Working Group on Obesity
    Exhibition Hall C
    Chair: Erica van den Akker (Rotterdam, The Netherlands)
    Sat 16 08:00
    ESPE Working Group on Obesity
    Welcome and Update on Working Group Acitivities - Global Obesity Guidelines
    Sat 16 08:15
    ESPE Working Group on Obesity
    Pubertal Development in Chinese Children and the Impact of Overnutrition, Lifestyle, and Perinatal Factors
    Zhejiang, China
    Sat 16 08:40
    ESPE Working Group on Obesity
    Early growth trajectories in chidlren with genetic obesity. A European collaboration project
    Ulm, Germany
    Sat 16 09:00
    ESPE Working Group on Obesity
    The CEW Clinic Concept
    Liverpool, UK
    Sat 16 09:20
    ESPE Working Group on Obesity
    Childhood obesity in 2024 - shortlist of highlights
    Stockholm, Sweden
    08:00 - 09:30 
    ESPE Working Group on Gender Incongruence
    Hall 2H
    Chair: Sabine Hannema (Amsterdam, The Netherlands)
    Sat 16 08:00
    ESPE Working Group on Gender Incongruence
    Immunological effects of gender affirming hormone treatment
    London, UK
    Sat 16 08:30
    ESPE Working Group on Gender Incongruence
    Mental health/psychosocial outcomes versus mental health and brain effects
    Chicago, USA
    Sat 16 09:00
    ESPE Working Group on Gender Incongruence
    CORE ENDOCRINE REGISTRY: transgender module – preliminary data and future plans
    Ghent, Belgium
    08:00 - 09:30 
    ESPE Working Group on Paediatric and Adolescent Gynaecology
    Hall 2K
    Chair: Lourdes Ibanez (Barcelona, Spain)
    Sat 16 08:00
    ESPE Working Group on Paediatric and Adolescent Gynaecology
    Genetics of POI
    São Paulo, Brazil
    Sat 16 08:30
    ESPE Working Group on Paediatric and Adolescent Gynaecology
    Clinical management
    London, UK
    Sat 16 09:00
    ESPE Working Group on Paediatric and Adolescent Gynaecology
    Fertility preservation in girls
    Edinburgh, UK
    08:00 - 09:30 
    ESPE Working Group on Turner Syndrome
    This session is dedicated to the memory of Malcolm Donaldson, who was originally scheduled to speak
    Around Updated Guidelines for TS
    Hall 2J
    Chair: Aneta Gawlik (Katowice, Poland)
    Sat 16
    ESPE Working Group on Turner Syndrome
    Welcome
    Katowice, Poland
    Sat 16 08:00
    ESPE Working Group on Turner Syndrome
    News and doubts around growth and puberty therapy
    Umea, Sweden
    Sat 16 08:20
    ESPE Working Group on Turner Syndrome
    Beyond growth and puberty issues in girls with TS
    Cincinnati, USA
    Sat 16 08:40
    ESPE Working Group on Turner Syndrome
    Challenges from the adult endocrinologist perspective
    Aarhus, Denmark
    Sat 16 09:00
    ESPE Working Group on Turner Syndrome
    To present multi-central experience/data and invite to prospective study
    Katowice, Poland
    Sat 16 09:20
    ESPE Working Group on Turner Syndrome
    Round Table/Discussion
    08:00 - 09:30 
    ESPE Working Group on Bone and Growth Plate
    Meeting Room 3
    Chair: Evelien Gevers (London, UK)
    Sat 16 08:00
    ESPE Working Group on Bone and Growth Plate
    Update on Working Group Activities
    Sat 16 08:10
    ESPE Working Group on Bone and Growth Plate
    Regulation of the Epiphyseal Stem Cells
    Solna, Sweden
    Sat 16 08:35
    ESPE Working Group on Bone and Growth Plate
    Osteogenesis imperfecta, update and the OI XIV Animal model
    Pavia, Italy
    Sat 16 09:00
    ESPE Working Group on Bone and Growth Plate
    A case of osteogenesis imperfecta with Antonella Forlio’s expert opinion
    08:00 - 09:30 
    ESPE Working Group on DSD/Differences in Sex Development
    Hall 1
    Chair: Jan Idkowiak (Birmingham, UK)
    Sat 16
    ESPE Working Group on DSD/Differences in Sex Development
    A rare cause of 46, XY gonadal dysgenesis: Case presentation
    Istanbul, Turkey
    Sat 16
    ESPE Working Group on DSD/Differences in Sex Development
    Partial gonadal dysgenesis due to chromosomal mosaicism – a challenging case
    Birmingham, UK
    Sat 16
    ESPE Working Group on DSD/Differences in Sex Development
    Novel insights into the diagnosis of gonadal dysgnesis: findings from the 46,XY gonadal dysgenesis study based on the I-DSD Registry
    Cambridge, United Kingdom
    Sat 16
    ESPE Working Group on DSD/Differences in Sex Development
    Pathophysiology and Management of Dysgenetic Gonads
    Ghent, Belgium
    08:00 - 09:30 
    ESPE Working Group - Nurse
    Hall 2G
    Chair: Camilla Ernstsson (Västerbotten County, Sweden)
    Sat 16 08:00
    ESPE Working Group - Nurse
    Research and innovation in nursing
    Sat 16 08:45
    ESPE Working Group - Nurse
    Transition in endocrinology - the challenges - change to Complications after cancer treatment
    09:30 - 10:00 
    Coffee, Exhibition & Posters
    Exhibition Hall
    10:00 - 10:15 
    Opening Ceremony
    Arena Plenary
    10:15 - 10:45 
    Plenary 1 - Impact of GH treatment on DNA damage
    Arena Plenary
    Chairs: Mehul Dattani (London, UK) & Mohamad Maghnie (Geneva, Italy)
    Sat 16 10:15
    PL1
    Plenary 1 - Impact of GH treatment on DNA damage
    Impact of GH on DNA damage
    Los Angeles CA , USA
    10:45 - 11:15 
    Awards 1 - Henning Andersen Prizes
    Arena Plenary
    Chair: Peter Kuhnen (Berlin, Germany)
    11:25 - 12:55 
    Symposium 1 - Disorders of Sex Development: Novel advances in management
    Hall 1
    Chairs: Faisal Ahmed (Glasgow, UK) & Carla Bizzarri (Rome, Italy)
    Sat 16 11:25
    S1.1
    Symposium 1 - Disorders of Sex Development: Novel advances in management
    Vascular reactivity and morbidity in DSD
    Glasgow, UK
    Sat 16 11:55
    S1.2
    Symposium 1 - Disorders of Sex Development: Novel advances in management
    Novel mechanisms leading to DSD (genomic, digenic/ollogenic and non-coding variation)
    Paris, France
    Sat 16 12:25
    S1.3
    Symposium 1 - Disorders of Sex Development: Novel advances in management
    Hypospadias - surgery and beyond
    Stockholm, Sweden
    11:25 - 12:55 
    Symposium 2 - Bone and Mineral Disorders: Recent Developments
    Hall 2K
    Chairs: Wolfgang Hoegler (Linz, Austria) & Suma Uday (Birmingham, UK)
    Sat 16 11:25
    S2.1
    Symposium 2 - Bone and Mineral Disorders: Recent Developments
    Phosphate sensing in normal physiology and disease
    Zurich, Switzerland
    Sat 16 11:55
    S2.2
    Symposium 2 - Bone and Mineral Disorders: Recent Developments
    Advances in FGF 23 related disorders
    Maryland, USA
    Sat 16 12:25
    S2.3
    Symposium 2 - Bone and Mineral Disorders: Recent Developments
    PTH Resistance Syndromes
    Paris, France
    11:25 - 12:55 
    Symposium 3 - Novel Advances and Treatments of Hypothalamic disease
    Hall 2H
    Chairs: Hanneke Van Santen (Utrecht, the Netherlands) & Peter Clayton (Manchester, UK)
    Sat 16 11:25
    S3.1
    Symposium 3 - Novel Advances and Treatments of Hypothalamic disease
    National UK Guidelines for the Management of Paediatric Craniopharyngioma
    London, UK
    Sat 16 11:55
    S3.2
    Symposium 3 - Novel Advances and Treatments of Hypothalamic disease
    Use of MC4R agonist in hypothalamic obesity
    Madrid, Spain
    Sat 16 12:25
    S3.3
    Symposium 3 - Novel Advances and Treatments of Hypothalamic disease
    Proton Beam Therapy in childhood brain tumours
    Tennessee, USA
    11:25 - 12:55 
    Symposium 4 - New Adjuvant Therapy in Pediatric Diabetes (ISPAD/ESPE)
    Hall 2J
    Chairs: Jacques Beltrand (Paris, France) & Ram Weiss (Haifa, Israel)
    Sat 16 11:25
    S4.1
    Symposium 4 - New Adjuvant Therapy in Pediatric Diabetes (ISPAD/ESPE)
    Use of Verapamil in newly diagnosed T1D
    Colorado , USA
    Sat 16 11:55
    S4.2
    Symposium 4 - New Adjuvant Therapy in Pediatric Diabetes (ISPAD/ESPE)
    Use of GLP1 receptor agonists in Wolfram syndrome
    Ixelles, Belgium
    Sat 16 12:25
    S4.3
    Symposium 4 - New Adjuvant Therapy in Pediatric Diabetes (ISPAD/ESPE)
    Statins and Cardiovascular risk in T1D
    Cambridge, UK
    11:25 - 12:25 
    Yearbook 1
    Hall 2G
    Sat 16 11:25
    Yearbook 1
    Type 2 Diabetes, Metabolic Syndrome and Lipids
    Tel Aviv, Israel
    Sat 16 11:37
    Yearbook 1
    Global Health for the Paediatric Endocrinologist
    Stanford, USA
    Sat 16 11:49
    Yearbook 1
    Growth and Growth Factors
    Rome, Italy
    Sat 16 12:01
    Yearbook 1
    Puberty
    Liège, Belgium
    Sat 16 12:13
    Yearbook 1
    Adrenals
    Athens, Greece
    12:55 - 14:25 
    Lunch, Exhibition & Posters
    Exhibition Hall
    13:15 - 14:15 
    Satellite Symposium 1
    For more information please see satellite programme
    Hall 1
    13:15 - 14:15 
    Satellite Symposium 2
    For more information please see satellite programme
    Meeting Room 3
    14:25 - 14:55 
    Rapid Free Communications 1: Diabetes and Insulin
    Hall 2J
    Chairs: Catherine Peters (London, UK) & Ruben Willemsen (London, UK)
    Sat 16 14:25
    RFC1.1
    Rapid Free Communications 1: Diabetes and Insulin
    Perceptions and Experiences of PDSNs on Different Hybrid Closed Loop Systems (HCLS) across Wales
    Cardiff, United Kingdom
    Sat 16 14:30
    RFC1.2
    Rapid Free Communications 1: Diabetes and Insulin
    Evaluating Glucose-6-Phosphate Dehydrogenase Enzyme Activity In Children With Type 1 Diabetes Mellitus.
    Alexandria, Egypt
    Alexandria, Egypt
    Sat 16 14:35
    RFC1.3
    Rapid Free Communications 1: Diabetes and Insulin
    Akkermansia muciniphila induces immune homeostasis in type 1 diabetic mice by up-regulating CD4 + FoxP3 + Treg expression.
    Guangzhou, China
    Sat 16 14:40
    RFC1.4
    Rapid Free Communications 1: Diabetes and Insulin
    Children born small for gestational age (SGA) under growth hormone treatment have similarly impaired glucose-insulin metabolism as children with obesity
    Leipzig, Germany
    Sat 16 14:45
    RFC1.5
    Rapid Free Communications 1: Diabetes and Insulin
    Evaluation of Arterial Stiffness in Children with Type 1 Diabetes Mellitus Using Speckle Tracking Carotid Strain Ultrasonography: Do Atherosclerotic Changes Begin in Childhood?
    Aydın, Turkey
    Sat 16 14:50
    RFC1.6
    Rapid Free Communications 1: Diabetes and Insulin
    METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE AND ITS ASSOCIATION WITH GLYCEMIC CONTROL METRICS IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES: AN EXPLORATORY STUDY
    Verona, Italy
    14:25 - 14:55 
    Rapid Free Communications 2: Bone, Growth Plate and Mineral Metabolism
    Hall 2K
    Chair: Gabriele Hartmann (Vienna, Austria) and Renuka Ramakrishnan (Liverpool, United Kingdom)
    Sat 16 14:25
    RFC2.1
    Rapid Free Communications 2: Bone, Growth Plate and Mineral Metabolism
    Bone and Body Composition after one year of Vosorotide treatment in children with Achondroplasia: a longitudinal prospective study.
    Genova, Italy
    Sat 16 14:30
    RFC2.2
    Rapid Free Communications 2: Bone, Growth Plate and Mineral Metabolism
    Microarchitectural Alterations in Children with Rheumatological conditions on Long‑term Glucocorticoid Treatment
    Hong Kong SAR, China
    Sat 16 14:35
    RFC2.3
    Rapid Free Communications 2: Bone, Growth Plate and Mineral Metabolism
    Optimizing the Growth Outcome follow up in Hypophosphatemic Rickets Treated with Burosumab: The Critical Role of Auxological Measurements
    Padova, Italy
    Sat 16 14:40
    RFC2.4
    Rapid Free Communications 2: Bone, Growth Plate and Mineral Metabolism
    CYP24A1 MUTATIONS:, CLINICAL AND LABORATORY FEATURES IN PATIENTS PRESENTING WITH HYPERCALCEMIA
    Istanbul, Turkey
    Sat 16 14:45
    RFC2.5
    Rapid Free Communications 2: Bone, Growth Plate and Mineral Metabolism
    Prediction of residual growth potential in adolescent boys by linear regression modeling based on the radiomics features extracted by knee DR images and clinical characteristics
    Shanghai, China
    Shanghai, China
    Shanghai, China
    Shanghai, China
    Sat 16 14:50
    RFC2.6
    Rapid Free Communications 2: Bone, Growth Plate and Mineral Metabolism
    Comparison of two automated bone age evaluation methods in pediatric patients with growth and puberty disorders
    Lausanne, Switzerland
    14:25 - 14:55 
    Rapid Free Communications 3: Pituitary, Neuroendocrinology and Puberty (1)
    Hall 1
    Chairs: Bradley Miller (Minnesota, USA) & Rachel Reynaud (Marseille, France)
    Sat 16 14:25
    RFC3.1
    Rapid Free Communications 3: Pituitary, Neuroendocrinology and Puberty (1)
    DNA Methylation profiles in girls with anorexia nervosa and amenorrhea: a pilot study
    Naples, Italy
    Sat 16 14:30
    RFC3.2
    Rapid Free Communications 3: Pituitary, Neuroendocrinology and Puberty (1)
    Results from a targeted hypopituitarism gene panel in patients with variable congenital hypopituitarism identifies variants in known and novel candidate genes.
    London, United Kingdom
    Sat 16 14:35
    RFC3.3
    Rapid Free Communications 3: Pituitary, Neuroendocrinology and Puberty (1)
    Analysis of the expression levels of spexin and kisspeptin in serum, ovarian tissue and white adipose tissue as related to pubertal status and metabolic surrogates of puberty in female albino Wistar rats
    Istanbul, Turkey
    Sat 16 14:40
    RFC3.4
    Rapid Free Communications 3: Pituitary, Neuroendocrinology and Puberty (1)
    Longitudinal Changes in Serum DLK1 Concentrations During Pubertal Transition in Healthy Girls and in girls with Precocious Puberty during GnRHa treatment
    Copenhagen, Denmark
    Sat 16 14:45
    RFC3.5
    Rapid Free Communications 3: Pituitary, Neuroendocrinology and Puberty (1)
    Long-Term Health Outcomes of Delayed Puberty in Males: A Comprehensive Population-Based Study
    Örebro, Sweden
    Sat 16 14:50
    RFC3.6
    Rapid Free Communications 3: Pituitary, Neuroendocrinology and Puberty (1)
    Final Height and Endocrine Complications in Children with Pilocytic Astrocytomas: A Retrospective Study
    Istanbul, Turkey
    14:25 - 14:55 
    Rapid Free Communications 4: Adrenals and HPA Axis (1)
    Hall 2H
    Chairs: Evangelia Charmandari (London, UK) & Harshini Katugampola (London, UK)
    Sat 16 14:25
    RFC4.1
    Rapid Free Communications 4: Adrenals and HPA Axis (1)
    Screening for Adrenal Insufficiency in Children by Home Waking Salivary Cortisone testing
    Liverpool, UK
    Sat 16 14:30
    RFC4.2
    Rapid Free Communications 4: Adrenals and HPA Axis (1)
    Salivary cortisol and cortisone is related to age
    Liverpool, United Kingdon
    Sat 16 14:35
    RFC4.3
    Rapid Free Communications 4: Adrenals and HPA Axis (1)
    Differences and similarities in salivary diurnal adrenal hormones in monozygotic twins with intra-twin birthweight-differences
    Bonn, Germany
    Sat 16 14:40
    RFC4.4
    Rapid Free Communications 4: Adrenals and HPA Axis (1)
    Serum cortisol correlates strongly with salivary cortisol and cortisone in girls and boys, and across all ages
    Liverpool, United Kingdom
    Sat 16 14:45
    RFC4.5
    Rapid Free Communications 4: Adrenals and HPA Axis (1)
    Ontogenesis of the urinary steroid metabolome in infancy assessed by gas chromatography/mass spectrometry (GC-MS)
    Gießen, Germany
    Sat 16 14:50
    RFC4.6
    Rapid Free Communications 4: Adrenals and HPA Axis (1)
    Machine Learning-Based Decision Tree Model for the Diagnosis of Congenital Disorders of Adrenal Steroidogenesis Using LC-MS/MS-based Plasma Steroid Hormone Profiles
    Istanbul, Turkey
    14:25 - 14:55 
    Rapid Free Communications 5: Growth and Syndromes
    Hall 2G
    Chair: Assunta Albanese (London, United Kingdom) and Aneta Gawlik (Katowice, Poland)
    Sat 16 14:25
    RFC5.1
    Rapid Free Communications 5: Growth and Syndromes
    ABOUT CARING FOR PATIENTS AND UNDERSTANDING THEIR PATHWAYS: 10 YEARS OF ‘THE ROTTERDAM CENTRE FOR ADULTS WITH RARE GENETIC SYNDROMES’
    Rotterdam, The Netherlands
    Sat 16 14:30
    RFC5.2
    Rapid Free Communications 5: Growth and Syndromes
    The development and validation of Bone age-guided Interpretation of Growth (BIG), a web-based tool for the guidance of evaluation of children and adolescents with growth disorders.
    kanpur, India
    Sat 16 14:35
    RFC5.3
    Rapid Free Communications 5: Growth and Syndromes
    Neuroradiological Findings in Noonan Syndrome: a multicentric Italian study
    Genova, Italy
    Sat 16 14:40
    RFC5.4
    Rapid Free Communications 5: Growth and Syndromes
    Analysis of growth patterns in Klinefelter syndrome using the QEPS growth model
    Gothenburg, Sweden
    Sat 16 14:45
    RFC5.5
    Rapid Free Communications 5: Growth and Syndromes
    Searching for associated dysmorphic and cardiac abnormalities in youth tall basketball players
    Prague, Czech republic
    Sat 16 14:50
    RFC5.6
    Rapid Free Communications 5: Growth and Syndromes
    Pubertal induction in girls with Turner syndrome – retrospective data from the International TS registry
    Katowice, Poland
    14:55 - 15:55 
    Free Communications 1: Diabetes and Insulin
    Hall 2J
    Chairs: Catherine Peters (London, UK) & Ruben Willemsen (London, UK)
    Sat 16 14:55
    FC1.1
    Free Communications 1: Diabetes and Insulin
    Does Type 1 Diabetes Effect Left Ventricular Function in Children? Evaluation with Treadmill Exercise Stress Echocardiography
    Izmir, Turkey
    Sat 16 15:05
    FC1.2
    Free Communications 1: Diabetes and Insulin
    EFFECT OF HYDROXYCHLOROQUINE THERAPY IN NEWLY DIAGNOSED TYPE 1 DIABETES: A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROL PILOT TRIAL
    Chandigarh, India
    Sat 16 15:15
    FC1.3
    Free Communications 1: Diabetes and Insulin
    A Non-Invasive Diagnostic Tool for Early Detection of Microvascular Alterations in Children with Type 1 Diabetes Mellitus: Nail-Fold Capillaroscopy
    Izmir, Turkey
    Sat 16 15:25
    FC1.4
    Free Communications 1: Diabetes and Insulin
    A personalized approach to classify the degree of liver insulin resistance in children with obesity
    Hertogenbosch, The Netherlands
    Sat 16 15:35
    FC1.5
    Free Communications 1: Diabetes and Insulin
    The Side-Effects of Lanreotide in Children with Congenital Hyperinsulinism (CHI): A Decade-long Exploration
    Basildon, United Kingdom
    Sat 16 15:45
    FC1.6
    Free Communications 1: Diabetes and Insulin
    Comprehensive rescreening of the known congenital hyperinsulinism genes provides a new genetic diagnosis for 18% of the Finnish cohort
    Exeter, United Kingdom
    14:55 - 15:55 
    Free Communications 2: Bone, Growth Plate and Mineral Metabolism
    Hall 2K
    Chair: Gabriele Hartmann (Vienna, Austria) and Renuka Ramakrishnan (Liverpool, United Kingdom)
    Sat 16 14:55
    FC2.1
    Free Communications 2: Bone, Growth Plate and Mineral Metabolism
    A highly selective FGFR3 inhibitor alleviates achondroplasia symptoms and restores chondrocyte growth in mice model
    Shanghai, China
    Shanghai, China
    Shanghai, China
    Shanghai, China
    Shanghai, China
    Sat 16 15:05
    FC2.2
    Free Communications 2: Bone, Growth Plate and Mineral Metabolism
    Therapeutic Effects of Human Bone Marrow Mesenchymal Stem Cells Derived Exosomes on Glucocorticoid-Induced Osteoporosis: In Vitro Model
    İstanbul, Turkey
    Sat 16 15:15
    FC2.3
    Free Communications 2: Bone, Growth Plate and Mineral Metabolism
    Molecular mechanism of FBN1 variants result to acromicric dysplasia by mechano-transduction
    Hangzhou, China
    Sat 16 15:25
    FC2.4
    Free Communications 2: Bone, Growth Plate and Mineral Metabolism
    Analysis of baseline data from the SUNFLOWER longitudinal, observational cohort study of patients with XLH: relationship between various complications and QOL
    Tottori, Japan
    Sat 16 15:35
    FC2.5
    Free Communications 2: Bone, Growth Plate and Mineral Metabolism
    Bone health in adolescents with cow’s milk allergy during infancy
    Helsinki, Finland
    Sat 16 15:45
    FC2.6
    Free Communications 2: Bone, Growth Plate and Mineral Metabolism
    Expansion of the CrescNet Registry Achondroplasia Module: Real-World Demographic Data and Outcomes After up to 2 Years of Vosoritide Treatment
    Magdeburg, Germany
    14:55 - 15:55 
    Free Communications 3: Pituitary, Neuroendocrinology and Puberty (1)
    Hall 1
    Chairs: Bradley Miller (Minnesota, USA) & Rachel Reynaud (Marseille, France)
    Sat 16 14:55
    FC3.1
    Free Communications 3: Pituitary, Neuroendocrinology and Puberty (1)
    The Effects of Blue Light Exposure on the Epiphyseal Plate and IGF1 - IGFBP3 Expression in Rats
    Ankara, Turkey
    Sat 16 15:05
    FC3.2
    Free Communications 3: Pituitary, Neuroendocrinology and Puberty (1)
    Disruption of the Wnt-antagonist APC in the pituitary stem cells is a driver of adamantinomatous craniopharyngioma
    London, United Kingdom
    Sat 16 15:15
    FC3.3
    Free Communications 3: Pituitary, Neuroendocrinology and Puberty (1)
    Analysis of clinical factors affecting retinal ganglion cell complex thickness reduction in patients with childhood‑onset craniopharyngioma.
    Warsaw, Poland
    Sat 16 15:25
    FC3.4
    Free Communications 3: Pituitary, Neuroendocrinology and Puberty (1)
    The spectrum of Endocrinopathies in Children with Ectopic Posterior Pituitary (EPP) correlates with the severity of associated hypothalamo-pituitary abnormalities on imaging: a decade long experience from two tertiary centers.
    Basildon, United Kingdom
    Sat 16 15:35
    FC3.5
    Free Communications 3: Pituitary, Neuroendocrinology and Puberty (1)
    Screening for First Morning Voided (FMV) Urinary Gonadotropin (Gn) in Children with Normal and Precocious Puberty (PP): A Prospective, Multi-Center, Large-Sample based Study in China
    Wuhan, China
    Sat 16 15:45
    FC3.6
    Free Communications 3: Pituitary, Neuroendocrinology and Puberty (1)
    Adolescent Acne: Association to Sex, Age, Pubertal Stage and Circulating Concentrations of Testosterone and DHT
    Copenhagen, Denmark
    14:55 - 15:55 
    Free Communications 4: Adrenals and HPA Axis (1)
    Hall 2H
    Chairs: Evangelia Charmandari (London, UK) & Harshini Katugampola (London, UK)
    Sat 16 14:55
    FC4.1
    Free Communications 4: Adrenals and HPA Axis (1)
    Real world data analysis of contemporary therapy and its association to anthropometric outcomes in 1500 patients with congenital adrenal hyperplasia (CAH).
    Sheffield, United Kingdom
    Sat 16 15:05
    FC4.2
    Free Communications 4: Adrenals and HPA Axis (1)
    11-oxygenated androgens are abundantly produced by first and second-trimester foetal adrenal glands in ex vivo culture
    Birmingham, United Kingdom
    Sat 16 15:15
    FC4.3
    Free Communications 4: Adrenals and HPA Axis (1)
    Plasma reference values for C19 oxy-steroids, 11-keto testosterone and 11-keto androstenedione in a paediatric cohort
    Kiel, Germany
    Sat 16 15:25
    FC4.4
    Free Communications 4: Adrenals and HPA Axis (1)
    Crinecerfont, a Corticotropin-Releasing Factor Type 1 Receptor (CRF1) Antagonist, Reduced Excess Adrenal Androgens and Glucocorticoid Doses in Children and Adolescents with Classic Congenital Adrenal Hyperplasia: Results from CAHtalystTM Pediatric
    Minneapolis, United States
    Sat 16 15:35
    FC4.5
    Free Communications 4: Adrenals and HPA Axis (1)
    3D printed, personalized hydrocortisone for hypocortisolemia.
    Rotterdam, The Netherlands
    Sat 16 15:45
    FC4.6
    Free Communications 4: Adrenals and HPA Axis (1)
    Comparative Efficacy of Modified-Release versus Conventional Hydrocortisone Treatment in Adolescents and Young Adults with Congenital Adrenal Hyperplasia: A Retrospective Observational Study
    Agios Nikolaos, Greece
    14:55 - 15:55 
    Free Communications 5: Growth and Syndromes
    Hall 2G
    Chair: Assunta Albanese (London, United Kingdom) and Aneta Gawlik (Katowice, Poland)
    Sat 16 14:55
    FC5.1
    Free Communications 5: Growth and Syndromes
    A homozygous variant in ZSWIM6 causes short stature, microcephaly and developmental delay
    Prague, Czech Republic
    Sat 16 15:05
    FC5.2
    Free Communications 5: Growth and Syndromes
    The pathogenesis of Noonan syndrome and associated growth restriction is modulated by NOC2L, a novel interactor of LZTR1 leading to impaired p53 signalling
    London, United Kingdom
    Sat 16 15:15
    FC5.3
    Free Communications 5: Growth and Syndromes
    Gene expression of monosomy X during human development reveals potential mechanisms in Turner syndrome
    London, United Kingdom
    Sat 16 15:25
    FC5.4
    Free Communications 5: Growth and Syndromes
    Predictors of short stature at age 6-7 years in Israeli children
    Petach Tikva, Israel
    Sat 16 15:35
    FC5.5
    Free Communications 5: Growth and Syndromes
    Phase 2 Trial of Vosoritide Use in patients with Hypochondroplasia: Pharmacokinetic/ Pharmacodynamic analysis from 12 Month Data
    Washington DC, United States of America (USA)
    Sat 16 15:45
    FC5.6
    Free Communications 5: Growth and Syndromes
    First line treatment evaluation in patients with severe primary insulin-like growth factor 1 deficiency (SPIGFD): Data from the Global Increlex® Registry
    Linköping, Sweden
    14:25 - 15:55 
    How Do I...1
    Arena Plenary
    Chairs: Veronica Mericq (Santiago, Chile) & Jo Blair (Liverpool, UK)
    Sat 16 14:25
    HDI1.1
    How Do I...1
    How do I...Use Bisphosphonates
    Genoa, Italy
    Sat 16 14:55
    HDI1.2
    How Do I...1
    How do I...Handle GLP-1 analogue treatment in adolescents with obesity
    Salzburg, Austria
    Sat 16 15:25
    HDI1.3
    How Do I...1
    How do I...Manage the infant with hypoglycaemia
    Brussels, Belgium
    15:55 - 16:15 
    Coffee, Posters & Exhibition
    Exhibition Hall
    16:15 - 16:45 
    Plenary 2 - Addressing Inequalities in Child Health. Lessons from the UK policy experiments in poverty and adversity
    Arena Plenary
    Chairs: Rasha Hamza (Cairo, Egypt) & Poonam Dharmaraj (Liverpool, UK)
    Sat 16 16:15
    PL2
    Plenary 2 - Addressing Inequalities in Child Health. Lessons from the UK policy experiments in poverty and adversity
    Addressing Inequalities in Child Health. Lessons from the UK policy experiments in poverty and adversity
    Liverpool, UK
    16:55 - 17:40 
    Meet The Expert 1.1
    Hall 2G
    Sat 16 16:55
    MTE1.1
    Meet The Expert 1.1
    Genetic Testing in Hypogonadism
    Paris, France
    16:55 - 17:40 
    Meet The Expert 2.1
    Hall 2K
    Sat 16 16:55
    MTE2.1
    Meet The Expert 2.1
    Management of Lipodystrophy
    Cambridge, UK
    16:55 - 17:40 
    Meet The Expert 3.1
    Hall 2H
    Sat 16 16:55
    MTE3.1
    Meet The Expert 3.1
    Pharmacological treatment options for adolescents with Obesity
    Rotterdam, The Netherlands
    16:55 - 17:40 
    Meet The Expert 4.1
    Hall 2J
    Sat 16 16:55
    MTE4.1
    Meet The Expert 4.1
    Closed loop in the very young
    Luxembourg, Luxembourg
    16:55 - 17:55 
    Novel Advances
    Exhibition Hall C
    Chairs: Irene Netchine (Paris, France) & Rod Mitchell (Edinburgh, United Kingdom)
    Sat 16 16:55
    NA1
    Novel Advances
    Relevance of single cell analysis and spatial transcriptomics for endocrine research to unravel new mechanisms?
    London, UK
    17:50 - 19:20 
    Satellite Symposium 3
    For more information please see satellite programme
    Hall 1A
    17:50 - 19:20 
    Satellite Symposium 4
    For more information please see satellite programme
    Hall 1B
    17:50 - 19:20 
    Satellite Symposium 5
    For more information please see satellite programme
    Hall 1C

    07:15 - 19:30 
    Registration Open
    ACC Cityside Galleria
    08:00 - 08:30 
    Plenary 3 - Adipogenic Hits on Kids
    Arena Plenary
    Chairs: Annette Grüters-Kieslich (Berlin, Germany) & Agnès Linglart (Paris, France)
    Sun 17 08:00
    PL3
    Plenary 3 - Adipogenic Hits on Kids
    Adipogenic Hits on Kids
    Leipzig, Germany
    08:35 - 09:20 
    Meet The Expert 5.1
    Hall 2G
    Sun 17 08:35
    MTE5.1
    Meet The Expert 5.1
    Managing difficult menstrual periods
    London, UK
    08:35 - 09:20 
    Meet The Expert 6.1
    Hall 2K
    Sun 17 08:35
    MTE6.1
    Meet The Expert 6.1
    Management of sodium and water regulation disorders
    Leuven, Belgium
    08:35 - 09:20 
    Meet The Expert 7.1
    Hall 2H
    Sun 17 08:35
    MTE7.1
    Meet The Expert 7.1
    Diagnosis and Management of PCOS
    Tel Aviv, Israel
    08:35 - 09:20 
    Meet The Expert 8.1
    Hall 2J
    Sun 17 08:35
    MTE8.1
    Meet The Expert 8.1
    The Diagnosis & Management of Rickets in the 21st Century
    Dubai , UAE
    08:35 - 09:20 
    Meet The Expert 2.2
    Hall 1
    Sun 17 08:35
    MTE2.2
    Meet The Expert 2.2
    Management of Lipodystrophy
    Cambridge, UK
    08:30 - 09:30 
    Controvery: Should we restrict height in tall stature?
    Exhibition Hall C
    Chairs: Jan Maarten Wit (Leiden, the Netherlands) & Peter Simm (Melbourne, Australia)
    Sun 17 08:30
    C1.1
    Controvery: Should we restrict height in tall stature?
    Should we restrict height in tall stature? - FOR
    Stockholm, Sweden
    Sun 17 09:00
    C1.2
    Controvery: Should we restrict height in tall stature?
    Should we restrict height in tall stature? - AGAINST
    Pittsburgh, USA
    09:30 - 11:00 
    ESPE-ESE Joint Symposium
    Arena Plenary
    Chairs: Anita Hokken-Koelega (Rotterdam, The Netherlands) & Jérôme Bertherat (Paris, France)
    Sun 17 09:30
    ES1.1
    ESPE-ESE Joint Symposium
    Endocrine disrupting effects of over-the-counter mild analgesics such as paracetamol in humans
    Copenhagen, Denmark
    Sun 17 10:00
    ES1.2
    ESPE-ESE Joint Symposium
    Prenatal Exposure to Over-the-Counter Antifugal Drugs Affects Fetal Steroidogenesis and is Associated with Persistent Effects in Children
    Copenhagen, Denmark
    Sun 17 10:30
    ES1.3
    ESPE-ESE Joint Symposium
    Effect of EDCs on the hypothalamic regulation of energy homeostasis and GnRH activity
    Liège, Belgium
    09:30 - 10:00 
    Rapid Free Communications 6: Fat, Metabolism and Obesity (1)
    Hall 2G
    Chairs: Cosimo Gianini (Chieti, Italy) & Violeta Iotova (Varna, Bulgaria)
    Sun 17 09:30
    RFC6.1
    Rapid Free Communications 6: Fat, Metabolism and Obesity (1)
    Frequency of genetic variants in a population with early-onset obesity: a single center experience
    Naples, Italy
    Sun 17 09:35
    RFC6.2
    Rapid Free Communications 6: Fat, Metabolism and Obesity (1)
    Genetic Diagnostic Yield of Obesity
    Leipzig, Germany
    Sun 17 09:40
    RFC6.3
    Rapid Free Communications 6: Fat, Metabolism and Obesity (1)
    Identification and clinical characterization of new patients with novel monogenic agouti-like obesity trait
    Leipzig, Germany
    Sun 17 09:45
    RFC6.4
    Rapid Free Communications 6: Fat, Metabolism and Obesity (1)
    Investigation of GNAS Variations as Causes of Monogenic Obesity in Qatar: An Integrative Approach Utilizing In Silico, In Vivo, and In Vitro Studies
    Doha, Qatar
    Sun 17 09:50
    RFC6.5
    Rapid Free Communications 6: Fat, Metabolism and Obesity (1)
    GRB10 METHYLATION IN UMBILICAL CORD ASSOCIATES POSTNATALLY WITH OBESITY IN HEALTHY CHILDREN
    Girona, Spain
    Sun 17 09:55
    RFC6.6
    Rapid Free Communications 6: Fat, Metabolism and Obesity (1)
    POTENTIAL ROLE OF ASPG METHYLATION AS A BIOMARKER OF CHILDHOOD OBESITY
    Girona, Spain
    09:30 - 10:00 
    Rapid Free Communications 7: GH and IGFs
    Hall 2K
    Chairs: Maria Carolina Salerno (Naples, Italy) & TBC
    Sun 17 09:30
    RFC7.1
    Rapid Free Communications 7: GH and IGFs
    Understanding the molecular basis of short stature in Fanconi Anemia: Impact of pappalysins and stanniocalcins on IGF-I bioavailability
    Toledo, Spain
    Sun 17 09:35
    RFC7.2
    Rapid Free Communications 7: GH and IGFs
    Time-Restricted Feeding Restored Growth Hormone Pulsatile Profile in LEAP-2 KO Mice with High Fat Diet
    Jinan, China
    Sun 17 09:40
    RFC7.3
    Rapid Free Communications 7: GH and IGFs
    Incidence of false positive results of growth hormone stimulation tests in children with short stature – from theoretical background to clinical approach
    Lodz, Poland
    Sun 17 09:45
    RFC7.4
    Rapid Free Communications 7: GH and IGFs
    Use of iSYS-IDS IGF1-Assay Normative Data as a STANDARD in the Diagnosis of Pediatric Growth Hormone Deficiency
    ALGIERS, ALGERIA
    Sun 17 09:50
    RFC7.5
    Rapid Free Communications 7: GH and IGFs
    HEALTH-RELATED QUALITY OF LIFE AT MID-PUBERTY IN ADOLESCENTS WITH IDIOPATHIC ISOLATED GROWTH HORMONE DEFICIENCY
    Rotterdam, The Netherlands
    Sun 17 09:55
    RFC7.6
    Rapid Free Communications 7: GH and IGFs
    Big data as a strategy in the development of population auxological studies
    Vitoria, Spain
    09:30 - 10:00 
    Rapid Free Communications 8: Adrenals and HPA Axis (2)
    Hall 2H
    Chairs: Tülay Güran (Istanbul, Turkey) & Anna Nordenstrom (Solna, Sweden)
    Sun 17 09:30
    RFC8.1
    Rapid Free Communications 8: Adrenals and HPA Axis (2)
    PREDICT – A randomized investigation of a reduced prenatal dexamethasone dose to reduce virilization in female fetuses with congenital adrenal hyperplasia
    Berlin, Germany
    Sun 17 09:35
    RFC8.2
    Rapid Free Communications 8: Adrenals and HPA Axis (2)
    A Novel Peroxisomal Cause of Primary Adrenal İnsufficiency: Pseudo-neonatal Adrenoleukodystrophy Due to ACOX1 Mutations.
    Istanbul, Turkey
    Sun 17 09:40
    RFC8.3
    Rapid Free Communications 8: Adrenals and HPA Axis (2)
    Multi-hit Model of Primary Adrenal Insufficiency in CPOX mutations
    Istanbul, Turkey
    Sun 17 09:45
    RFC8.4
    Rapid Free Communications 8: Adrenals and HPA Axis (2)
    Rare Genetic Etiology of Primary Adrenal Insufficiency in Children; Clinical and Genetic Characterization Of a Large Sudanese Cohort
    Khartoum, Sudan
    Sun 17 09:50
    RFC8.5
    Rapid Free Communications 8: Adrenals and HPA Axis (2)
    Mitochondrial Nicotinamide Nucleotide Transidrogenase (NNT) and NNT-AS1 impairment is associated with worse outcomes in patients with adrenocortical tumors
    Ribeirão Preto, Brazil
    Sun 17 09:55
    RFC8.6
    Rapid Free Communications 8: Adrenals and HPA Axis (2)
    Prospective evaluation of urinary outcome after partial urogenital sinus mobilization (PUM) for toilet trained female patients with classic congenital adrenal hyperplasia (CAH).
    Cairo, Egypt
    Cairo, Egypt
    09:30 - 10:00 
    Rapid Free Communications 9: Sex Endocrinology and Gonads
    Hall 2J
    Chairs: Sabah Alvi (Leeds, United Kingdom) & Sabine Hannema (Amsterdam, The Netherlands)
    Sun 17 09:30
    RFC9.1
    Rapid Free Communications 9: Sex Endocrinology and Gonads
    Prenatal Steroid profiling in 46,XY Disorders of sexual Development (DSD) : A 10 year Retrospective Cohort study
    Bron, France
    Sun 17 09:35
    RFC9.2
    Rapid Free Communications 9: Sex Endocrinology and Gonads
    Effects of the modified release hydrocortisone preparation Efmody® on hormones, spermatogenesis and body weight in males with congenital adrenal hyperplasia
    St.Gallen, Switzerland
    Sun 17 09:40
    RFC9.3
    Rapid Free Communications 9: Sex Endocrinology and Gonads
    Nanoencapsulated Curcumin-Piperine Complex: A Breakthrough in Targeting CYP17A1 for Managing Androgen Excess in Adolescents with PCOS.
    Bern, Switzerland
    Sun 17 09:45
    RFC9.4
    Rapid Free Communications 9: Sex Endocrinology and Gonads
    Testicular function in prepubertal boys with haematological malignancies during and post chemotherapy: a prospective, longitudinal study
    Buenos Aires, Argentina
    Sun 17 09:50
    RFC9.5
    Rapid Free Communications 9: Sex Endocrinology and Gonads
    Reevaluating Guidelines for Primary Ovarian Insufficiency Workup: Is It Time for a Change?
    Ramat Gan, Israel
    Sun 17 09:55
    RFC9.6
    Rapid Free Communications 9: Sex Endocrinology and Gonads
    GnRHa TREATMENT OF CRYPTORCHIDISM ALTERS TESTICULAR SUMO GENE EXPRESSION
    Liestal, Switzerland
    09:30 - 10:00 
    Rapid Free Communications 10: Multisystem Endocrine Disorders
    Hall 1
    Chairs: Abdelhadi Habeb (Madinah, Saudi Arabia) & Leena Patel (Manchester, UK)
    Sun 17 09:30
    RFC10.1
    Rapid Free Communications 10: Multisystem Endocrine Disorders
    Long-Term Endocrine Outcomes of Acute Lymphoblastic Leukemia Treatment with Special Emphasis on the Gonadal Impact
    Istanbul, Turkey
    Sun 17 09:35
    RFC10.2
    Rapid Free Communications 10: Multisystem Endocrine Disorders
    Ten-year follow up for Children with non-lethal form of Raine Syndrome: Single Center Experience in Oman
    Muscat, Oman
    Sun 17 09:40
    RFC10.3
    Rapid Free Communications 10: Multisystem Endocrine Disorders
    Anthropometric changes in survivors of childhood acute lymphoblastic leukemia treated on the Italian Association of Pediatric Hematology and Oncology protocols without radiotherapy in the last two decades: preliminary data from an Italian tertiary center.
    MODENA, ITALY
    Sun 17 09:45
    RFC10.4
    Rapid Free Communications 10: Multisystem Endocrine Disorders
    Manifestation of PTEN and MUTYH gene mutations: A Case Report
    Kaunas, Lithuania
    Sun 17 09:50
    RFC10.5
    Rapid Free Communications 10: Multisystem Endocrine Disorders
    GAD-65 antibody positive autoimmune encephalitis with type III autoimmune polyendocrine syndrome: a rare pediatric case report
    Suzhou, China
    Sun 17 09:55
    RFC10.6
    Rapid Free Communications 10: Multisystem Endocrine Disorders
    Different Faces of Carney Complex: Report of Three Cases
    Istanbul, Turkey
    10:00 - 11:00 
    Free Communications 6: Fat, Metabolism and Obesity (1)
    Hall 2G
    Chairs: Cosimo Gianini (Chieti, Italy) & Violeta Iotova (Varna, Bulgaria)
    Sun 17 10:00
    FC6.1
    Free Communications 6: Fat, Metabolism and Obesity (1)
    Corneal Nerve Loss and regeneration after GLP-1 Therapy in Children with Simple and Monogenic Obesity
    Doha, Qatar
    Sun 17 10:10
    FC6.2
    Free Communications 6: Fat, Metabolism and Obesity (1)
    Frequency of Bardet-Biedl syndrome variants in a population with early-onset obesity
    Madrid, Spain
    Sun 17 10:20
    FC6.3
    Free Communications 6: Fat, Metabolism and Obesity (1)
    SPISE is more strongly correlated with cardiometabolic factors in adolescents with obesity than HOMA-IR, and is related to the amount of body weight reduction under lifestyle intervention
    Genoa, Italy
    Sun 17 10:30
    FC6.4
    Free Communications 6: Fat, Metabolism and Obesity (1)
    Relaxation of Food Control Parameters Based on Improvements in the Food Safe Zone Questionnaire Occurs with Reduction of Hyperphagia in Clinical Trials of Diazoxide Choline Extended Release (DCCR) in Participants with Prader-Willi Syndrome
    London, United Kingdom
    Sun 17 10:40
    FC6.5
    Free Communications 6: Fat, Metabolism and Obesity (1)
    FIRST CROSS SECTIONAL ANALYSIS OF THE ECLIP REGISTRY
    Ulm, Germany
    Sun 17 10:50
    FC6.6
    Free Communications 6: Fat, Metabolism and Obesity (1)
    Novel Melanocortin and Gut-peptide Dual Agonist for Obesity and Diabetes Treatment
    Seattle, USA
    10:00 - 11:00 
    Free Communications 7: GH and IGFs
    Hall 2K
    Chairs: Maria Carolina Salerno (Naples, Italy) & TBC
    Sun 17 10:00
    FC7.1
    Free Communications 7: GH and IGFs
    Clinical characteristics and response to growth hormone treatment in 27 children and adolescents with pathogenic NPR2 variants
    Rotterdam, The Netherlands
    Sun 17 10:10
    FC7.2
    Free Communications 7: GH and IGFs
    Stratifying genetic etiology in children born small for gestational age with persistent short stature (SGA-SS): 5-year growth hormone (GH) treatment outcomes in genetic subgroups
    Prague, Czech Republic
    Sun 17 10:20
    FC7.3
    Free Communications 7: GH and IGFs
    Growth hormone (GH) deficiency and subsequent replacement therapy trigger differential expression of specific miRNAs in males and females: not just a matter of height
    Parma, Italy
    Sun 17 10:30
    FC7.4
    Free Communications 7: GH and IGFs
    Growth Hormone Response to Glucagon Stimulation Test in Transitional Age
    Genova, Italy
    Sun 17 10:40
    FC7.5
    Free Communications 7: GH and IGFs
    Use of overnight GH sampling in the diagnosis of growth disorders in children: neuroimaging findings and response to treatment
    London, United Kingdom
    Sun 17 10:50
    FC7.6
    Free Communications 7: GH and IGFs
    Growth, IGF-1 and IGFBP-3 Responses to Oral LUM-201 in OraGrowtH210 and OraGrowtH212 Trials in Pediatric Growth Hormone Deficiency (PGHD) over 12 to 24 Months on Treatment
    Szczecin, Poland
    10:00 - 11:00 
    Free Communications 8: Adrenals and HPA Axis (2)
    Hall 2H
    Chairs: Tülay Güran (Istanbul, Turkey) & Anna Nordenstrom (Solna, Sweden)
    Sun 17 10:00
    FC8.1
    Free Communications 8: Adrenals and HPA Axis (2)
    Quantitative proteomics of pediatric adrenocortical tumors provides insights into zone of origin and identifies overrepresented pathways
    Augsburg, Germany
    Sun 17 10:10
    FC8.2
    Free Communications 8: Adrenals and HPA Axis (2)
    Detection and differentiation of adrenocortical tumors (ACTs) in children by gas chromatography-mass spectrometry (GC-MS) based urinary steroid metabotyping
    Giessen, Germany
    Sun 17 10:20
    FC8.3
    Free Communications 8: Adrenals and HPA Axis (2)
    Insight into the role of TXNRD2 in steroidogenesis through a novel homozygous TXNRD2 splice variant
    Brussels, Belgium
    Sun 17 10:30
    FC8.4
    Free Communications 8: Adrenals and HPA Axis (2)
    A deep intronic splice variant of CYP11B1 is the most common in Caucasian patients with 11-beta hydroxylase deficiency: functional, clinical and hormonal findings in 36 families
    Bron, France
    Sun 17 10:40
    FC8.5
    Free Communications 8: Adrenals and HPA Axis (2)
    Free cortisol and free 21-deoxycortisol in the clinical evaluation of adrenal insufficiency in congenital adrenal hyperplasia
    Nijmegen, Netherlands
    Sun 17 10:50
    FC8.6
    Free Communications 8: Adrenals and HPA Axis (2)
    Plasma concentrations of renin and ACTH in children and adolescents from the general population: new reference intervals according to sex, age, and pubertal stage
    Copenhagen, Denmark
    10:00 - 11:00 
    Free Communications 9: Sex Endocrinology and Gonads
    Hall 2J
    Chairs: Sabah Alvi (Leeds, United Kingdom) & Sabine Hannema (Amsterdam, The Netherlands)
    Sun 17 10:00
    FC9.1
    Free Communications 9: Sex Endocrinology and Gonads
    A tiered approach to exome sequencing analysis in early-onset Primary Ovarian Insufficiency
    London, United Kingdom
    Sun 17 10:10
    FC9.2
    Free Communications 9: Sex Endocrinology and Gonads
    Unveiling DHT-driven Androgen Receptor target genes in genital skin fibroblasts
    Kiel, Germany
    Sun 17 10:20
    FC9.3
    Free Communications 9: Sex Endocrinology and Gonads
    Prenatal exposure to paracetamol is associated with reduced uterine volume at infancy - A COPANA Cohort study of 302 healthy girls
    Copenhagen, Denmark
    Sun 17 10:30
    FC9.4
    Free Communications 9: Sex Endocrinology and Gonads
    Prenatal exposure to paracetamol is associated with smaller testis volume and decreased levels of steroid metabolites during infancy in healthy males: A COPANA cohort study of 287 boys
    Copenhagen, Denmark
    Sun 17 10:40
    FC9.5
    Free Communications 9: Sex Endocrinology and Gonads
    Sex hormones shape the skeleton: The impact of puberty suppression and gender affirming hormone therapy on skeletal dimensions in transgender individuals
    Amsterdam, The Netherlands
    Sun 17 10:50
    FC9.6
    Free Communications 9: Sex Endocrinology and Gonads
    The Gender Identity Questionnaire for Children: a useful tool for gender identity detection in early life
    Modena, Italy
    10:00 - 11:00 
    Free Communications 10: Multisystem Endocrine Disorders
    Hall 1
    Chairs: Abdelhadi Habeb (Madinah, Saudi Arabia) & Leena Patel (Manchester, UK)
    Sun 17 10:00
    FC10.1
    Free Communications 10: Multisystem Endocrine Disorders
    Genetic screening and tumour surveillance program outcomes in rare paediatric hereditary endocrine tumour syndromes
    London, United Kingdom
    Sun 17 10:10
    FC10.2
    Free Communications 10: Multisystem Endocrine Disorders
    Characterising the natural history of Multiple Endocrine Neoplasia 2B caused by M918TRET pathogenic variants in children and young people
    London, United Kingdom
    Sun 17 10:20
    FC10.3
    Free Communications 10: Multisystem Endocrine Disorders
    Endocrine disorders in a wide cohort of children and adolescents affected by Neurofibromatosis type 1
    Milan, Italy
    Sun 17 10:30
    FC10.4
    Free Communications 10: Multisystem Endocrine Disorders
    A novel de novo SAMD9 gene variant causing MIRAGE syndrome associated with steroid-resistant nephrotic syndrome in a 46,XY male.
    ATHENS, GREECE
    Sun 17 10:40
    FC10.5
    Free Communications 10: Multisystem Endocrine Disorders
    Using sno-lncRNAs as potential markers for Prader-Willi syndrome diagnosis
    Zhejiang, China
    Sun 17 10:50
    FC10.6
    Free Communications 10: Multisystem Endocrine Disorders
    Comprehensive analysis of disease spectrum and mortality in Sanjad-Sakati Syndrome: A Rare Disease Perspective
    Riyadh, Saudi Arabia
    11:00 - 11:30 
    Coffee, Posters & Exhibition
    Exhibition Hall
    11:30 - 12:00 
    Awards 2 - ESPE Research Award
    Arena Plenary
    Chair: Rasa Verkauskiene (Kaunas, Lithuania)
    12:00 - 12:30 
    Plenary 4 - The importance of chronobiology for medicine – when time matters
    Arena Plenary
    Chairs: Peter Kühnen (Berlin, Germany) & Martine Cools (Ghent, Belgium)
    Sun 17 12:00
    PL4
    Plenary 4 - The importance of chronobiology for medicine – when time matters
    The importance of chronobiology for medicine – when time matters
    Munich, Germany
    12:30 - 13:00 
    Awards 3
    Arena Plenary
    Sun 17
    Awards 3
    ESPE International Outstanding Clinician Award
    Rotterdam, The Netherlands
    Sun 17
    Awards 3
    Outstanding Clinician Award
    Rotterdam, The Netherlands
    Sun 17
    Awards 3
    ESPE Hormone Research in Paediatrics Prizes
    Rome, Italy
    Sun 17
    Awards 3
    IFCAH-ESPE Award
    Ghent, Belgium
    13:00 - 14:30 
    Lunch, Posters & Exhibition
    Exhibition Hall
    13:20 - 14:20 
    Satellite Symposium 6
    For more information please see satellite programme
    Exhibition Hall C
    13:20 - 14:20 
    Satellite Symposium 7
    For more information please see satellite programme
    Meeting Room 3
    14:30 - 16:00 
    Endo-ERN
    Meeting Room 3
    Sun 17 14:30
    Endo-ERN
    Introduction
    Lübeck, Germany
    Sun 17 14:35
    Endo-ERN
    Future of Registers for Rare Disease: the example E-REC
    Rotterdam, The Netherlands
    Sun 17 15:00
    Endo-ERN
    Genetic testing in rare forms of primary adrenal insufficiency
    Sun 17 15:30
    Endo-ERN
    The patient perspective on new treatment options (example hypogonadotropic hypogonadism)
    Hertfordshire, United Kingdom
    14:30 - 16:00 
    Symposium 5 - Adrenal Disorders
    Hall 2K
    Chairs: Svetlana Lajic (Solna, Sweden) & Li Chan (London, UK)
    Sun 17 14:30
    S5.1
    Symposium 5 - Adrenal Disorders
    Innovations in pharmacotherapy of CAH
    Michigan, USA
    Sun 17 15:00
    S5.2
    Symposium 5 - Adrenal Disorders
    Translational Clinical Applications of Complex Steroidobolome Data
    Giessen, Germany
    Sun 17 15:30
    S5.3
    Symposium 5 - Adrenal Disorders
    Lessons from CAH service evaluation and real world data
    Sheffield, UK
    14:30 - 16:00 
    Symposium 6 - Novel Insights into Pituitary Disorders
    Hall 1
    Chairs: Roland Pfaeffle (Leipzig, Germany) & Cécile Brachet (Brussels, Belgium)
    Sun 17 14:30
    S6.1
    Symposium 6 - Novel Insights into Pituitary Disorders
    Molecular Basis of Congenital Hypopituitarism
    Michigan, USA
    Sun 17 15:00
    S6.2
    Symposium 6 - Novel Insights into Pituitary Disorders
    New insights into Gonadotrope development
    London, UK
    Sun 17 15:30
    S6.3
    Symposium 6 - Novel Insights into Pituitary Disorders
    Management of pituitary stalk thickening in children and young people
    London, UK
    14:30 - 16:00 
    Symposium 7 - Future Hope for skeletal disorders
    Hall 2H
    Chairs: Moira Cheung (London, UK) & Ola Nilsson (Stockholm, Sweden)
    Sun 17 14:30
    S7.1
    Symposium 7 - Future Hope for skeletal disorders
    Stem cells in skeletal development and growth
    Texas, USA
    Sun 17 15:00
    S7.2
    Symposium 7 - Future Hope for skeletal disorders
    Genetic disorders of bone - historic perspectives and novel advances
    London, UK
    Sun 17 15:30
    S7.3
    Symposium 7 - Future Hope for skeletal disorders
    Consensus statement on management of achondroplasia
    Nesoddtangen, Norway
    14:30 - 16:00 
    Symposium 8 - Improving treatment strategies in Obesity
    Hall 2J
    Chairs: Christian Roth & Feyza Darendelier (Istanbul, Turkey)
    Sun 17 14:30
    S8.1
    Symposium 8 - Improving treatment strategies in Obesity
    Pharmacotherapy of Obesity

    Unknown speaker

    Liverpool, United Kingdom
    Sun 17 15:00
    S8.2
    Symposium 8 - Improving treatment strategies in Obesity
    Impact of adolescent obesity on adult morbidity and mortality
    Ramat Gan, Israel
    Sun 17 15:30
    S8.3
    Symposium 8 - Improving treatment strategies in Obesity
    Bariatic surgery: impact beyond weight
    Boston, USA
    14:30 - 15:30 
    Yearbook 2
    Hall 2G
    Chair: Christa Flück (Bern, Switzerland)
    Sun 17 14:30
    Yearbook 2
    Antenatal and Neonatal Endocrinology
    Montreal, Canada
    Sun 17 14:42
    Yearbook 2
    Oncology and Chronic Disease
    Rome, Italy
    Sun 17 14:54
    Yearbook 2
    Type 1 Diabetes
    Cambridge, UK
    Sun 17 15:06
    Yearbook 2
    Obesity and Weight Regulation
    Germany
    Sun 17 15:18
    Yearbook 2
    The Year in Science & Medicine
    Switzerland
    16:10 - 16:40 
    Plenary 5 - MKRN3 and the initiation of puberty
    Arena Plenary
    Chairs: Anders Juul (Copenhagen, Denmark) & Rasa Verkauskiene (Kaunas, Lithuania)
    Sun 17 16:10
    PL5
    Plenary 5 - MKRN3 and the initiation of puberty
    MKRN3 and the initiation of puberty
    Boston, USA
    16:40 - 17:00 
    Coffee, Posters & Exhibition
    Exhibition Hall
    17:00 - 18:30 
    Satellite Symposium 8
    For more information please see satellite programme
    Hall 1
    17:00 - 18:30 
    Satellite Symposium 9
    For more information please see satellite programme
    Exhibition Hall C
    18:30 - 19:45 
    ESPE Annual Business Meeting
    Arena Plenary

    07:15 - 18:30 
    Registration Opens
    ACC Cityside Galleria
    08:00 - 08:45 
    Meet the Expert 3.2
    Hall 2J
    Mon 18 08:00
    MTE3.2
    Meet the Expert 3.2
    Pharmacological treatment options for adolescents with Obesity
    Rotterdam, The Netherlands
    08:00 - 08:45 
    Meet The Expert 4.2
    Hall 2H
    Mon 18 08:00
    MTE4.2
    Meet The Expert 4.2
    Closed loop in the very young
    Luxembourg, Luxembourg
    08:00 - 08:45 
    Meet The Expert 5.2
    Hall 1
    Mon 18 08:00
    MTE 5.2
    Meet The Expert 5.2
    Managing difficult menstrual periods
    London, UK
    08:00 - 08:45 
    Meet The Expert 8.2
    Hall 2K
    Mon 18 08:00
    MTE8.2
    Meet The Expert 8.2
    The Diagnosis & Management of Rickets in the 21st Century
    Dubai , UAE
    08:00 - 09:00 
    Yearbook 3
    Hall 2G
    Chair: Ken Ong (Cambridge, UK)
    Mon 18 08:00
    Yearbook 3
    Bone, Growth Plate and Mineral Metabolism
    Mon 18 08:12
    Yearbook 3
    DSD and gender incongruence
    Istanbul, Turkey
    Mon 18 08:24
    Yearbook 3
    Thyroid
    Amsterdam, The Netherlands
    Mon 18 08:36
    Yearbook 3
    Pituitary and Neuroendocrinology
    London, UK
    Mon 18 08:48
    Yearbook 3
    Editors' Choice
    Cambridge, UK
    09:00 - 10:30 
    How Do I...2
    Arena Plenary
    Chairs: Justin Davies (Southampton, UK) & Reiko Horikawa (Tokyo, Japan)
    Mon 18 09:00
    HDI2.1
    How Do I...2
    How do I...Manage Fertility Preservation in Young People with Klinefelter syndrome?
    London, UK
    Mon 18 09:30
    HDI2.2
    How Do I...2
    How do I...Manage a child with Hypopituitarism
    Marseille, France
    Mon 18 10:00
    HDI2.3
    How Do I...2
    How do I...Diagnose and manage pre-diabetes
    Chieti, Italy
    09:00 - 09:30 
    Rapid Free Communications 11: Fat, Metabolism and Obesity (2)
    Hall 2G
    Chairs: Liz Crowne (Bristol, United Kingdom) & Anuja Natarajan (Doncaster, UK)
    Mon 18 09:00
    RFC11.1
    Rapid Free Communications 11: Fat, Metabolism and Obesity (2)
    Assessing how the Edmonton Obesity Staging System for Pediatrics (EOSS-P) in childhood relates to later cardiometabolic health compared to other anthropometric measures of obesity
    Montreal, Canada
    Mon 18 09:05
    RFC11.2
    Rapid Free Communications 11: Fat, Metabolism and Obesity (2)
    Is the Single Point Insulin Sensitivity Estimator (SPISE) index a reliable tool for children and adolescents with overweight/obesity?
    Genoa, Italy
    Mon 18 09:10
    RFC11.3
    Rapid Free Communications 11: Fat, Metabolism and Obesity (2)
    Ultrasound evaluation of kidney and liver involvement in Bardet-Biedl syndrome
    Essen, Germany
    Mon 18 09:15
    RFC11.4
    Rapid Free Communications 11: Fat, Metabolism and Obesity (2)
    Association of whole blood amino acid and acylcarnitine metabolome with anthropometry and IGF1 serum levels in healthy children and adolescents
    Leipzig, Germany
    Mon 18 09:20
    RFC11.5
    Rapid Free Communications 11: Fat, Metabolism and Obesity (2)
    Hepatic lipogenesis increases FGF21 in children/adolescents with obesity.
    Verona, Italy
    Mon 18 09:25
    RFC11.6
    Rapid Free Communications 11: Fat, Metabolism and Obesity (2)
    Pten knockout in osteoprogenitor cells leads to loss of adipose tissue
    Leipzig, Germany
    09:00 - 09:30 
    Rapid Free Communications 12: Thyroid
    Hall 2K
    Chairs: Marek Niedziela (Poznan, Poland) & Luisa De Sanctis (Turin, Italy)
    Mon 18 09:00
    RFC12.1
    Rapid Free Communications 12: Thyroid
    From neurology to endocrine: Misdiagnosed MCT8 deficiency
    Bursa, Turkey
    Mon 18 09:05
    RFC12.2
    Rapid Free Communications 12: Thyroid
    Prevalence and etiology of thyroid disorders and Characteristic of thyroid function tests in preterm infants
    Bangkok, Thailand
    Mon 18 09:10
    RFC12.3
    Rapid Free Communications 12: Thyroid
    Mechanisms and natural history of pituitary resistance to exogenous thyroxine in children with congenital hypothyroidism
    Baku, Azerbaijan
    Mon 18 09:15
    RFC12.4
    Rapid Free Communications 12: Thyroid
    Establishing Outcomes and Management of Mild Neonatal Hyperthyrotropinaemia, a Retrospective Multi-Centre Review
    Dublin, Ireland
    Mon 18 09:20
    RFC12.5
    Rapid Free Communications 12: Thyroid
    Use of the FT3/FT4 ratio as a predictor of relapse in autoimmune hyperthyroidism: retrospective study on a cohort of 80 pediatric patients
    Milan, Italy
    Milan , Italy
    Italy
    Mon 18 09:25
    RFC12.6
    Rapid Free Communications 12: Thyroid
    Evaluation of thyroid nodules in children and adolescents by shear wave elastography (SWE)
    Bialystok, Poland
    09:00 - 09:30 
    Rapid Free Communications 13: Pituitary, Neuroendocrinology and Puberty (2)
    Hall 2H
    Chairs: Anne-Simone Parent (Liego, Belgium) & Hoong-Wei Gan (London, UK)
    Mon 18 09:00
    RFC13.1
    Rapid Free Communications 13: Pituitary, Neuroendocrinology and Puberty (2)
    MRI-based radiomics of the pituitary gland is highly predictive of CentralPrecocious Puberty in girls: pilot study
    Parma, Italy
    Mon 18 09:05
    RFC13.2
    Rapid Free Communications 13: Pituitary, Neuroendocrinology and Puberty (2)
    Novel anatomical quantification of all hypothalamic, pituitary, and stalk components predicts the severity of neuroendocrine phenotypes.
    London, United Kingdom
    Mon 18 09:10
    RFC13.3
    Rapid Free Communications 13: Pituitary, Neuroendocrinology and Puberty (2)
    Unstimulated copeptin and oxytocin concentrations correlate with hypothalamic volumes and posterior pituitary location in congenital and acquired salt-water imbalance disorders.
    London, United Kingdom
    Mon 18 09:15
    RFC13.4
    Rapid Free Communications 13: Pituitary, Neuroendocrinology and Puberty (2)
    Investigation of Pituitary Function in Langerhans Cell Histiocytosis: A Comprehensive Analysis of Clinical and Radiological Findings
    Istanbul, Turkey
    Mon 18 09:20
    RFC13.5
    Rapid Free Communications 13: Pituitary, Neuroendocrinology and Puberty (2)
    The Development and Validation of Bone-age guided Interpretation of Puberty, a web-based tool for guidance of pubertal disorders
    Kanpur, India
    Mon 18 09:25
    RFC13.6
    Rapid Free Communications 13: Pituitary, Neuroendocrinology and Puberty (2)
    Hypogonadism hyperprolactinemia-related and its treatment in three patients with inherited disorders of biogenic amine metabolism
    Florence, Italy
    09:00 - 09:30 
    Rapid Free Communications 14: Fetal and Neonatal Endocrinology
    Hall 2J
    Chairs: Pratik Shah (London, UK) & Hussain Alsaffar (Wasit, Iraq)
    Mon 18 09:00
    RFC14.1
    Rapid Free Communications 14: Fetal and Neonatal Endocrinology
    The LIFE-MILCH project: preliminary data from the risk assessment model of exposure to Endocrine Disrupting Chemicals (EDCs) in mother-infant dyads during the first 3 months of life.
    Reggio Emilia, Italy
    Mon 18 09:05
    RFC14.2
    Rapid Free Communications 14: Fetal and Neonatal Endocrinology
    Does gestational diabetes mellitus influence mitochondrial dynamics in offspring?
    Istanbul, TURKEY
    Mon 18 09:10
    RFC14.3
    Rapid Free Communications 14: Fetal and Neonatal Endocrinology
    Complex Glycerol Kinase Deficiency: four new cases and a review of the literature
    Jinan, China
    Mon 18 09:15
    RFC14.4
    Rapid Free Communications 14: Fetal and Neonatal Endocrinology
    Neurodevelopmental response to nifedipine treatment in an infant with Congenital Hyperinsulinism due to de novo gain-of-function CACNA1D variant.
    Mumbai, India
    Mon 18 09:20
    RFC14.5
    Rapid Free Communications 14: Fetal and Neonatal Endocrinology
    The utility of ketones in screening for congenital hyperinsulinism: a retrospective evaluation.
    Manchester, United Kingdom
    Mon 18 09:25
    RFC14.6
    Rapid Free Communications 14: Fetal and Neonatal Endocrinology
    Utility of Continuous Glucose Monitoring in hospital monitoring of patients with Hyperinsulinism
    Manchester, United Kingdom
    09:00 - 09:30 
    Rapid Free Communications 15: Late Breaking
    Hall 1
    Chairs: Ritika Kapoor (London, United Kingdom) & Xiao Ping Luo (Shanghai, China)
    Mon 18 09:00
    RFC15.1
    Rapid Free Communications 15: Late Breaking
    Altered expression of epigenetic regulators is associated with high infertility risk in patients diagnosed with cryptorchidism.
    Liestal, Switzerland
    Mon 18 09:05
    RFC15.2
    Rapid Free Communications 15: Late Breaking
    Study on effects of poly- and perfluoroalkyl substances on hormones in girls with central precocious puberty
    Shanghai, China
    Mon 18 09:10
    RFC15.3
    Rapid Free Communications 15: Late Breaking
    The different faces of acquired hypothalamic dysfunction.
    Utrecht, Netherlands
    Mon 18 09:15
    RFC15.4
    Rapid Free Communications 15: Late Breaking
    Autoimmunity in children with type 1 diabetes in association with the COVID_19 pandemic - results from the prospective DPV Registry
    Bern, Switzerland
    Mon 18 09:20
    RFC15.5
    Rapid Free Communications 15: Late Breaking
    Prevalence and management of modifiable cardiovascular risk factors among adolescents and young adults with type 1 diabetes – a cross-sectional analysis from the Diabetes Prospective Follow-Up Registry DPV
    Duesseldorf, Germany
    Mon 18 09:25
    RFC15.6
    Rapid Free Communications 15: Late Breaking
    Macrophage switch and iron metabolism regulation by Burosumab in XLH pediatric patients: implications in inflammation and pain modulation.
    Naples, Italy
    09:30 - 10:30 
    Free Communications 11: Fat, Metabolism and Obesity (2)
    Hall 2G
    Chairs: Liz Crowne (Bristol, United Kingdom) & Anuja Natarajan (Doncaster, UK)
    Mon 18 09:30
    FC11.1
    Free Communications 11: Fat, Metabolism and Obesity (2)
    Frequency of rare syndromic diseases in a population with early-onset obesity
    Rome, Italy
    Mon 18 09:40
    FC11.2
    Free Communications 11: Fat, Metabolism and Obesity (2)
    Frequency of rare non-syndromic diseases in a population with early-onset obesity
    Madrid, Spain
    Mon 18 09:50
    FC11.3
    Free Communications 11: Fat, Metabolism and Obesity (2)
    Asprosin serum levels in subjects with Prader-Willi Syndrome: associations with hyperphagia, anthropometric, and metabolic parameters
    Bari, Italy
    Mon 18 10:00
    FC11.4
    Free Communications 11: Fat, Metabolism and Obesity (2)
    Long-term Efficacy Results of Diazoxide Choline Extended-Release (DCCR) Tablets in Participants with Prader-Willi Syndrome from the Completed C601 (DESTINY PWS) and C602 Open Label Extension (OLE) Studies
    London, UK
    Mon 18 10:10
    FC11.5
    Free Communications 11: Fat, Metabolism and Obesity (2)
    Complement 3 Alleviates Obesity Hypoventilation by Inhibiting Caspase-8/GSDME-Related Pyroptosis
    Jinan, China
    Jinan, China
    Jinan, China
    Mon 18 10:20
    FC11.6
    Free Communications 11: Fat, Metabolism and Obesity (2)
    Poly- and Perfluoroalkyl substances (PFAS) levels and breastfeeding have opposite associations with growth and body composition at age 3 years
    Rotterdam, The Netherlands
    09:30 - 10:30 
    Free Communications 12: Thyroid
    Hall 2K
    Chairs: Marek Niedziela (Poznan, Poland) & Luisa De Sanctis (Turin, Italy)
    Mon 18 09:30
    FC12.1
    Free Communications 12: Thyroid
    Use of targeted Next-Generation Sequencing panel in patients with non-autoimmune hypothyroidism: the experience of an Italian Pediatric Endocrinology Center
    Bologna, Italy
    Mon 18 09:40
    FC12.2
    Free Communications 12: Thyroid
    Molecular Characterization of Childhood Thyroid Nodules and Thyroid Cancer with DNA/RNA Next Generation Sequencing and Investigation of Phenotype-Genotype Correlation
    Ankara, Turkey
    Mon 18 09:50
    FC12.3
    Free Communications 12: Thyroid
    Usefulness of application novel TurboTM TSAb bioassay in the monitoring of pediatric Graves’ patients
    Białystok, Poland
    Mon 18 10:00
    FC12.4
    Free Communications 12: Thyroid
    Docosahexaenoic acid (DHA) is reduced and could be protective against Hashimoto’s thyroiditis in children with Down syndrome: a cross-sectional study
    Piacenza, Italy
    Mon 18 10:10
    FC12.5
    Free Communications 12: Thyroid
    The Association between Plasma Thyroxine Levels and Attention-Deficit/Hyperactivity Disorder
    Izmir, Turkey
    Mon 18 10:20
    FC12.6
    Free Communications 12: Thyroid
    The First Robust Bioavailability/Bioequivalence (BA/BE) Study of Thyromimetic Tiratricol, a Treatment in Development for MCT8 Deficiency.
    Stockport, UK
    09:30 - 10:30 
    Free Communications 13: Pituitary, Neuroendocrinology and Puberty (2)
    Hall 2H
    Chairs: Anne-Simone Parent (Liego, Belgium) & Hoong-Wei Gan (London, UK)
    Mon 18 09:30
    FC13.1
    Free Communications 13: Pituitary, Neuroendocrinology and Puberty (2)
    Defect in C-terminal alpha-amidation during Kisspeptin synthesis: a new mechanism of hypogonadotropic hypogonadism
    Paris, France
    Mon 18 09:40
    FC13.2
    Free Communications 13: Pituitary, Neuroendocrinology and Puberty (2)
    Copy Number Variation (CNV) in Self-limited Delayed Puberty (SLDP)
    London, UK
    Mon 18 09:50
    FC13.3
    Free Communications 13: Pituitary, Neuroendocrinology and Puberty (2)
    Effect of Precocious Puberty and GnRHa Treatment on Glucose Metabolism in Female Rats
    Guangzhou, China
    Mon 18 10:00
    FC13.4
    Free Communications 13: Pituitary, Neuroendocrinology and Puberty (2)
    Relationship between the timing of the physical changes of puberty and total pubertal growth in healthy adolescents: new insights which can provide helpful clinical guidance
    London, United Kingdom
    Mon 18 10:10
    FC13.5
    Free Communications 13: Pituitary, Neuroendocrinology and Puberty (2)
    Rising in body mass index during childhood in girls with idiopathic CPP : a 20-year experience in a tertiary Belgian centre.
    Brussels, Belgium
    Mon 18 10:20
    FC13.6
    Free Communications 13: Pituitary, Neuroendocrinology and Puberty (2)
    Voice frequency in healthy children and adolescents: A biomarker of androgen action in puberty
    Copenhagen, Denmark
    09:30 - 10:30 
    Free Communications 14: Fetal and Neonatal Endocrinology
    Hall 2J
    Chairs: Pratik Shah (London, UK) & Hussain Alsaffar (Wasit, Iraq)
    Mon 18 09:30
    FC14.1
    Free Communications 14: Fetal and Neonatal Endocrinology
    Non-invasive prenatal testing can detect maternally and paternally inherited variants in the KCNJ11 and ABCC8 genes: implications for clinical management of neonatal diabetes during pregnancy and beyond
    Exeter, United Kingdom
    Mon 18 09:40
    FC14.2
    Free Communications 14: Fetal and Neonatal Endocrinology
    Cord glucose: A normal reference and a potential of an ideal universal screening tool for pathological hyperinsulinism.
    Odense, Denmark
    Mon 18 09:50
    FC14.3
    Free Communications 14: Fetal and Neonatal Endocrinology
    Reduction of Overnight Hypoglycemia in Congenital Hyperinsulinism: Results from the RZ358-606 (RIZE) Study
    London, UK
    Mon 18 10:00
    FC14.4
    Free Communications 14: Fetal and Neonatal Endocrinology
    Efficacy and Safety across Subgroups in Children with Congenital Hyperinsulinism Treated with Dasiglucagon
    Manchester, UK
    Mon 18 10:10
    FC14.5
    Free Communications 14: Fetal and Neonatal Endocrinology
    A novel 94bp deletion in the SLC16A1 promoter causes fasting and exercise-induced hyperinsulinaemic hypoglycaemia
    Exeter, United Kingdom
    Mon 18 10:20
    FC14.6
    Free Communications 14: Fetal and Neonatal Endocrinology
    Patient and Carer Perspectives: A National Survey of Continuous Glucose Monitoring in Children with Congenital Hyperinsulinism in the UK
    Cambridge, United Kingdom
    09:30 - 10:30 
    Free Communications 15: Late Breaking
    Hall 1
    Chairs: Ritika Kapoor (London, United Kingdom) & Xiao Ping Luo (Shanghai, China)
    Mon 18 09:30
    FC15.1
    Free Communications 15: Late Breaking
    Response  to Daily and Weekly Recombinant Human Growth Hormone Treatment in Children Born Small for Gestational Age is Predicted More Accurately by Pre-treatment Blood Transcriptome than Clinical Variables
    Manchester, United Kingdom
    Mon 18 09:40
    FC15.2
    Free Communications 15: Late Breaking
    Amount and Pattern Of Pulsatile GH Secretion Induced By The Oral Growth Hormone Secretagogue LUM-201 Is Related To Growth And IGF-1 Responses In Moderate Pediatric Growth Hormone Deficiency (PGHD)
    Manchester, United Kingdom
    Mon 18 09:50
    FC15.3
    Free Communications 15: Late Breaking
    Assessment of actionable secondary genetic findings in a large cohort of children with short stature
    Sao Paulo, Brazil
    Mon 18 10:00
    FC15.4
    Free Communications 15: Late Breaking
    Oral infigratinib for children with achondroplasia: Month 18 results from the PROPEL 2 study demonstrate safety and durability of treatment effect on linear growth with improved body proportionality
    London, United Kingdom
    Mon 18 10:10
    FC15.5
    Free Communications 15: Late Breaking
    Presence of neuropathy in children and adolescents with type 1 diabetes evaluated with bedside modalities
    Herlev, Denmark
    Mon 18 10:20
    FC15.6
    Free Communications 15: Late Breaking
    Pharmacodynamic Endpoints After Once-Weekly Somapacitan in Children With GHD: 3-year results from REAL4 phase 3 study
    Minneapolis, USA
    10:30 - 11:00 
    Coffee, Posters & Exhibition
    Exhibition Hall
    11:00 - 11:30 
    Plenary 6 - Pancreatic and islet plasticity in early life: implications for diabetes risk
    Arena Plenary
    Chairs: Indi Banerjee (Manchester, UK) & Zdeněk Sumnik (Prague, Czechia)
    Mon 18 11:00
    PL6
    Plenary 6 - Pancreatic and islet plasticity in early life: implications for diabetes risk
    Pancreatic and islet plasticity in early life: implications for diabetes risk
    Tennessee, USA
    11:30 - 12:15 
    Awards 4
    Arena Plenary
    Chair: Anita Hokken-Koelega (Rotterdam, The Netherlands)
    Mon 18 11:30
    Awards 4
    Andrea Prader Prize
    Mon 18 12:00
    Awards 4
    ESPE International Award
    12:15 - 12:45 
    Plenary 7 - Genomics in Rare Diseases
    Arena Plenary
    Chairs: Martin Wabitsch (Ulm, Germany) & Senthil Senniappan (Liverpool, UK)
    Mon 18 17:05
    PL8
    Plenary 7 - Genomics in Rare Diseases
    Genomics in rare diseases
    Cambridge, UK
    12:45 - 14:15 
    Lunch, Posters & Exhibition
    Exhibition Hall
    13:05 - 14:05 
    Satellite Symposium 10
    For more information please see satellite programme
    Hall 1
    14:15 - 15:00 
    Meet The Expert 1.2
    Hall 2G
    Mon 18 14:15
    MTE1.2
    Meet The Expert 1.2
    Genetic Testing in Hypogonadism
    Paris, France
    14:15 - 15:00 
    Meet The Expert 6.2
    Hall 2K
    Mon 18 14:15
    MTE6.2
    Meet The Expert 6.2
    Management of sodium and water regulation disorders
    Leuven, Belgium
    14:15 - 15:00 
    Meet The Expert 7.2
    Hall 2H
    Mon 18 14:15
    MTE7.2
    Meet The Expert 7.2
    Diagnosis and Management of PCOS
    Tel Aviv, Israel
    14:15 - 15:15 
    Young Investigators Awards
    Exhibition Hall C
    Chair: Martine Cools (Ghent, Belgium)
    Mon 18
    Young Investigators Awards
    ESPE Young Investigator Awards
    Mon 18
    Young Investigators Awards
    Research Unit Lecture
    Mon 18
    Young Investigators Awards
    Research Fellowship Lecture
    15:10 - 15:30 
    Coffee, Posters & Exhibition
    Exhibition Hall
    15:30 - 17:00 
    Symposium 9 - Novel advances in paediatric thyroid disease
    Hall 2J
    Chairs: Paul Van Trotesenberg (Amsterdam, the Netherlands) & Malgorzata Wasniewska (Messina, Italy)
    Mon 18 15:30
    S9.1
    Symposium 9 - Novel advances in paediatric thyroid disease
    Challenges in congenital hypothyroidism: including genetics, newborn screening and treatment optimization
    Paris, France
    Mon 18 16:00
    S9.2
    Symposium 9 - Novel advances in paediatric thyroid disease
    Pediatric thyroid cancer guidelines: challenges in stratifying care based on limited data
    Philadelphia, USA
    Mon 18 16:30
    S9.3
    Symposium 9 - Novel advances in paediatric thyroid disease
    The pathophysiology of transient congenital hypothyroidism
    Cambridge, UK
    15:30 - 17:00 
    Symposium 10 - Challenges in the management of Prader Willi Syndrome
    Hall 2H
    Chairs: Evelien Gevers (London, UK) & Susanna Wiegand (Berlin, Germany)
    Mon 18 15:30
    S10.1
    Symposium 10 - Challenges in the management of Prader Willi Syndrome
    Hypothalamic dysfunction in PWS – research perspective
    London, UK
    Mon 18 16:00
    S10.2
    Symposium 10 - Challenges in the management of Prader Willi Syndrome
    Long-term management and outcomes in PWS
    Cambridge, UK
    Mon 18 16:30
    S10.3
    Symposium 10 - Challenges in the management of Prader Willi Syndrome
    Growth hormone treatment in adults with PWS
    Stockholm, Sweden
    15:30 - 17:00 
    Symposium 11 - Microbiota in type 1 diabetes
    Hall 2G
    Chairs: Francesco Chiarelli (Chieti, Italy) & Esko Wiltshire (Wellington, New Zealand)
    Mon 18 15:30
    S11.1
    Symposium 11 - Microbiota in type 1 diabetes
    Gut dysbiosis in type 1 diabetes
    Helsinki, Finland
    Mon 18 16:00
    S11.2
    Symposium 11 - Microbiota in type 1 diabetes
    MAIT cells, an immune link between microbiota and type 1 diabetes
    Paris, France
    Mon 18 16:30
    S11.3
    Symposium 11 - Microbiota in type 1 diabetes
    Diet and microbiota in type 1 diabetes
    Chicago, USA
    15:30 - 17:00 
    Symposium 12 - The impact of gonadotrophin dysregulation on neurocognition
    Hall 2K
    Chairs: Sasha Howard (London, UK) & Katharina Main (Copenhagen, Denmark)
    Mon 18 15:30
    S12.1
    Symposium 12 - The impact of gonadotrophin dysregulation on neurocognition
    The Role of MiniPuberty in Non-Reproductive Outcomes
    Lille, France
    Mon 18 16:00
    S12.2
    Symposium 12 - The impact of gonadotrophin dysregulation on neurocognition
    Neurodevelopmental syndromes associated with Centra Precocious Puberty
    São Paulo, Brazil
    Mon 18 16:30
    S12.3
    Symposium 12 - The impact of gonadotrophin dysregulation on neurocognition
    Studying the genetic interplay between GnRH deficiency and associated neurocognitive disorders by combining in silico, in vitro and in vivo tools.
    Milan, Italy
    17:05 - 17:35 
    Plenary 8 - Fat & Bone; where are we now?
    Hall 1
    Chairs: Anita Hokken-Koelega (Rotterdam, the Netherlands) & Stefano Cianfarani (Rome, Italy)
    Mon 18 12:15
    PL7
    Plenary 8 - Fat & Bone; where are we now?
    Fat & Bone: where are we now?
    Maine, USA
    17:35 - 17:55 
    ESPE Awards 5 - ESPE Meeting Host Poster Awards
    Hall 1
    Chair: Mehul Dattani (London, United Kingdom)
    17:55 - 18:10 
    Closing Ceremony
    Hall 1
Claude	Marcus
Stockholm, Sweden
Sat 16 09:20
ESPE Working Group on Obesity
Childhood obesity in 2024 - shortlist of highlights
Stockholm, Sweden
Kate	Davies
Sat 16 08:00
ESPE Working Group - Nurse
Research and innovation in nursing
Loredana	Marcovecchio
Cambridge, UK
Sat 16 12:25
S4.3
Symposium 4 - New Adjuvant Therapy in Pediatric Diabetes (ISPAD/ESPE)
Statins and Cardiovascular risk in T1D
Cambridge, UK
Sun 17 14:54
Yearbook 2
Type 1 Diabetes
Cambridge, UK
Antje	Körner
Leipzig, Germany
Sun 17 08:00
PL3
Plenary 3 - Adipogenic Hits on Kids
Adipogenic Hits on Kids
Leipzig, Germany
Lars	Sävendahl
Stockholm, Sweden
Sun 17 08:30
C1.1
Controvery: Should we restrict height in tall stature?
Should we restrict height in tall stature? - FOR
Stockholm, Sweden
Loredana	Marcovecchio
Cambridge, UK
Sat 16 12:25
S4.3
Symposium 4 - New Adjuvant Therapy in Pediatric Diabetes (ISPAD/ESPE)
Statins and Cardiovascular risk in T1D
Cambridge, UK
Sun 17 14:54
Yearbook 2
Type 1 Diabetes
Cambridge, UK
Ursula	Kaiser
Boston, USA
Sun 17 16:10
PL5
Plenary 5 - MKRN3 and the initiation of puberty
MKRN3 and the initiation of puberty
Boston, USA
Ken	Ong
Cambridge, UK
Mon 18 08:48
Yearbook 3
Editors' Choice
Cambridge, UK
Robert  Stein
Leipzig, Germany
Sat 16 14:40
RFC1.4
Rapid Free Communications 1: Diabetes and Insulin
Children born small for gestational age (SGA) under growth hormone treatment have similarly impaired glucose-insulin metabolism as children with obesity
Leipzig, Germany
Vibha  Yadav
kanpur, India
Sat 16 14:30
RFC5.2
Rapid Free Communications 5: Growth and Syndromes
The development and validation of Bone age-guided Interpretation of Growth (BIG), a web-based tool for the guidance of evaluation of children and adolescents with growth disorders.
kanpur, India
Irina A Bacila
Sheffield, United Kingdom
Sat 16 14:55
FC4.1
Free Communications 4: Adrenals and HPA Axis (1)
Real world data analysis of contemporary therapy and its association to anthropometric outcomes in 1500 patients with congenital adrenal hyperplasia (CAH).
Sheffield, United Kingdom
Stine A Holmboe
Copenhagen, Denmark
Sat 16 15:45
FC3.6
Free Communications 3: Pituitary, Neuroendocrinology and Puberty (1)
Adolescent Acne: Association to Sex, Age, Pubertal Stage and Circulating Concentrations of Testosterone and DHT
Copenhagen, Denmark
Stefan A Wudy
Giessen, Germany
Sun 17 10:10
FC8.2
Free Communications 8: Adrenals and HPA Axis (2)
Detection and differentiation of adrenocortical tumors (ACTs) in children by gas chromatography-mass spectrometry (GC-MS) based urinary steroid metabotyping
Giessen, Germany
Saygin Abali
Istanbul, TURKEY
Mon 18 09:05
RFC14.2
Rapid Free Communications 14: Fetal and Neonatal Endocrinology
Does gestational diabetes mellitus influence mitochondrial dynamics in offspring?
Istanbul, TURKEY
Marco Abbate
Milan, Italy
Mon 18 09:20
RFC12.5
Rapid Free Communications 12: Thyroid
Use of the FT3/FT4 ratio as a predictor of relapse in autoimmune hyperthyroidism: retrospective study on a cohort of 80 pediatric patients
Milan, Italy
Milan , Italy
Italy
Yasmine Abdelmeguid
Alexandria, Egypt
Sat 16 14:30
RFC1.2
Rapid Free Communications 1: Diabetes and Insulin
Evaluating Glucose-6-Phosphate Dehydrogenase Enzyme Activity In Children With Type 1 Diabetes Mellitus.
Alexandria, Egypt
Alexandria, Egypt
John Acherman
Sun 17 15:00
Endo-ERN
Genetic testing in rare forms of primary adrenal insufficiency
Julie Agner Damm
Herlev, Denmark
Mon 18 10:10
FC15.5
Free Communications 15: Late Breaking
Presence of neuropathy in children and adolescents with type 1 diabetes evaluated with bedside modalities
Herlev, Denmark
Hanan AL Azkawi
Muscat, Oman
Sun 17 09:35
RFC10.2
Rapid Free Communications 10: Multisystem Endocrine Disorders
Ten-year follow up for Children with non-lethal form of Raine Syndrome: Single Center Experience in Oman
Muscat, Oman
Tara Al-Barazenji
Doha, Qatar
Sun 17 09:45
RFC6.4
Rapid Free Communications 6: Fat, Metabolism and Obesity (1)
Investigation of GNAS Variations as Causes of Monogenic Obesity in Qatar: An Integrative Approach Utilizing In Silico, In Vivo, and In Vitro Studies
Doha, Qatar
Yasmin Al-Sayed
London, UK
Mon 18 09:40
FC13.2
Free Communications 13: Pituitary, Neuroendocrinology and Puberty (2)
Copy Number Variation (CNV) in Self-limited Delayed Puberty (SLDP)
London, UK
Angham Almutair
Riyadh, Saudi Arabia
Sun 17 10:50
FC10.6
Free Communications 10: Multisystem Endocrine Disorders
Comprehensive analysis of disease spectrum and mortality in Sanjad-Sakati Syndrome: A Rare Disease Perspective
Riyadh, Saudi Arabia
Ilayda Altun
Istanbul, Turkey
Sun 17 09:55
RFC10.6
Rapid Free Communications 10: Multisystem Endocrine Disorders
Different Faces of Carney Complex: Report of Three Cases
Istanbul, Turkey
Richard Anderson
Edinburgh, UK
Sat 16 09:00
ESPE Working Group on Paediatric and Adolescent Gynaecology
Fertility preservation in girls
Edinburgh, UK
Alessia Angelelli
Genova, Italy
Sat 16 14:25
RFC2.1
Rapid Free Communications 2: Bone, Growth Plate and Mineral Metabolism
Bone and Body Composition after one year of Vosorotide treatment in children with Achondroplasia: a longitudinal prospective study.
Genova, Italy
Huseyin Anil Korkmaz
Izmir, Turkey
Mon 18 10:10
FC12.5
Free Communications 12: Thyroid
The Association between Plasma Thyroxine Levels and Attention-Deficit/Hyperactivity Disorder
Izmir, Turkey
Shenali Anne Amaratunga
Prague, Czech Republic
Sat 16 14:55
FC5.1
Free Communications 5: Growth and Syndromes
A homozygous variant in ZSWIM6 causes short stature, microcephaly and developmental delay
Prague, Czech Republic
Noha Arafa
Cairo, Egypt
Sun 17 09:55
RFC8.6
Rapid Free Communications 8: Adrenals and HPA Axis (2)
Prospective evaluation of urinary outcome after partial urogenital sinus mobilization (PUM) for toilet trained female patients with classic congenital adrenal hyperplasia (CAH).
Cairo, Egypt
Cairo, Egypt
Jesús Argente
Madrid, Spain
Sat 16 11:55
S3.2
Symposium 3 - Novel Advances and Treatments of Hypothalamic disease
Use of MC4R agonist in hypothalamic obesity
Madrid, Spain
Jesús Argente
Madrid, Spain
Sun 17 10:10
FC6.2
Free Communications 6: Fat, Metabolism and Obesity (1)
Frequency of Bardet-Biedl syndrome variants in a population with early-onset obesity
Madrid, Spain
Mon 18 09:40
FC11.2
Free Communications 11: Fat, Metabolism and Obesity (2)
Frequency of rare non-syndromic diseases in a population with early-onset obesity
Madrid, Spain
Mohamed Ahmed Ateya
Cairo, Egypt
Sun 17 09:55
RFC8.6
Rapid Free Communications 8: Adrenals and HPA Axis (2)
Prospective evaluation of urinary outcome after partial urogenital sinus mobilization (PUM) for toilet trained female patients with classic congenital adrenal hyperplasia (CAH).
Cairo, Egypt
Cairo, Egypt
Richard Auchus
Michigan, USA
Sun 17 14:30
S5.1
Symposium 5 - Adrenal Disorders
Innovations in pharmacotherapy of CAH
Michigan, USA
Sejad Ayyoubi
Rotterdam, The Netherlands
Sat 16 15:35
FC4.5
Free Communications 4: Adrenals and HPA Axis (1)
3D printed, personalized hydrocortisone for hypocortisolemia.
Rotterdam, The Netherlands
Philippe Backeljauw
Cincinnati, USA
Sat 16 08:20
ESPE Working Group on Turner Syndrome
Beyond growth and puberty issues in girls with TS
Cincinnati, USA
Chamila Balagamage
Birmingham, UK
Sat 16
ESPE Working Group on DSD/Differences in Sex Development
Partial gonadal dysgenesis due to chromosomal mosaicism – a challenging case
Birmingham, UK
Indraneel Banerjee
Manchester, UK
Mon 18 10:00
FC14.4
Free Communications 14: Fetal and Neonatal Endocrinology
Efficacy and Safety across Subgroups in Children with Congenital Hyperinsulinism Treated with Dasiglucagon
Manchester, UK
Peter  Bang
Linköping, Sweden
Sat 16 15:45
FC5.6
Free Communications 5: Growth and Syndromes
First line treatment evaluation in patients with severe primary insulin-like growth factor 1 deficiency (SPIGFD): Data from the Global Increlex® Registry
Linköping, Sweden
Andrew Bauer
Philadelphia, USA
Mon 18 16:00
S9.2
Symposium 9 - Novel advances in paediatric thyroid disease
Pediatric thyroid cancer guidelines: challenges in stratifying care based on limited data
Philadelphia, USA
Valentina Bianco
Parma, Italy
Sun 17 10:20
FC7.3
Free Communications 7: GH and IGFs
Growth hormone (GH) deficiency and subsequent replacement therapy trigger differential expression of specific miRNAs in males and females: not just a matter of height
Parma, Italy
Margit Bistrup Fischer
Copenhagen, Denmark
Sun 17 10:20
FC9.3
Free Communications 9: Sex Endocrinology and Gonads
Prenatal exposure to paracetamol is associated with reduced uterine volume at infancy - A COPANA Cohort study of 302 healthy girls
Copenhagen, Denmark
Professor Carla Bizzarri
Rome, Italy
Sun 17 14:42
Yearbook 2
Oncology and Chronic Disease
Rome, Italy
James Blackburn
London, United Kingdom
Sat 16 15:05
FC3.2
Free Communications 3: Pituitary, Neuroendocrinology and Puberty (1)
Disruption of the Wnt-antagonist APC in the pituitary stem cells is a driver of adamantinomatous craniopharyngioma
London, United Kingdom
Emma Blackburn
Montreal, Canada
Mon 18 09:00
RFC11.1
Rapid Free Communications 11: Fat, Metabolism and Obesity (2)
Assessing how the Edmonton Obesity Staging System for Pediatrics (EOSS-P) in childhood relates to later cardiometabolic health compared to other anthropometric measures of obesity
Montreal, Canada
Elena  Bochukova
London, UK
Mon 18 15:30
S10.1
Symposium 10 - Challenges in the management of Prader Willi Syndrome
Hypothalamic dysfunction in PWS – research perspective
London, UK
Detlef  Bockenhauer
Leuven, Belgium
Sun 17 08:35
MTE6.1
Meet The Expert 6.1
Management of sodium and water regulation disorders
Leuven, Belgium
Mon 18 14:15
MTE6.2
Meet The Expert 6.2
Management of sodium and water regulation disorders
Leuven, Belgium
Claudia Boettcher
Bern, Switzerland
Mon 18 09:15
RFC15.4
Rapid Free Communications 15: Late Breaking
Autoimmunity in children with type 1 diabetes in association with the COVID_19 pandemic - results from the prospective DPV Registry
Bern, Switzerland
Agnieszka Bogusz-Wójcik
Warsaw, Poland
Sat 16 15:15
FC3.3
Free Communications 3: Pituitary, Neuroendocrinology and Puberty (1)
Analysis of clinical factors affecting retinal ganglion cell complex thickness reduction in patients with childhood‑onset craniopharyngioma.
Warsaw, Poland
Lidewij Boogers
Amsterdam, The Netherlands
Sun 17 10:40
FC9.5
Free Communications 9: Sex Endocrinology and Gonads
Sex hormones shape the skeleton: The impact of puberty suppression and gender affirming hormone therapy on skeletal dimensions in transgender individuals
Amsterdam, The Netherlands
Elisa Bortolamedi
Bologna, Italy
Mon 18 09:30
FC12.1
Free Communications 12: Thyroid
Use of targeted Next-Generation Sequencing panel in patients with non-autoimmune hypothyroidism: the experience of an Italian Pediatric Endocrinology Center
Bologna, Italy
Hanna Borysewicz-Sańczyk
Bialystok, Poland
Mon 18 09:25
RFC12.6
Rapid Free Communications 12: Thyroid
Evaluation of thyroid nodules in children and adolescents by shear wave elastography (SWE)
Bialystok, Poland
Artur Bossowski
Białystok, Poland
Mon 18 09:50
FC12.3
Free Communications 12: Thyroid
Usefulness of application novel TurboTM TSAb bioassay in the monitoring of pediatric Graves’ patients
Białystok, Poland
Dania Bouzigh
Bron, France
Sun 17 09:30
RFC9.1
Rapid Free Communications 9: Sex Endocrinology and Gonads
Prenatal Steroid profiling in 46,XY Disorders of sexual Development (DSD) : A 10 year Retrospective Cohort study
Bron, France
Pamela Bowman
Exeter, United Kingdom
Mon 18 09:30
FC14.1
Free Communications 14: Fetal and Neonatal Endocrinology
Non-invasive prenatal testing can detect maternally and paternally inherited variants in the KCNJ11 and ABCC8 genes: implications for clinical management of neonatal diabetes during pregnancy and beyond
Exeter, United Kingdom
Cecile Brachet
Brussels, Belgium
Sun 17 10:20
FC8.3
Free Communications 8: Adrenals and HPA Axis (2)
Insight into the role of TXNRD2 in steroidogenesis through a novel homozygous TXNRD2 splice variant
Brussels, Belgium
Nicola Bridges
London, United Kingdom
Sun 17 10:30
FC6.4
Free Communications 6: Fat, Metabolism and Obesity (1)
Relaxation of Food Control Parameters Based on Improvements in the Food Safe Zone Questionnaire Occurs with Reduction of Hyperphagia in Clinical Trials of Diazoxide Choline Extended Release (DCCR) in Participants with Prader-Willi Syndrome
London, United Kingdom
Patrizia Bruzzi
MODENA, ITALY
Sun 17 09:40
RFC10.3
Rapid Free Communications 10: Multisystem Endocrine Disorders
Anthropometric changes in survivors of childhood acute lymphoblastic leukemia treated on the Italian Association of Pediatric Hematology and Oncology protocols without radiotherapy in the last two decades: preliminary data from an Italian tertiary center.
MODENA, ITALY
Olivia Buckingham-Woodhouse
Liverpool, United Kingdom
Sat 16 14:40
RFC4.4
Rapid Free Communications 4: Adrenals and HPA Axis (1)
Serum cortisol correlates strongly with salivary cortisol and cortisone in girls and boys, and across all ages
Liverpool, United Kingdom
Jimena C. Lopez Dacal
Buenos Aires, Argentina
Sun 17 09:45
RFC9.4
Rapid Free Communications 9: Sex Endocrinology and Gonads
Testicular function in prepubertal boys with haematological malignancies during and post chemotherapy: a prospective, longitudinal study
Buenos Aires, Argentina
Sally Camper
Michigan, USA
Sun 17 14:30
S6.1
Symposium 6 - Novel Insights into Pituitary Disorders
Molecular Basis of Congenital Hypopituitarism
Michigan, USA
Giuseppe Cannalire
Piacenza, Italy
Mon 18 10:00
FC12.4
Free Communications 12: Thyroid
Docosahexaenoic acid (DHA) is reduced and could be protective against Hashimoto’s thyroiditis in children with Down syndrome: a cross-sectional study
Piacenza, Italy
Raissa Carneiro Rezende
Sao Paulo, Brazil
Mon 18 09:50
FC15.3
Free Communications 15: Late Breaking
Assessment of actionable secondary genetic findings in a large cohort of children with short stature
Sao Paulo, Brazil
Manuela Cerbone
London, UK
Sun 17 15:30
S6.3
Symposium 6 - Novel Insights into Pituitary Disorders
Management of pituitary stalk thickening in children and young people
London, UK
Manuela Cerbone
London, United Kingdom
Mon 18 09:05
RFC13.2
Rapid Free Communications 13: Pituitary, Neuroendocrinology and Puberty (2)
Novel anatomical quantification of all hypothalamic, pituitary, and stalk components predicts the severity of neuroendocrine phenotypes.
London, United Kingdom
Mon 18 09:10
RFC13.3
Rapid Free Communications 13: Pituitary, Neuroendocrinology and Puberty (2)
Unstimulated copeptin and oxytocin concentrations correlate with hypothalamic volumes and posterior pituitary location in congenital and acquired salt-water imbalance disorders.
London, United Kingdom
Metin Cetiner
Essen, Germany
Mon 18 09:10
RFC11.3
Rapid Free Communications 11: Fat, Metabolism and Obesity (2)
Ultrasound evaluation of kidney and liver involvement in Bardet-Biedl syndrome
Essen, Germany
Konstantina  Chachlaki
Lille, France
Mon 18 15:30
S12.1
Symposium 12 - The impact of gonadotrophin dysregulation on neurocognition
The Role of MiniPuberty in Non-Reproductive Outcomes
Lille, France
Andrei Chagin
Solna, Sweden
Sat 16 08:10
ESPE Working Group on Bone and Growth Plate
Regulation of the Epiphyseal Stem Cells
Solna, Sweden
Professor Evangelia Charmandari
Athens, Greece
Sat 16 12:13
Yearbook 1
Adrenals
Athens, Greece
Diane Chen
Chicago, USA
Sat 16 08:30
ESPE Working Group on Gender Incongruence
Mental health/psychosocial outcomes versus mental health and brain effects
Chicago, USA
Yao Chen
Shanghai, China
Sat 16 14:45
RFC2.5
Rapid Free Communications 2: Bone, Growth Plate and Mineral Metabolism
Prediction of residual growth potential in adolescent boys by linear regression modeling based on the radiomics features extracted by knee DR images and clinical characteristics
Shanghai, China
Shanghai, China
Shanghai, China
Shanghai, China
Qingqing Chen
Hangzhou, China
Sat 16 15:15
FC2.3
Free Communications 2: Bone, Growth Plate and Mineral Metabolism
Molecular mechanism of FBN1 variants result to acromicric dysplasia by mechano-transduction
Hangzhou, China
Qiuli Chen
Guangzhou, China
Mon 18 09:50
FC13.3
Free Communications 13: Pituitary, Neuroendocrinology and Puberty (2)
Effect of Precocious Puberty and GnRHa Treatment on Glucose Metabolism in Female Rats
Guangzhou, China
Alexander Chervonsky
Chicago, USA
Mon 18 16:30
S11.3
Symposium 11 - Microbiota in type 1 diabetes
Diet and microbiota in type 1 diabetes
Chicago, USA
Mariangela Chiarito
Bari, Italy
Mon 18 09:50
FC11.3
Free Communications 11: Fat, Metabolism and Obesity (2)
Asprosin serum levels in subjects with Prader-Willi Syndrome: associations with hyperphagia, anthropometric, and metabolic parameters
Bari, Italy
Silvia Ciancia
Ghent, Belgium
Sat 16 09:00
ESPE Working Group on Gender Incongruence
CORE ENDOCRINE REGISTRY: transgender module – preliminary data and future plans
Ghent, Belgium
Professor  Stefano Cianfarani
Rome, Italy
Sun 17
Awards 3
ESPE Hormone Research in Paediatrics Prizes
Rome, Italy
Miriam Cnop
Ixelles, Belgium
Sat 16 11:55
S4.2
Symposium 4 - New Adjuvant Therapy in Pediatric Diabetes (ISPAD/ESPE)
Use of GLP1 receptor agonists in Wolfram syndrome
Ixelles, Belgium
Valentina Collini
Milan, Italy
Sun 17 10:20
FC10.3
Free Communications 10: Multisystem Endocrine Disorders
Endocrine disorders in a wide cohort of children and adolescents affected by Neurofibromatosis type 1
Milan, Italy
Martine Cools
Ghent, Belgium
Sat 16
ESPE Working Group on DSD/Differences in Sex Development
Pathophysiology and Management of Dysgenetic Gonads
Ghent, Belgium
Sun 17
Awards 3
IFCAH-ESPE Award
Ghent, Belgium
Beatriz Corredor
Toledo, Spain
Sun 17 09:30
RFC7.1
Rapid Free Communications 7: GH and IGFs
Understanding the molecular basis of short stature in Fanconi Anemia: Impact of pappalysins and stanniocalcins on IGF-I bioavailability
Toledo, Spain
Helen Couch
Cambridge, United Kingdom
Mon 18 10:20
FC14.6
Free Communications 14: Fetal and Neonatal Endocrinology
Patient and Carer Perspectives: A National Survey of Continuous Glucose Monitoring in Children with Congenital Hyperinsulinism in the UK
Cambridge, United Kingdom
Jessica Craig
Liverpool, UK
Sat 16 14:25
RFC4.1
Rapid Free Communications 4: Adrenals and HPA Axis (1)
Screening for Adrenal Insufficiency in Children by Home Waking Salivary Cortisone testing
Liverpool, UK
Giuseppe d'Annunzio
Genoa, Italy
Mon 18 09:05
RFC11.2
Rapid Free Communications 11: Fat, Metabolism and Obesity (2)
Is the Single Point Insulin Sensitivity Estimator (SPISE) index a reliable tool for children and adolescents with overweight/obesity?
Genoa, Italy
Antonia Dastamani
London, UK
Mon 18 09:50
FC14.3
Free Communications 14: Fetal and Neonatal Endocrinology
Reduction of Overnight Hypoglycemia in Congenital Hyperinsulinism: Results from the RZ358-606 (RIZE) Study
London, UK
Carine de Beaufort
Luxembourg, Luxembourg
Sat 16 16:55
MTE4.1
Meet The Expert 4.1
Closed loop in the very young
Luxembourg, Luxembourg
Mon 18 08:00
MTE4.2
Meet The Expert 4.2
Closed loop in the very young
Luxembourg, Luxembourg
Nicolas de Roux
Paris, France
Mon 18 09:30
FC13.1
Free Communications 13: Pituitary, Neuroendocrinology and Puberty (2)
Defect in C-terminal alpha-amidation during Kisspeptin synthesis: a new mechanism of hypogonadotropic hypogonadism
Paris, France
Shamani De Silva
Manchester, United Kingdom
Mon 18 09:25
RFC14.6
Rapid Free Communications 14: Fetal and Neonatal Endocrinology
Utility of Continuous Glucose Monitoring in hospital monitoring of patients with Hyperinsulinism
Manchester, United Kingdom
Cheri Deal, MD, PhD
Montreal, Canada
Sun 17 14:30
Yearbook 2
Antenatal and Neonatal Endocrinology
Montreal, Canada
Yasemin Denkboy Öngen
Bursa, Turkey
Mon 18 09:00
RFC12.1
Rapid Free Communications 12: Thyroid
From neurology to endocrine: Misdiagnosed MCT8 deficiency
Bursa, Turkey
Reyhan Deveci Sevim
Aydın, Turkey
Sat 16 14:45
RFC1.5
Rapid Free Communications 1: Diabetes and Insulin
Evaluation of Arterial Stiffness in Children with Type 1 Diabetes Mellitus Using Speckle Tracking Carotid Strain Ultrasonography: Do Atherosclerotic Changes Begin in Childhood?
Aydın, Turkey
Natasha Di Iorgi
Genoa, Italy
Sat 16 14:25
HDI1.1
How Do I...1
How do I...Use Bisphosphonates
Genoa, Italy
Paul Dickinson
Stockport, UK
Mon 18 10:20
FC12.6
Free Communications 12: Thyroid
The First Robust Bioavailability/Bioequivalence (BA/BE) Study of Thyromimetic Tiratricol, a Treatment in Development for MCT8 Deficiency.
Stockport, UK
Ignacio Diez-Lopez
Vitoria, Spain
Sun 17 09:55
RFC7.6
Rapid Free Communications 7: GH and IGFs
Big data as a strategy in the development of population auxological studies
Vitoria, Spain
ADEL DJERMANE
ALGIERS, ALGERIA
Sun 17 09:45
RFC7.4
Rapid Free Communications 7: GH and IGFs
Use of iSYS-IDS IGF1-Assay Normative Data as a STANDARD in the Diagnosis of Pediatric Growth Hormone Deficiency
ALGIERS, ALGERIA
Demi Dorrepaal
Rotterdam, The Netherlands
Mon 18 10:20
FC11.6
Free Communications 11: Fat, Metabolism and Obesity (2)
Poly- and Perfluoroalkyl substances (PFAS) levels and breastfeeding have opposite associations with growth and body composition at age 3 years
Rotterdam, The Netherlands
Peter E. Clayton
Manchester, United Kingdom
Mon 18 09:40
FC15.2
Free Communications 15: Late Breaking
Amount and Pattern Of Pulsatile GH Secretion Induced By The Oral Growth Hormone Secretagogue LUM-201 Is Related To Growth And IGF-1 Responses In Moderate Pediatric Growth Hormone Deficiency (PGHD)
Manchester, United Kingdom
Thomas  Edouard
Mon 18 08:00
Yearbook 3
Bone, Growth Plate and Mineral Metabolism
Pernille Edström
Copenhagen, Denmark
Sun 17 10:50
FC8.6
Free Communications 8: Adrenals and HPA Axis (2)
Plasma concentrations of renin and ACTH in children and adolescents from the general population: new reference intervals according to sex, age, and pubertal stage
Copenhagen, Denmark
Simge Eren
İstanbul, Turkey
Sat 16 15:05
FC2.2
Free Communications 2: Bone, Growth Plate and Mineral Metabolism
Therapeutic Effects of Human Bone Marrow Mesenchymal Stem Cells Derived Exosomes on Glucocorticoid-Induced Osteoporosis: In Vitro Model
İstanbul, Turkey
Aline Faccioli Bodoni
Ribeirão Preto, Brazil
Sun 17 09:50
RFC8.5
Rapid Free Communications 8: Adrenals and HPA Axis (2)
Mitochondrial Nicotinamide Nucleotide Transidrogenase (NNT) and NNT-AS1 impairment is associated with worse outcomes in patients with adrenocortical tumors
Ribeirão Preto, Brazil
Fanglong Yang Fanglong Yang
Shanghai, China
Sat 16 14:55
FC2.1
Free Communications 2: Bone, Growth Plate and Mineral Metabolism
A highly selective FGFR3 inhibitor alleviates achondroplasia symptoms and restores chondrocyte growth in mice model
Shanghai, China
Shanghai, China
Shanghai, China
Shanghai, China
Shanghai, China
Ioanna  Farakla
ATHENS, GREECE
Sun 17 10:30
FC10.4
Free Communications 10: Multisystem Endocrine Disorders
A novel de novo SAMD9 gene variant causing MIRAGE syndrome associated with steroid-resistant nephrotic syndrome in a 46,XY male.
ATHENS, GREECE
Professor Sadaf Farooqi
Cambridge, UK
Mon 18 17:05
PL8
Plenary 7 - Genomics in Rare Diseases
Genomics in rare diseases
Cambridge, UK
Daniela Fava
Genova, Italy
Sun 17 10:30
FC7.4
Free Communications 7: GH and IGFs
Growth Hormone Response to Glucagon Stimulation Test in Transitional Age
Genova, Italy
Naama Fisch-Shvalb
Petach Tikva, Israel
Sat 16 15:25
FC5.4
Free Communications 5: Growth and Syndromes
Predictors of short stature at age 6-7 years in Israeli children
Petach Tikva, Israel
Dr Christa  Flueck
Switzerland
Sun 17 15:18
Yearbook 2
The Year in Science & Medicine
Switzerland
Gregory  Forlenza
Colorado , USA
Sat 16 11:25
S4.1
Symposium 4 - New Adjuvant Therapy in Pediatric Diabetes (ISPAD/ESPE)
Use of Verapamil in newly diagnosed T1D
Colorado , USA
Antonella Forlino
Pavia, Italy
Sat 16 08:35
ESPE Working Group on Bone and Growth Plate
Osteogenesis imperfecta, update and the OI XIV Animal model
Pavia, Italy
Svein Fredwall
Nesoddtangen, Norway
Sun 17 15:30
S7.3
Symposium 7 - Future Hope for skeletal disorders
Consensus statement on management of achondroplasia
Nesoddtangen, Norway
Junfen Fu
Zhejiang, China
Sat 16 08:15
ESPE Working Group on Obesity
Pubertal Development in Chinese Children and the Impact of Overnutrition, Lifestyle, and Perinatal Factors
Zhejiang, China
Donglin Fu
Shanghai, China
Sat 16 14:55
FC2.1
Free Communications 2: Bone, Growth Plate and Mineral Metabolism
A highly selective FGFR3 inhibitor alleviates achondroplasia symptoms and restores chondrocyte growth in mice model
Shanghai, China
Shanghai, China
Shanghai, China
Shanghai, China
Shanghai, China
Hoda Gad
Doha, Qatar
Sun 17 10:00
FC6.1
Free Communications 6: Fat, Metabolism and Obesity (1)
Corneal Nerve Loss and regeneration after GLP-1 Therapy in Children with Simple and Monogenic Obesity
Doha, Qatar
Despoina Galetaki
Washington DC, United States of America (USA)
Sat 16 15:35
FC5.5
Free Communications 5: Growth and Syndromes
Phase 2 Trial of Vosoritide Use in patients with Hypochondroplasia: Pharmacokinetic/ Pharmacodynamic analysis from 12 Month Data
Washington DC, United States of America (USA)
Hoong-Wei Gan
London, UK
Sat 16 11:25
S3.1
Symposium 3 - Novel Advances and Treatments of Hypothalamic disease
National UK Guidelines for the Management of Paediatric Craniopharyngioma
London, UK
Terence Garner
Manchester, United Kingdom
Mon 18 09:30
FC15.1
Free Communications 15: Late Breaking
Response  to Daily and Weekly Recombinant Human Growth Hormone Treatment in Children Born Small for Gestational Age is Predicted More Accurately by Pre-treatment Blood Transcriptome than Clinical Variables
Manchester, United Kingdom
Antje Garten
Leipzig, Germany
Sun 17 09:35
RFC6.2
Rapid Free Communications 6: Fat, Metabolism and Obesity (1)
Genetic Diagnostic Yield of Obesity
Leipzig, Germany
Mon 18 09:15
RFC11.4
Rapid Free Communications 11: Fat, Metabolism and Obesity (2)
Association of whole blood amino acid and acylcarnitine metabolome with anthropometry and IGF1 serum levels in healthy children and adolescents
Leipzig, Germany
Carles Gaston-Massuet
London, UK
Mon 18 08:36
Yearbook 3
Pituitary and Neuroendocrinology
London, UK
Aneta Gawlik-Starzyk
Katowice, Poland
Sat 16
ESPE Working Group on Turner Syndrome
Welcome
Katowice, Poland
Sat 16 09:00
ESPE Working Group on Turner Syndrome
To present multi-central experience/data and invite to prospective study
Katowice, Poland
Sat 16 14:50
RFC5.6
Rapid Free Communications 5: Growth and Syndromes
Pubertal induction in girls with Turner syndrome – retrospective data from the International TS registry
Katowice, Poland
Arun George
Chandigarh, India
Sat 16 15:05
FC1.2
Free Communications 1: Diabetes and Insulin
EFFECT OF HYDROXYCHLOROQUINE THERAPY IN NEWLY DIAGNOSED TYPE 1 DIABETES: A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROL PILOT TRIAL
Chandigarh, India
Evelien Gevers
London, UK
Mon 18 10:00
FC11.4
Free Communications 11: Fat, Metabolism and Obesity (2)
Long-term Efficacy Results of Diazoxide Choline Extended-Release (DCCR) Tablets in Participants with Prader-Willi Syndrome from the Completed C601 (DESTINY PWS) and C602 Open Label Extension (OLE) Studies
London, UK
Cosimo Giannini
Chieti, Italy
Mon 18 10:00
HDI2.3
How Do I...2
How do I...Diagnose and manage pre-diabetes
Chieti, Italy
Ariadna Gomez-Vilarrubla
Girona, Spain
Sun 17 09:55
RFC6.6
Rapid Free Communications 6: Fat, Metabolism and Obesity (1)
POTENTIAL ROLE OF ASPG METHYLATION AS A BIOMARKER OF CHILDHOOD OBESITY
Girona, Spain
Jacqueline Goos
Rotterdam, The Netherlands
Sat 16 14:25
RFC5.1
Rapid Free Communications 5: Growth and Syndromes
ABOUT CARING FOR PATIENTS AND UNDERSTANDING THEIR PATHWAYS: 10 YEARS OF ‘THE ROTTERDAM CENTRE FOR ADULTS WITH RARE GENETIC SYNDROMES’
Rotterdam, The Netherlands
Anna Grandone
Naples, Italy
Sat 16 14:25
RFC3.1
Rapid Free Communications 3: Pituitary, Neuroendocrinology and Puberty (1)
DNA Methylation profiles in girls with anorexia nervosa and amenorrhea: a pilot study
Naples, Italy
Mon 18 09:25
RFC15.6
Rapid Free Communications 15: Late Breaking
Macrophage switch and iron metabolism regulation by Burosumab in XLH pediatric patients: implications in inflammation and pain modulation.
Naples, Italy
Professor Claus Gravholt
Aarhus, Denmark
Sat 16 08:40
ESPE Working Group on Turner Syndrome
Challenges from the adult endocrinologist perspective
Aarhus, Denmark
Katerina Gregorova
Prague, Czech republic
Sat 16 14:45
RFC5.5
Rapid Free Communications 5: Growth and Syndromes
Searching for associated dysmorphic and cardiac abnormalities in youth tall basketball players
Prague, Czech republic
Louise Gregory
London, United Kingdom
Sat 16 14:30
RFC3.2
Rapid Free Communications 3: Pituitary, Neuroendocrinology and Puberty (1)
Results from a targeted hypopituitarism gene panel in patients with variable congenital hypopituitarism identifies variants in known and novel candidate genes.
London, United Kingdom
Noah Gruber
Ramat Gan, Israel
Sun 17 09:50
RFC9.5
Rapid Free Communications 9: Sex Endocrinology and Gonads
Reevaluating Guidelines for Primary Ovarian Insufficiency Workup: Is It Time for a Change?
Ramat Gan, Israel
Laura  Guazzarotti
Padova, Italy
Sat 16 14:35
RFC2.3
Rapid Free Communications 2: Bone, Growth Plate and Mineral Metabolism
Optimizing the Growth Outcome follow up in Hypophosphatemic Rickets Treated with Burosumab: The Critical Role of Auxological Measurements
Padova, Italy
Tülay Güran
Istanbul, Turkey
Mon 18 08:12
Yearbook 3
DSD and gender incongruence
Istanbul, Turkey
Busra Gurpinar Tosun
Istanbul, Turkey
Sat 16 14:50
RFC4.6
Rapid Free Communications 4: Adrenals and HPA Axis (1)
Machine Learning-Based Decision Tree Model for the Diagnosis of Congenital Disorders of Adrenal Steroidogenesis Using LC-MS/MS-based Plasma Steroid Hormone Profiles
Istanbul, Turkey
Faruk Hadziselimovic
Liestal, Switzerland
Sun 17 09:55
RFC9.6
Rapid Free Communications 9: Sex Endocrinology and Gonads
GnRHa TREATMENT OF CRYPTORCHIDISM ALTERS TESTICULAR SUMO GENE EXPRESSION
Liestal, Switzerland
Mon 18 09:00
RFC15.1
Rapid Free Communications 15: Late Breaking
Altered expression of epigenetic regulators is associated with high infertility risk in patients diagnosed with cryptorchidism.
Liestal, Switzerland
Casper Hagen
Copenhagen, Denmark
Sun 17 10:00
ES1.2
ESPE-ESE Joint Symposium
Prenatal Exposure to Over-the-Counter Antifugal Drugs Affects Fetal Steroidogenesis and is Associated with Persistent Effects in Children
Copenhagen, Denmark
Tian Han
Shanghai, China
Sat 16 14:55
FC2.1
Free Communications 2: Bone, Growth Plate and Mineral Metabolism
A highly selective FGFR3 inhibitor alleviates achondroplasia symptoms and restores chondrocyte growth in mice model
Shanghai, China
Shanghai, China
Shanghai, China
Shanghai, China
Shanghai, China
Linqi Han
Jinan, China
Mon 18 10:10
FC11.5
Free Communications 11: Fat, Metabolism and Obesity (2)
Complement 3 Alleviates Obesity Hypoventilation by Inhibiting Caspase-8/GSDME-Related Pyroptosis
Jinan, China
Jinan, China
Jinan, China
Naresh Hanchate
London, UK
Sat 16 16:55
NA1
Novel Advances
Relevance of single cell analysis and spatial transcriptomics for endocrine research to unravel new mechanisms?
London, UK
Didem Helvacıoğlu
Istanbul, Turkey
Sun 17 09:35
RFC8.2
Rapid Free Communications 8: Adrenals and HPA Axis (2)
A Novel Peroxisomal Cause of Primary Adrenal İnsufficiency: Pseudo-neonatal Adrenoleukodystrophy Due to ACOX1 Mutations.
Istanbul, Turkey
Olaf Hiort
Lübeck, Germany
Sun 17 14:30
Endo-ERN
Introduction
Lübeck, Germany
Anita Hokken-Koelega
Rotterdam, The Netherlands
Sun 17
Awards 3
ESPE International Outstanding Clinician Award
Rotterdam, The Netherlands
Sun 17
Awards 3
Outstanding Clinician Award
Rotterdam, The Netherlands
Tony Holland
Cambridge, UK
Mon 18 16:00
S10.2
Symposium 10 - Challenges in the management of Prader Willi Syndrome
Long-term management and outcomes in PWS
Cambridge, UK
Anton Holmgren
Gothenburg, Sweden
Sat 16 14:40
RFC5.4
Rapid Free Communications 5: Growth and Syndromes
Analysis of growth patterns in Klinefelter syndrome using the QEPS growth model
Gothenburg, Sweden
Jasmin Hopkins
Exeter, United Kingdom
Mon 18 10:10
FC14.5
Free Communications 14: Fetal and Neonatal Endocrinology
A novel 94bp deletion in the SLC16A1 promoter causes fasting and exercise-induced hyperinsulinaemic hypoglycaemia
Exeter, United Kingdom
Naomi Howard-James
Dublin, Ireland
Mon 18 09:15
RFC12.4
Rapid Free Communications 12: Thyroid
Establishing Outcomes and Management of Mild Neonatal Hyperthyrotropinaemia, a Retrospective Multi-Centre Review
Dublin, Ireland
Charlotte Höybye
Stockholm, Sweden
Mon 18 16:30
S10.3
Symposium 10 - Challenges in the management of Prader Willi Syndrome
Growth hormone treatment in adults with PWS
Stockholm, Sweden
Zhilong Hu
Shanghai, China
Sat 16 14:55
FC2.1
Free Communications 2: Bone, Growth Plate and Mineral Metabolism
A highly selective FGFR3 inhibitor alleviates achondroplasia symptoms and restores chondrocyte growth in mice model
Shanghai, China
Shanghai, China
Shanghai, China
Shanghai, China
Shanghai, China
Jan Idkowiak
Birmingham, United Kingdom
Sat 16 15:05
FC4.2
Free Communications 4: Adrenals and HPA Axis (1)
11-oxygenated androgens are abundantly produced by first and second-trimester foetal adrenal glands in ex vivo culture
Birmingham, United Kingdom
Melita Irving
London, UK
Sun 17 15:00
S7.2
Symposium 7 - Future Hope for skeletal disorders
Genetic disorders of bone - historic perspectives and novel advances
London, UK
Melita Irving
London, United Kingdom
Mon 18 10:00
FC15.4
Free Communications 15: Late Breaking
Oral infigratinib for children with achondroplasia: Month 18 results from the PROPEL 2 study demonstrate safety and durability of treatment effect on linear growth with improved body proportionality
London, United Kingdom
Clément Janot
Bron, France
Sun 17 10:30
FC8.4
Free Communications 8: Adrenals and HPA Axis (2)
A deep intronic splice variant of CYP11B1 is the most common in Caucasian patients with 11-beta hydroxylase deficiency: functional, clinical and hormonal findings in 36 families
Bron, France
Barbora  Jírová
Prague, Czech Republic
Sun 17 10:10
FC7.2
Free Communications 7: GH and IGFs
Stratifying genetic etiology in children born small for gestational age with persistent short stature (SGA-SS): 5-year growth hormone (GH) treatment outcomes in genetic subgroups
Prague, Czech Republic
Anders Juul
Copenhagen, Denmark
Mon 18 10:20
FC13.6
Free Communications 13: Pituitary, Neuroendocrinology and Puberty (2)
Voice frequency in healthy children and adolescents: A biomarker of androgen action in puberty
Copenhagen, Denmark
Gözde Akın  Kağızmanlı
Izmir, Turkey
Sat 16 15:15
FC1.3
Free Communications 1: Diabetes and Insulin
A Non-Invasive Diagnostic Tool for Early Detection of Microvascular Alterations in Children with Type 1 Diabetes Mellitus: Nail-Fold Capillaroscopy
Izmir, Turkey
Hasan Karakaş
Istanbul, Turkey
Sun 17 09:30
RFC10.1
Rapid Free Communications 10: Multisystem Endocrine Disorders
Long-Term Endocrine Outcomes of Acute Lymphoblastic Leukemia Treatment with Special Emphasis on the Gonadal Impact
Istanbul, Turkey
Elif Kelestemur
Istanbul, Turkey
Sun 17 09:40
RFC8.3
Rapid Free Communications 8: Adrenals and HPA Axis (2)
Multi-hit Model of Primary Adrenal Insufficiency in CPOX mutations
Istanbul, Turkey
Doaa Khater
Alexandria, Egypt
Sat 16 14:30
RFC1.2
Rapid Free Communications 1: Diabetes and Insulin
Evaluating Glucose-6-Phosphate Dehydrogenase Enzyme Activity In Children With Type 1 Diabetes Mellitus.
Alexandria, Egypt
Alexandria, Egypt
Aylin  Kilinç Uğurlu
Ankara, Turkey
Sat 16 14:55
FC3.1
Free Communications 3: Pituitary, Neuroendocrinology and Puberty (1)
The Effects of Blue Light Exposure on the Epiphyseal Plate and IGF1 - IGFBP3 Expression in Rats
Ankara, Turkey
Sirmen Kızılcan Çetin
Ankara, Turkey
Mon 18 09:40
FC12.2
Free Communications 12: Thyroid
Molecular Characterization of Childhood Thyroid Nodules and Thyroid Cancer with DNA/RNA Next Generation Sequencing and Investigation of Phenotype-Genotype Correlation
Ankara, Turkey
Cansu Koc
Istanbul, Turkey
Mon 18 09:15
RFC13.4
Rapid Free Communications 13: Pituitary, Neuroendocrinology and Puberty (2)
Investigation of Pituitary Function in Langerhans Cell Histiocytosis: A Comprehensive Analysis of Clinical and Radiological Findings
Istanbul, Turkey
Florentien Kolbig
Leipzig, Germany
Mon 18 09:25
RFC11.6
Rapid Free Communications 11: Fat, Metabolism and Obesity (2)
Pten knockout in osteoprogenitor cells leads to loss of adipose tissue
Leipzig, Germany
Özge Köprülü
Izmir, Turkey
Sat 16 14:55
FC1.1
Free Communications 1: Diabetes and Insulin
Does Type 1 Diabetes Effect Left Ventricular Function in Children? Evaluation with Treadmill Exercise Stress Echocardiography
Izmir, Turkey
David  Kristensen
Copenhagen, Denmark
Sun 17 09:30
ES1.1
ESPE-ESE Joint Symposium
Endocrine disrupting effects of over-the-counter mild analgesics such as paracetamol in humans
Copenhagen, Denmark
Berit Kriström
Umea, Sweden
Sat 16 08:00
ESPE Working Group on Turner Syndrome
News and doubts around growth and puberty therapy
Umea, Sweden
Nils Krone
Sheffield, UK
Sun 17 15:30
S5.3
Symposium 5 - Adrenal Disorders
Lessons from CAH service evaluation and real world data
Sheffield, UK
Michaela Kuhlen
Augsburg, Germany
Sun 17 10:00
FC8.1
Free Communications 8: Adrenals and HPA Axis (2)
Quantitative proteomics of pediatric adrenocortical tumors provides insights into zone of origin and identifies overrepresented pathways
Augsburg, Germany
Alexandra Kulle
Kiel, Germany
Sat 16 15:15
FC4.3
Free Communications 4: Adrenals and HPA Axis (1)
Plasma reference values for C19 oxy-steroids, 11-keto testosterone and 11-keto androstenedione in a paediatric cohort
Kiel, Germany
Ilknur Kurt
Istanbul, Turkey
Sat 16 14:40
RFC2.4
Rapid Free Communications 2: Bone, Growth Plate and Mineral Metabolism
CYP24A1 MUTATIONS:, CLINICAL AND LABORATORY FEATURES IN PATIENTS PRESENTING WITH HYPERCALCEMIA
Istanbul, Turkey
Ana Claudia Latronico
São Paulo, Brazil
Mon 18 16:00
S12.2
Symposium 12 - The impact of gonadotrophin dysregulation on neurocognition
Neurodevelopmental syndromes associated with Centra Precocious Puberty
São Paulo, Brazil
Miss Hazel  Learner
London, UK
Sun 17 08:35
MTE5.1
Meet The Expert 5.1
Managing difficult menstrual periods
London, UK
Mon 18 08:00
MTE 5.2
Meet The Expert 5.2
Managing difficult menstrual periods
London, UK
Yael Lebenthal
Tel Aviv, Israel
Sun 17 08:35
MTE7.1
Meet The Expert 7.1
Diagnosis and Management of PCOS
Tel Aviv, Israel
Mon 18 14:15
MTE7.2
Meet The Expert 7.2
Diagnosis and Management of PCOS
Tel Aviv, Israel
Agnes Lehuen
Paris, France
Mon 18 16:00
S11.2
Symposium 11 - Microbiota in type 1 diabetes
MAIT cells, an immune link between microbiota and type 1 diabetes
Paris, France
Yan Li
Shanghai, China
Mon 18 09:05
RFC15.2
Rapid Free Communications 15: Late Breaking
Study on effects of poly- and perfluoroalkyl substances on hormones in girls with central precocious puberty
Shanghai, China
Agnès Linglart, MD, PhD
Paris, France
Sat 16 12:25
S2.3
Symposium 2 - Bone and Mineral Disorders: Recent Developments
PTH Resistance Syndromes
Paris, France
Maria Lodefalk
Örebro, Sweden
Sat 16 14:45
RFC3.5
Rapid Free Communications 3: Pituitary, Neuroendocrinology and Puberty (1)
Long-Term Health Outcomes of Delayed Puberty in Males: A Comprehensive Population-Based Study
Örebro, Sweden
Abel López-Bermejo
Girona, Spain
Sun 17 09:50
RFC6.5
Rapid Free Communications 6: Fat, Metabolism and Obesity (1)
GRB10 METHYLATION IN UMBILICAL CORD ASSOCIATES POSTNATALLY WITH OBESITY IN HEALTHY CHILDREN
Girona, Spain
Inge Lore Ruiz Arana
Lausanne, Switzerland
Sat 16 14:50
RFC2.6
Rapid Free Communications 2: Bone, Growth Plate and Mineral Metabolism
Comparison of two automated bone age evaluation methods in pediatric patients with growth and puberty disorders
Lausanne, Switzerland
Angela Lucas-Herald
Glasgow, UK
Sat 16 11:25
S1.1
Symposium 1 - Disorders of Sex Development: Novel advances in management
Vascular reactivity and morbidity in DSD
Glasgow, UK
Philippe Lysy
Brussels, Belgium
Sat 16 15:25
HDI1.3
How Do I...1
How do I...Manage the infant with hypoglycaemia
Brussels, Belgium
Jonna M E Männistö
Exeter, United Kingdom
Sat 16 15:45
FC1.6
Free Communications 1: Diabetes and Insulin
Comprehensive rescreening of the known congenital hyperinsulinism genes provides a new genetic diagnosis for 18% of the Finnish cohort
Exeter, United Kingdom
Hanneke M. van Santen
Utrecht, Netherlands
Mon 18 09:10
RFC15.3
Rapid Free Communications 15: Late Breaking
The different faces of acquired hypothalamic dysfunction.
Utrecht, Netherlands
Avinaash V Maharaj
London, United Kingdom
Sat 16 15:05
FC5.2
Free Communications 5: Growth and Syndromes
The pathogenesis of Noonan syndrome and associated growth restriction is modulated by NOC2L, a novel interactor of LZTR1 leading to impaired p53 signalling
London, United Kingdom
Francesca Mainieri
London, United Kingdom
Sun 17 10:40
FC7.5
Free Communications 7: GH and IGFs
Use of overnight GH sampling in the diagnosis of growth disorders in children: neuroimaging findings and response to treatment
London, United Kingdom
Neha Malhotra
Basildon, United Kingdom
Sat 16 15:35
FC1.5
Free Communications 1: Diabetes and Insulin
The Side-Effects of Lanreotide in Children with Congenital Hyperinsulinism (CHI): A Decade-long Exploration
Basildon, United Kingdom
Sat 16 15:25
FC3.4
Free Communications 3: Pituitary, Neuroendocrinology and Puberty (1)
The spectrum of Endocrinopathies in Children with Ectopic Posterior Pituitary (EPP) correlates with the severity of associated hypothalamo-pituitary abnormalities on imaging: a decade long experience from two tertiary centers.
Basildon, United Kingdom
Jamala Mammadova
Baku, Azerbaijan
Mon 18 09:10
RFC12.3
Rapid Free Communications 12: Thyroid
Mechanisms and natural history of pituitary resistance to exogenous thyroxine in children with congenital hypothyroidism
Baku, Azerbaijan
Valentina Mancioppi
Verona, Italy
Sat 16 14:50
RFC1.6
Rapid Free Communications 1: Diabetes and Insulin
METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE AND ITS ASSOCIATION WITH GLYCEMIC CONTROL METRICS IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES: AN EXPLORATORY STUDY
Verona, Italy
Melania Manco
Rome, Italy
Mon 18 09:30
FC11.1
Free Communications 11: Fat, Metabolism and Obesity (2)
Frequency of rare syndromic diseases in a population with early-onset obesity
Rome, Italy
Lydia Mavraki
Agios Nikolaos, Greece
Sat 16 15:45
FC4.6
Free Communications 4: Adrenals and HPA Axis (1)
Comparative Efficacy of Modified-Release versus Conventional Hydrocortisone Treatment in Adolescents and Young Adults with Congenital Adrenal Hyperplasia: A Retrospective Observational Study
Agios Nikolaos, Greece
Kenneth McElreavey
Paris, France
Sat 16 11:55
S1.2
Symposium 1 - Disorders of Sex Development: Novel advances in management
Novel mechanisms leading to DSD (genomic, digenic/ollogenic and non-coding variation)
Paris, France
Sinead McGlacken-Byrne
London, United Kingdom
Sun 17 10:00
FC9.1
Free Communications 9: Sex Endocrinology and Gonads
A tiered approach to exome sequencing analysis in early-onset Primary Ovarian Insufficiency
London, United Kingdom
Sun 17 10:10
FC10.2
Free Communications 10: Multisystem Endocrine Disorders
Characterising the natural history of Multiple Endocrine Neoplasia 2B caused by M918TRET pathogenic variants in children and young people
London, United Kingdom
Sarah McNally
Liverpool, United Kingdon
Sat 16 14:30
RFC4.2
Rapid Free Communications 4: Adrenals and HPA Axis (1)
Salivary cortisol and cortisone is related to age
Liverpool, United Kingdon
Shlomo Melmed
Los Angeles CA , USA
Sat 16 10:15
PL1
Plenary 1 - Impact of GH treatment on DNA damage
Impact of GH on DNA damage
Los Angeles CA , USA
Berenice Mendonça
São Paulo, Brazil
Sat 16 08:00
ESPE Working Group on Paediatric and Adolescent Gynaecology
Genetics of POI
São Paulo, Brazil
Tom Merchant
Tennessee, USA
Sat 16 12:25
S3.3
Symposium 3 - Novel Advances and Treatments of Hypothalamic disease
Proton Beam Therapy in childhood brain tumours
Tennessee, USA
Madhusmita Misra
Boston, USA
Sun 17 15:30
S8.3
Symposium 8 - Improving treatment strategies in Obesity
Bariatic surgery: impact beyond weight
Boston, USA
Klaus Mohnike
Magdeburg, Germany
Sat 16 15:45
FC2.6
Free Communications 2: Bone, Growth Plate and Mineral Metabolism
Expansion of the CrescNet Registry Achondroplasia Module: Real-World Demographic Data and Outcomes After up to 2 Years of Vosoritide Treatment
Magdeburg, Germany
Gylli Mola
Copenhagen, Denmark
Sun 17 10:30
FC9.4
Free Communications 9: Sex Endocrinology and Gonads
Prenatal exposure to paracetamol is associated with smaller testis volume and decreased levels of steroid metabolites during infancy in healthy males: A COPANA cohort study of 287 boys
Copenhagen, Denmark
Anita Morandi
Verona, Italy
Mon 18 09:20
RFC11.5
Rapid Free Communications 11: Fat, Metabolism and Obesity (2)
Hepatic lipogenesis increases FGF21 in children/adolescents with obesity.
Verona, Italy
Zulf Mughal
Dubai , UAE
Sun 17 08:35
MTE8.1
Meet The Expert 8.1
The Diagnosis & Management of Rickets in the 21st Century
Dubai , UAE
Mon 18 08:00
MTE8.2
Meet The Expert 8.2
The Diagnosis & Management of Rickets in the 21st Century
Dubai , UAE
Salwa Musa
Khartoum, Sudan
Sun 17 09:45
RFC8.4
Rapid Free Communications 8: Adrenals and HPA Axis (2)
Rare Genetic Etiology of Primary Adrenal Insufficiency in Children; Clinical and Genetic Characterization Of a Large Sudanese Cohort
Khartoum, Sudan
Noriyuki Namba
Tottori, Japan
Sat 16 15:25
FC2.4
Free Communications 2: Bone, Growth Plate and Mineral Metabolism
Analysis of baseline data from the SUNFLOWER longitudinal, observational cohort study of patients with XLH: relationship between various complications and QOL
Tottori, Japan
Ruta Navardauskaite
Kaunas, Lithuania
Sun 17 09:45
RFC10.4
Rapid Free Communications 10: Multisystem Endocrine Disorders
Manifestation of PTEN and MUTYH gene mutations: A Case Report
Kaunas, Lithuania
Uta Neumann
Berlin, Germany
Sun 17 09:30
RFC8.1
Rapid Free Communications 8: Adrenals and HPA Axis (2)
PREDICT – A randomized investigation of a reduced prenatal dexamethasone dose to reduce virilization in female fetuses with congenital adrenal hyperplasia
Berlin, Germany
Agneta Nordenskjӧld
Stockholm, Sweden
Sat 16 12:25
S1.3
Symposium 1 - Disorders of Sex Development: Novel advances in management
Hypospadias - surgery and beyond
Stockholm, Sweden
Nway Nway Htun Kyi
Cardiff, United Kingdom
Sat 16 14:25
RFC1.1
Rapid Free Communications 1: Diabetes and Insulin
Perceptions and Experiences of PDSNs on Different Hybrid Closed Loop Systems (HCLS) across Wales
Cardiff, United Kingdom
Roberto Oleari
Milan, Italy
Mon 18 16:30
S12.3
Symposium 12 - The impact of gonadotrophin dysregulation on neurocognition
Studying the genetic interplay between GnRH deficiency and associated neurocognitive disorders by combining in silico, in vitro and in vivo tools.
Milan, Italy
Noriaki Ono
Texas, USA
Sun 17 14:30
S7.1
Symposium 7 - Future Hope for skeletal disorders
Stem cells in skeletal development and growth
Texas, USA
Alina Oprea
London, United Kingdom
Sun 17 10:00
FC10.1
Free Communications 10: Multisystem Endocrine Disorders
Genetic screening and tumour surveillance program outcomes in rare paediatric hereditary endocrine tumour syndromes
London, United Kingdom
Bas P.H. Adriaansen
Nijmegen, Netherlands
Sun 17 10:40
FC8.5
Free Communications 8: Adrenals and HPA Axis (2)
Free cortisol and free 21-deoxycortisol in the clinical evaluation of adrenal insufficiency in congenital adrenal hyperplasia
Nijmegen, Netherlands
Valentina Pampanini
Rome, Italy
Sat 16 11:49
Yearbook 1
Growth and Growth Factors
Rome, Italy
Professor Anne-Simone Parent
Liège, Belgium
Sat 16 12:01
Yearbook 1
Puberty
Liège, Belgium
Sun 17 10:30
ES1.3
ESPE-ESE Joint Symposium
Effect of EDCs on the hypothalamic regulation of energy homeostasis and GnRH activity
Liège, Belgium
GIUSEPPA PATTI
Genova, Italy
Sat 16 14:35
RFC5.3
Rapid Free Communications 5: Growth and Syndromes
Neuroradiological Findings in Noonan Syndrome: a multicentric Italian study
Genova, Italy
Hannah Peckham
London, UK
Sat 16 08:00
ESPE Working Group on Gender Incongruence
Immunological effects of gender affirming hormone treatment
London, UK
Elzbieta Petriczko
Szczecin, Poland
Sun 17 10:50
FC7.6
Free Communications 7: GH and IGFs
Growth, IGF-1 and IGFBP-3 Responses to Oral LUM-201 in OraGrowtH210 and OraGrowtH212 Trials in Pediatric Growth Hormone Deficiency (PGHD) over 12 to 24 Months on Treatment
Szczecin, Poland
Sonja Piippo
Helsinki, Finland
Sat 16 15:35
FC2.5
Free Communications 2: Bone, Growth Plate and Mineral Metabolism
Bone health in adolescents with cow’s milk allergy during infancy
Helsinki, Finland
Orit Pinhas-Hamiel
Tel Aviv, Israel
Sat 16 11:25
Yearbook 1
Type 2 Diabetes, Metabolic Syndrome and Lipids
Tel Aviv, Israel
Michel	 Polak
Paris, France
Mon 18 15:30
S9.1
Symposium 9 - Novel advances in paediatric thyroid disease
Challenges in congenital hypothyroidism: including genetics, newborn screening and treatment optimization
Paris, France
Alvin Powers
Tennessee, USA
Mon 18 11:00
PL6
Plenary 6 - Pancreatic and islet plasticity in early life: implications for diabetes risk
Pancreatic and islet plasticity in early life: implications for diabetes risk
Tennessee, USA
Divya Pujari
Mumbai, India
Mon 18 09:15
RFC14.4
Rapid Free Communications 14: Fetal and Neonatal Endocrinology
Neurodevelopmental response to nifedipine treatment in an infant with Congenital Hyperinsulinism due to de novo gain-of-function CACNA1D variant.
Mumbai, India
Chen Qiuli
Guangzhou, China
Sat 16 14:35
RFC1.3
Rapid Free Communications 1: Diabetes and Insulin
Akkermansia muciniphila induces immune homeostasis in type 1 diabetic mice by up-regulating CD4 + FoxP3 + Treg expression.
Guangzhou, China
Dhvani Raithatha
Kanpur, India
Mon 18 09:20
RFC13.5
Rapid Free Communications 13: Pituitary, Neuroendocrinology and Puberty (2)
The Development and Validation of Bone-age guided Interpretation of Puberty, a web-based tool for guidance of pubertal disorders
Kanpur, India
H. Rakicioglu
Gießen, Germany
Sat 16 14:45
RFC4.5
Rapid Free Communications 4: Adrenals and HPA Axis (1)
Ontogenesis of the urinary steroid metabolome in infancy assessed by gas chromatography/mass spectrometry (GC-MS)
Gießen, Germany
Rachel Reynaud
Marseille, France
Mon 18 09:30
HDI2.2
How Do I...2
How do I...Manage a child with Hypopituitarism
Marseille, France
Beatrice Righi
Reggio Emilia, Italy
Mon 18 09:00
RFC14.1
Rapid Free Communications 14: Fetal and Neonatal Endocrinology
The LIFE-MILCH project: preliminary data from the risk assessment model of exposure to Endocrine Disrupting Chemicals (EDCs) in mother-infant dyads during the first 3 months of life.
Reggio Emilia, Italy
Karine Rizzoti
London, UK
Sun 17 15:00
S6.2
Symposium 6 - Novel Insights into Pituitary Disorders
New insights into Gonadotrope development
London, UK
Thea Roedig
Bonn, Germany
Sat 16 14:35
RFC4.3
Rapid Free Communications 4: Adrenals and HPA Axis (1)
Differences and similarities in salivary diurnal adrenal hormones in monozygotic twins with intra-twin birthweight-differences
Bonn, Germany
Till Roenneberg
Munich, Germany
Sun 17 12:00
PL4
Plenary 4 - The importance of chronobiology for medicine – when time matters
The importance of chronobiology for medicine – when time matters
Munich, Germany
Julia Rohayem
St.Gallen, Switzerland
Sun 17 09:35
RFC9.2
Rapid Free Communications 9: Sex Endocrinology and Gonads
Effects of the modified release hydrocortisone preparation Efmody® on hormones, spermatogenesis and body weight in males with congenital adrenal hyperplasia
St.Gallen, Switzerland
Giuseppina Rosaria Umano
Naples, Italy
Sun 17 09:30
RFC6.1
Rapid Free Communications 6: Fat, Metabolism and Obesity (1)
Frequency of genetic variants in a population with early-onset obesity: a single center experience
Naples, Italy
Prof Cliff Rosen
Maine, USA
Mon 18 12:15
PL7
Plenary 8 - Fat & Bone; where are we now?
Fat & Bone: where are we now?
Maine, USA
Kelly  Roszko
Maryland, USA
Sat 16 11:55
S2.2
Symposium 2 - Bone and Mineral Disorders: Recent Developments
Advances in FGF 23 related disorders
Maryland, USA
Christian Roth
Seattle, USA
Sun 17 10:50
FC6.6
Free Communications 6: Fat, Metabolism and Obesity (1)
Novel Melanocortin and Gut-peptide Dual Agonist for Obesity and Diabetes Treatment
Seattle, USA
Nicolas de Roux
Paris, France
Sat 16 16:55
MTE1.1
Meet The Expert 1.1
Genetic Testing in Hypogonadism
Paris, France
Mon 18 14:15
MTE1.2
Meet The Expert 1.2
Genetic Testing in Hypogonadism
Paris, France
Bradley S. Miller
Minneapolis, USA
Mon 18 10:20
FC15.6
Free Communications 15: Late Breaking
Pharmacodynamic Endpoints After Once-Weekly Somapacitan in Children With GHD: 3-year results from REAL4 phase 3 study
Minneapolis, USA
Judith S. Renes
Rotterdam, The Netherlands
Sun 17 10:00
FC7.1
Free Communications 7: GH and IGFs
Clinical characteristics and response to growth hormone treatment in 27 children and adolescents with pathogenic NPR2 variants
Rotterdam, The Netherlands
Philippa Sangster
London, UK
Mon 18 09:00
HDI2.1
How Do I...2
How do I...Manage Fertility Preservation in Young People with Klinefelter syndrome?
London, UK
Kyriakie Sarafoglou
Minneapolis, United States
Sat 16 15:25
FC4.4
Free Communications 4: Adrenals and HPA Axis (1)
Crinecerfont, a Corticotropin-Releasing Factor Type 1 Receptor (CRF1) Antagonist, Reduced Excess Adrenal Androgens and Glucocorticoid Doses in Children and Adolescents with Classic Congenital Adrenal Hyperplasia: Results from CAHtalystTM Pediatric
Minneapolis, United States
Nadia	 Schoenmakers
Cambridge, UK
Mon 18 16:30
S9.3
Symposium 9 - Novel advances in paediatric thyroid disease
The pathophysiology of transient congenital hypothyroidism
Cambridge, UK
Senthil Senniappan
Liverpool, UK
Sat 16 09:00
ESPE Working Group on Obesity
The CEW Clinic Concept
Liverpool, UK
Julie Siersbaek
Odense, Denmark
Mon 18 09:40
FC14.2
Free Communications 14: Fetal and Neonatal Endocrinology
Cord glucose: A normal reference and a potential of an ideal universal screening tool for pathological hyperinsulinism.
Odense, Denmark
Radhika Sivaprasad
Kiel, Germany
Sun 17 10:10
FC9.2
Free Communications 9: Sex Endocrinology and Gonads
Unveiling DHT-driven Androgen Receptor target genes in genital skin fibroblasts
Kiel, Germany
Neil Smith
Hertfordshire, United Kingdom
Sun 17 15:30
Endo-ERN
The patient perspective on new treatment options (example hypogonadotropic hypogonadism)
Hertfordshire, United Kingdom
Joanna Smyczyńska
Lodz, Poland
Sun 17 09:40
RFC7.3
Rapid Free Communications 7: GH and IGFs
Incidence of false positive results of growth hormone stimulation tests in children with short stature – from theoretical background to clinical approach
Lodz, Poland
Qijun Song
Jinan, China
Mon 18 10:10
FC11.5
Free Communications 11: Fat, Metabolism and Obesity (2)
Complement 3 Alleviates Obesity Hypoventilation by Inhibiting Caspase-8/GSDME-Related Pyroptosis
Jinan, China
Jinan, China
Jinan, China
Diane  Stafford
Stanford, USA
Sat 16 11:37
Yearbook 1
Global Health for the Paediatric Endocrinologist
Stanford, USA
Maria Elisabeth Street
Parma, Italy
Mon 18 09:00
RFC13.1
Rapid Free Communications 13: Pituitary, Neuroendocrinology and Puberty (2)
MRI-based radiomics of the pituitary gland is highly predictive of CentralPrecocious Puberty in girls: pilot study
Parma, Italy
Yan Sun
Jinan, China
Mon 18 10:10
FC11.5
Free Communications 11: Fat, Metabolism and Obesity (2)
Complement 3 Alleviates Obesity Hypoventilation by Inhibiting Caspase-8/GSDME-Related Pyroptosis
Jinan, China
Jinan, China
Jinan, China
Jenifer Suntharalingham
London, United Kingdom
Sat 16 15:15
FC5.3
Free Communications 5: Growth and Syndromes
Gene expression of monosomy X during human development reveals potential mechanisms in Turner syndrome
London, United Kingdom
Rieko Tadokoro-Cuccaro
Cambridge, United Kingdom
Sat 16
ESPE Working Group on DSD/Differences in Sex Development
Novel insights into the diagnosis of gonadal dysgnesis: findings from the 46,XY gonadal dysgenesis study based on the I-DSD Registry
Cambridge, United Kingdom
Giacomo Tantari
Genoa, Italy
Sun 17 10:20
FC6.3
Free Communications 6: Fat, Metabolism and Obesity (1)
SPISE is more strongly correlated with cardiometabolic factors in adolescents with obesity than HOMA-IR, and is related to the amount of body weight reduction under lifestyle intervention
Genoa, Italy
David Taylor-Robinson
Liverpool, UK
Sat 16 16:15
PL2
Plenary 2 - Addressing Inequalities in Child Health. Lessons from the UK policy experiments in poverty and adversity
Addressing Inequalities in Child Health. Lessons from the UK policy experiments in poverty and adversity
Liverpool, UK
Viola Trevisani
Modena, Italy
Sun 17 10:50
FC9.6
Free Communications 9: Sex Endocrinology and Gonads
The Gender Identity Questionnaire for Children: a useful tool for gender identity detection in early life
Modena, Italy
Eugenio Trinati
Florence, Italy
Mon 18 09:25
RFC13.6
Rapid Free Communications 13: Pituitary, Neuroendocrinology and Puberty (2)
Hypogonadism hyperprolactinemia-related and its treatment in three patients with inherited disorders of biogenic amine metabolism
Florence, Italy
Paul Trotsenburg
Amsterdam, The Netherlands
Mon 18 08:24
Yearbook 3
Thyroid
Amsterdam, The Netherlands
Aylin Tugba Canbaz
Istanbul, Turkey
Sat 16 14:50
RFC3.6
Rapid Free Communications 3: Pituitary, Neuroendocrinology and Puberty (1)
Final Height and Endocrine Complications in Children with Pilocytic Astrocytomas: A Retrospective Study
Istanbul, Turkey
Gilad Twig
Ramat Gan, Israel
Sun 17 15:00
S8.2
Symposium 8 - Improving treatment strategies in Obesity
Impact of adolescent obesity on adult morbidity and mortality
Ramat Gan, Israel
Ahmet  Uçar
Istanbul, Turkey
Sat 16 14:35
RFC3.3
Rapid Free Communications 3: Pituitary, Neuroendocrinology and Puberty (1)
Analysis of the expression levels of spexin and kisspeptin in serum, ovarian tissue and white adipose tissue as related to pubertal status and metabolic surrogates of puberty in female albino Wistar rats
Istanbul, Turkey
Erica van den Akker
Rotterdam, The Netherlands
Sat 16 16:55
MTE3.1
Meet The Expert 3.1
Pharmacological treatment options for adolescents with Obesity
Rotterdam, The Netherlands
Sun 17 14:35
Endo-ERN
Future of Registers for Rare Disease: the example E-REC
Rotterdam, The Netherlands
Mon 18 08:00
MTE3.2
Meet the Expert 3.2
Pharmacological treatment options for adolescents with Obesity
Rotterdam, The Netherlands
Edgar  van Mil
Hertogenbosch, The Netherlands
Sat 16 15:25
FC1.4
Free Communications 1: Diabetes and Insulin
A personalized approach to classify the degree of liver insulin resistance in children with obesity
Hertogenbosch, The Netherlands
Tomi Vatanen
Helsinki, Finland
Mon 18 15:30
S11.1
Symposium 11 - Microbiota in type 1 diabetes
Gut dysbiosis in type 1 diabetes
Helsinki, Finland
Pichaya Vathanasakpuban
Bangkok, Thailand
Mon 18 09:05
RFC12.2
Rapid Free Communications 12: Thyroid
Prevalence and etiology of thyroid disorders and Characteristic of thyroid function tests in preterm infants
Bangkok, Thailand
Alfredo Vicinanza
Brussels, Belgium
Mon 18 10:10
FC13.5
Free Communications 13: Pituitary, Neuroendocrinology and Puberty (2)
Rising in body mass index during childhood in girls with idiopathic CPP : a 20-year experience in a tertiary Belgian centre.
Brussels, Belgium
Dr Maria Cristina 	 Vigone
Italy
Mon 18 09:20
RFC12.5
Rapid Free Communications 12: Thyroid
Use of the FT3/FT4 ratio as a predictor of relapse in autoimmune hyperthyroidism: retrospective study on a cohort of 80 pediatric patients
Milan, Italy
Milan , Italy
Italy
Lea Vilmann
Copenhagen, Denmark
Sat 16 14:40
RFC3.4
Rapid Free Communications 3: Pituitary, Neuroendocrinology and Puberty (1)
Longitudinal Changes in Serum DLK1 Concentrations During Pubertal Transition in Healthy Girls and in girls with Precocious Puberty during GnRHa treatment
Copenhagen, Denmark
Gaia  Vincenzi
Milan , Italy
Mon 18 09:20
RFC12.5
Rapid Free Communications 12: Thyroid
Use of the FT3/FT4 ratio as a predictor of relapse in autoimmune hyperthyroidism: retrospective study on a cohort of 80 pediatric patients
Milan, Italy
Milan , Italy
Italy
Joeri  Vliegenthart
Rotterdam, The Netherlands
Sun 17 09:50
RFC7.5
Rapid Free Communications 7: GH and IGFs
HEALTH-RELATED QUALITY OF LIFE AT MID-PUBERTY IN ADOLESCENTS WITH IDIOPATHIC ISOLATED GROWTH HORMONE DEFICIENCY
Rotterdam, The Netherlands
Julia von Schnurbein
Ulm, Germany
Sun 17 10:40
FC6.5
Free Communications 6: Fat, Metabolism and Obesity (1)
FIRST CROSS SECTIONAL ANALYSIS OF THE ECLIP REGISTRY
Ulm, Germany
Professor Martin Wabitsch
Germany
Sun 17 15:06
Yearbook 2
Obesity and Weight Regulation
Germany
Prof. Carsten Wagner
Zurich, Switzerland
Sat 16 11:25
S2.1
Symposium 2 - Bone and Mineral Disorders: Recent Developments
Phosphate sensing in normal physiology and disease
Zurich, Switzerland
Yirou Wang
Shanghai, China
Sat 16 14:45
RFC2.5
Rapid Free Communications 2: Bone, Growth Plate and Mineral Metabolism
Prediction of residual growth potential in adolescent boys by linear regression modeling based on the radiomics features extracted by knee DR images and clinical characteristics
Shanghai, China
Shanghai, China
Shanghai, China
Shanghai, China
Xiumin Wang
Shanghai, China
Sat 16 14:45
RFC2.5
Rapid Free Communications 2: Bone, Growth Plate and Mineral Metabolism
Prediction of residual growth potential in adolescent boys by linear regression modeling based on the radiomics features extracted by knee DR images and clinical characteristics
Shanghai, China
Shanghai, China
Shanghai, China
Shanghai, China
Fengxue Wang
Jinan, China
Mon 18 09:10
RFC14.3
Rapid Free Communications 14: Fetal and Neonatal Endocrinology
Complex Glycerol Kinase Deficiency: four new cases and a review of the literature
Jinan, China
Lisa Webber
London, UK
Sat 16 08:30
ESPE Working Group on Paediatric and Adolescent Gynaecology
Clinical management
London, UK
Professor Daniel  Weghuber
Salzburg, Austria
Sat 16 14:55
HDI1.2
How Do I...1
How do I...Handle GLP-1 analogue treatment in adolescents with obesity
Salzburg, Austria
Alena Welters
Duesseldorf, Germany
Mon 18 09:20
RFC15.5
Rapid Free Communications 15: Late Breaking
Prevalence and management of modifiable cardiovascular risk factors among adolescents and young adults with type 1 diabetes – a cross-sectional analysis from the Diabetes Prospective Follow-Up Registry DPV
Duesseldorf, Germany
Eric  Wenzel
Leipzig, Germany
Sun 17 09:40
RFC6.3
Rapid Free Communications 6: Fat, Metabolism and Obesity (1)
Identification and clinical characterization of new patients with novel monogenic agouti-like obesity trait
Leipzig, Germany
Jennifer Whitehead
Manchester, United Kingdom
Mon 18 09:20
RFC14.5
Rapid Free Communications 14: Fetal and Neonatal Endocrinology
The utility of ketones in screening for congenital hyperinsulinism: a retrospective evaluation.
Manchester, United Kingdom
John Wilding
Liverpool, United Kingdom
Sun 17 14:30
S8.1
Symposium 8 - Improving treatment strategies in Obesity
Pharmacotherapy of Obesity

Unknown speaker

Liverpool, United Kingdom
Rachel Williams
Cambridge, UK
Sat 16 16:55
MTE2.1
Meet The Expert 2.1
Management of Lipodystrophy
Cambridge, UK
Sun 17 08:35
MTE2.2
Meet The Expert 2.2
Management of Lipodystrophy
Cambridge, UK
Selma Witchel
Pittsburgh, USA
Sun 17 09:00
C1.2
Controvery: Should we restrict height in tall stature?
Should we restrict height in tall stature? - AGAINST
Pittsburgh, USA
Professor Stefan Wudy
Giessen, Germany
Sun 17 15:00
S5.2
Symposium 5 - Adrenal Disorders
Translational Clinical Applications of Complex Steroidobolome Data
Giessen, Germany
Yuanfeng Xia
Shanghai, China
Sat 16 14:55
FC2.1
Free Communications 2: Bone, Growth Plate and Mineral Metabolism
A highly selective FGFR3 inhibitor alleviates achondroplasia symptoms and restores chondrocyte growth in mice model
Shanghai, China
Shanghai, China
Shanghai, China
Shanghai, China
Shanghai, China
Rongrong Xie
Suzhou, China
Sun 17 09:50
RFC10.5
Rapid Free Communications 10: Multisystem Endocrine Disorders
GAD-65 antibody positive autoimmune encephalitis with type III autoimmune polyendocrine syndrome: a rare pediatric case report
Suzhou, China
Xueqiong Xu
Shanghai, China
Sat 16 14:45
RFC2.5
Rapid Free Communications 2: Bone, Growth Plate and Mineral Metabolism
Prediction of residual growth potential in adolescent boys by linear regression modeling based on the radiomics features extracted by knee DR images and clinical characteristics
Shanghai, China
Shanghai, China
Shanghai, China
Shanghai, China
Jibira Yakubu
Bern, Switzerland
Sun 17 09:40
RFC9.3
Rapid Free Communications 9: Sex Endocrinology and Gonads
Nanoencapsulated Curcumin-Piperine Complex: A Breakthrough in Targeting CYP17A1 for Managing Androgen Excess in Adolescents with PCOS.
Bern, Switzerland
Georgina Yan
London, United Kingdom
Mon 18 10:00
FC13.4
Free Communications 13: Pituitary, Neuroendocrinology and Puberty (2)
Relationship between the timing of the physical changes of puberty and total pubertal growth in healthy adolescents: new insights which can provide helpful clinical guidance
London, United Kingdom
Jianmei Yang
Jinan, China
Sun 17 09:35
RFC7.2
Rapid Free Communications 7: GH and IGFs
Time-Restricted Feeding Restored Growth Hormone Pulsatile Profile in LEAP-2 KO Mice with High Fat Diet
Jinan, China
Zehra  Yavas Abali
Istanbul, Turkey
Sat 16
ESPE Working Group on DSD/Differences in Sex Development
A rare cause of 46, XY gonadal dysgenesis: Case presentation
Istanbul, Turkey
Feng Ye
Wuhan, China
Sat 16 15:35
FC3.5
Free Communications 3: Pituitary, Neuroendocrinology and Puberty (1)
Screening for First Morning Voided (FMV) Urinary Gonadotropin (Gn) in Children with Normal and Precocious Puberty (PP): A Prospective, Multi-Center, Large-Sample based Study in China
Wuhan, China
Joanna Yuet-ling Tung
Hong Kong SAR, China
Sat 16 14:30
RFC2.2
Rapid Free Communications 2: Bone, Growth Plate and Mineral Metabolism
Microarchitectural Alterations in Children with Rheumatological conditions on Long‑term Glucocorticoid Treatment
Hong Kong SAR, China
Stephanie Zorn
Ulm, Germany
Sat 16 08:40
ESPE Working Group on Obesity
Early growth trajectories in chidlren with genetic obesity. A European collaboration project
Ulm, Germany
Chaochun Zou
Zhejiang, China
Sun 17 10:40
FC10.5
Free Communications 10: Multisystem Endocrine Disorders
Using sno-lncRNAs as potential markers for Prader-Willi syndrome diagnosis
Zhejiang, China
Workshop 0
Oral 0
Expert 0
Plenary 0
Catering and Social 0
Nurse 0
Other 0
Symposium 10
Sat 16 13:15
Satellite Symposium 1
For more information please see satellite programme
Hall 1
Sat 16 13:15
Satellite Symposium 2
For more information please see satellite programme
Meeting Room 3
Sat 16 17:50
Satellite Symposium 3
For more information please see satellite programme
Hall 1A
Sat 16 17:50
Satellite Symposium 4
For more information please see satellite programme
Hall 1B
Sat 16 17:50
Satellite Symposium 5
For more information please see satellite programme
Hall 1C
Sun 17 13:20
Satellite Symposium 6
For more information please see satellite programme
Exhibition Hall C
Sun 17 13:20
Satellite Symposium 7
For more information please see satellite programme
Meeting Room 3
Sun 17 17:00
Satellite Symposium 8
For more information please see satellite programme
Hall 1
Sun 17 17:00
Satellite Symposium 9
For more information please see satellite programme
Exhibition Hall C
Mon 18 13:05
Satellite Symposium 10
For more information please see satellite programme
Hall 1
No Session Type 104
Sat 16 07:00
Registration Open
ACC Cityside Galleria
Sat 16 07:30
Breakfast for Working Group Attendees
Exhibition Hall
Sat 16 08:00
ESPE Working Group on Obesity
Exhibition Hall C
Chair: Erica van den Akker (Rotterdam, The Netherlands)
Sat 16 08:00
ESPE Working Group on Obesity
Welcome and Update on Working Group Acitivities - Global Obesity Guidelines
Sat 16 08:15
ESPE Working Group on Obesity
Pubertal Development in Chinese Children and the Impact of Overnutrition, Lifestyle, and Perinatal Factors
Zhejiang, China
Sat 16 08:40
ESPE Working Group on Obesity
Early growth trajectories in chidlren with genetic obesity. A European collaboration project
Ulm, Germany
Sat 16 09:00
ESPE Working Group on Obesity
The CEW Clinic Concept
Liverpool, UK
Sat 16 09:20
ESPE Working Group on Obesity
Childhood obesity in 2024 - shortlist of highlights
Stockholm, Sweden
Sat 16 08:00
ESPE Working Group on Gender Incongruence
Hall 2H
Chair: Sabine Hannema (Amsterdam, The Netherlands)
Sat 16 08:00
ESPE Working Group on Gender Incongruence
Immunological effects of gender affirming hormone treatment
London, UK
Sat 16 08:30
ESPE Working Group on Gender Incongruence
Mental health/psychosocial outcomes versus mental health and brain effects
Chicago, USA
Sat 16 09:00
ESPE Working Group on Gender Incongruence
CORE ENDOCRINE REGISTRY: transgender module – preliminary data and future plans
Ghent, Belgium
Sat 16 08:00
ESPE Working Group on Paediatric and Adolescent Gynaecology
Hall 2K
Chair: Lourdes Ibanez (Barcelona, Spain)
Sat 16 08:00
ESPE Working Group on Paediatric and Adolescent Gynaecology
Genetics of POI
São Paulo, Brazil
Sat 16 08:30
ESPE Working Group on Paediatric and Adolescent Gynaecology
Clinical management
London, UK
Sat 16 09:00
ESPE Working Group on Paediatric and Adolescent Gynaecology
Fertility preservation in girls
Edinburgh, UK
Sat 16 08:00
ESPE Working Group on Turner Syndrome
This session is dedicated to the memory of Malcolm Donaldson, who was originally scheduled to speak
Around Updated Guidelines for TS
Hall 2J
Chair: Aneta Gawlik (Katowice, Poland)
Sat 16
ESPE Working Group on Turner Syndrome
Welcome
Katowice, Poland
Sat 16 08:00
ESPE Working Group on Turner Syndrome
News and doubts around growth and puberty therapy
Umea, Sweden
Sat 16 08:20
ESPE Working Group on Turner Syndrome
Beyond growth and puberty issues in girls with TS
Cincinnati, USA
Sat 16 08:40
ESPE Working Group on Turner Syndrome
Challenges from the adult endocrinologist perspective
Aarhus, Denmark
Sat 16 09:00
ESPE Working Group on Turner Syndrome
To present multi-central experience/data and invite to prospective study
Katowice, Poland
Sat 16 09:20
ESPE Working Group on Turner Syndrome
Round Table/Discussion
Sat 16 08:00
ESPE Working Group on Bone and Growth Plate
Meeting Room 3
Chair: Evelien Gevers (London, UK)
Sat 16 08:00
ESPE Working Group on Bone and Growth Plate
Update on Working Group Activities
Sat 16 08:10
ESPE Working Group on Bone and Growth Plate
Regulation of the Epiphyseal Stem Cells
Solna, Sweden
Sat 16 08:35
ESPE Working Group on Bone and Growth Plate
Osteogenesis imperfecta, update and the OI XIV Animal model
Pavia, Italy
Sat 16 09:00
ESPE Working Group on Bone and Growth Plate
A case of osteogenesis imperfecta with Antonella Forlio’s expert opinion
Sat 16 08:00
ESPE Working Group on DSD/Differences in Sex Development
Hall 1
Chair: Jan Idkowiak (Birmingham, UK)
Sat 16
ESPE Working Group on DSD/Differences in Sex Development
A rare cause of 46, XY gonadal dysgenesis: Case presentation
Istanbul, Turkey
Sat 16
ESPE Working Group on DSD/Differences in Sex Development
Partial gonadal dysgenesis due to chromosomal mosaicism – a challenging case
Birmingham, UK
Sat 16
ESPE Working Group on DSD/Differences in Sex Development
Novel insights into the diagnosis of gonadal dysgnesis: findings from the 46,XY gonadal dysgenesis study based on the I-DSD Registry
Cambridge, United Kingdom
Sat 16
ESPE Working Group on DSD/Differences in Sex Development
Pathophysiology and Management of Dysgenetic Gonads
Ghent, Belgium
Sat 16 08:00
ESPE Working Group - Nurse
Hall 2G
Chair: Camilla Ernstsson (Västerbotten County, Sweden)
Sat 16 08:00
ESPE Working Group - Nurse
Research and innovation in nursing
Sat 16 08:45
ESPE Working Group - Nurse
Transition in endocrinology - the challenges - change to Complications after cancer treatment
Sat 16 09:30
Coffee, Exhibition & Posters
Exhibition Hall
Sat 16 10:00
Opening Ceremony
Arena Plenary
Sat 16 10:15
Plenary 1 - Impact of GH treatment on DNA damage
Arena Plenary
Chairs: Mehul Dattani (London, UK) & Mohamad Maghnie (Geneva, Italy)
Sat 16 10:15
PL1
Plenary 1 - Impact of GH treatment on DNA damage
Impact of GH on DNA damage
Los Angeles CA , USA
Sat 16 10:45
Awards 1 - Henning Andersen Prizes
Arena Plenary
Chair: Peter Kuhnen (Berlin, Germany)
Sat 16 11:25
Symposium 1 - Disorders of Sex Development: Novel advances in management
Hall 1
Chairs: Faisal Ahmed (Glasgow, UK) & Carla Bizzarri (Rome, Italy)
Sat 16 11:25
S1.1
Symposium 1 - Disorders of Sex Development: Novel advances in management
Vascular reactivity and morbidity in DSD
Glasgow, UK
Sat 16 11:55
S1.2
Symposium 1 - Disorders of Sex Development: Novel advances in management
Novel mechanisms leading to DSD (genomic, digenic/ollogenic and non-coding variation)
Paris, France
Sat 16 12:25
S1.3
Symposium 1 - Disorders of Sex Development: Novel advances in management
Hypospadias - surgery and beyond
Stockholm, Sweden
Sat 16 11:25
Symposium 2 - Bone and Mineral Disorders: Recent Developments
Hall 2K
Chairs: Wolfgang Hoegler (Linz, Austria) & Suma Uday (Birmingham, UK)
Sat 16 11:25
S2.1
Symposium 2 - Bone and Mineral Disorders: Recent Developments
Phosphate sensing in normal physiology and disease
Zurich, Switzerland
Sat 16 11:55
S2.2
Symposium 2 - Bone and Mineral Disorders: Recent Developments
Advances in FGF 23 related disorders
Maryland, USA
Sat 16 12:25
S2.3
Symposium 2 - Bone and Mineral Disorders: Recent Developments
PTH Resistance Syndromes
Paris, France
Sat 16 11:25
Symposium 3 - Novel Advances and Treatments of Hypothalamic disease
Hall 2H
Chairs: Hanneke Van Santen (Utrecht, the Netherlands) & Peter Clayton (Manchester, UK)
Sat 16 11:25
S3.1
Symposium 3 - Novel Advances and Treatments of Hypothalamic disease
National UK Guidelines for the Management of Paediatric Craniopharyngioma
London, UK
Sat 16 11:55
S3.2
Symposium 3 - Novel Advances and Treatments of Hypothalamic disease
Use of MC4R agonist in hypothalamic obesity
Madrid, Spain
Sat 16 12:25
S3.3
Symposium 3 - Novel Advances and Treatments of Hypothalamic disease
Proton Beam Therapy in childhood brain tumours
Tennessee, USA
Sat 16 11:25
Symposium 4 - New Adjuvant Therapy in Pediatric Diabetes (ISPAD/ESPE)
Hall 2J
Chairs: Jacques Beltrand (Paris, France) & Ram Weiss (Haifa, Israel)
Sat 16 11:25
S4.1
Symposium 4 - New Adjuvant Therapy in Pediatric Diabetes (ISPAD/ESPE)
Use of Verapamil in newly diagnosed T1D
Colorado , USA
Sat 16 11:55
S4.2
Symposium 4 - New Adjuvant Therapy in Pediatric Diabetes (ISPAD/ESPE)
Use of GLP1 receptor agonists in Wolfram syndrome
Ixelles, Belgium
Sat 16 12:25
S4.3
Symposium 4 - New Adjuvant Therapy in Pediatric Diabetes (ISPAD/ESPE)
Statins and Cardiovascular risk in T1D
Cambridge, UK
Sat 16 11:25
Yearbook 1
Hall 2G
Sat 16 11:25
Yearbook 1
Type 2 Diabetes, Metabolic Syndrome and Lipids
Tel Aviv, Israel
Sat 16 11:37
Yearbook 1
Global Health for the Paediatric Endocrinologist
Stanford, USA
Sat 16 11:49
Yearbook 1
Growth and Growth Factors
Rome, Italy
Sat 16 12:01
Yearbook 1
Puberty
Liège, Belgium
Sat 16 12:13
Yearbook 1
Adrenals
Athens, Greece
Sat 16 12:55
Lunch, Exhibition & Posters
Exhibition Hall
Sat 16 14:25
Rapid Free Communications 1: Diabetes and Insulin
Hall 2J
Chairs: Catherine Peters (London, UK) & Ruben Willemsen (London, UK)
Sat 16 14:25
RFC1.1
Rapid Free Communications 1: Diabetes and Insulin
Perceptions and Experiences of PDSNs on Different Hybrid Closed Loop Systems (HCLS) across Wales
Cardiff, United Kingdom
Sat 16 14:30
RFC1.2
Rapid Free Communications 1: Diabetes and Insulin
Evaluating Glucose-6-Phosphate Dehydrogenase Enzyme Activity In Children With Type 1 Diabetes Mellitus.
Alexandria, Egypt
Alexandria, Egypt
Sat 16 14:35
RFC1.3
Rapid Free Communications 1: Diabetes and Insulin
Akkermansia muciniphila induces immune homeostasis in type 1 diabetic mice by up-regulating CD4 + FoxP3 + Treg expression.
Guangzhou, China
Sat 16 14:40
RFC1.4
Rapid Free Communications 1: Diabetes and Insulin
Children born small for gestational age (SGA) under growth hormone treatment have similarly impaired glucose-insulin metabolism as children with obesity
Leipzig, Germany
Sat 16 14:45
RFC1.5
Rapid Free Communications 1: Diabetes and Insulin
Evaluation of Arterial Stiffness in Children with Type 1 Diabetes Mellitus Using Speckle Tracking Carotid Strain Ultrasonography: Do Atherosclerotic Changes Begin in Childhood?
Aydın, Turkey
Sat 16 14:50
RFC1.6
Rapid Free Communications 1: Diabetes and Insulin
METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE AND ITS ASSOCIATION WITH GLYCEMIC CONTROL METRICS IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES: AN EXPLORATORY STUDY
Verona, Italy
Sat 16 14:25
Rapid Free Communications 2: Bone, Growth Plate and Mineral Metabolism
Hall 2K
Chair: Gabriele Hartmann (Vienna, Austria) and Renuka Ramakrishnan (Liverpool, United Kingdom)
Sat 16 14:25
RFC2.1
Rapid Free Communications 2: Bone, Growth Plate and Mineral Metabolism
Bone and Body Composition after one year of Vosorotide treatment in children with Achondroplasia: a longitudinal prospective study.
Genova, Italy
Sat 16 14:30
RFC2.2
Rapid Free Communications 2: Bone, Growth Plate and Mineral Metabolism
Microarchitectural Alterations in Children with Rheumatological conditions on Long‑term Glucocorticoid Treatment
Hong Kong SAR, China
Sat 16 14:35
RFC2.3
Rapid Free Communications 2: Bone, Growth Plate and Mineral Metabolism
Optimizing the Growth Outcome follow up in Hypophosphatemic Rickets Treated with Burosumab: The Critical Role of Auxological Measurements
Padova, Italy
Sat 16 14:40
RFC2.4
Rapid Free Communications 2: Bone, Growth Plate and Mineral Metabolism
CYP24A1 MUTATIONS:, CLINICAL AND LABORATORY FEATURES IN PATIENTS PRESENTING WITH HYPERCALCEMIA
Istanbul, Turkey
Sat 16 14:45
RFC2.5
Rapid Free Communications 2: Bone, Growth Plate and Mineral Metabolism
Prediction of residual growth potential in adolescent boys by linear regression modeling based on the radiomics features extracted by knee DR images and clinical characteristics
Shanghai, China
Shanghai, China
Shanghai, China
Shanghai, China
Sat 16 14:50
RFC2.6
Rapid Free Communications 2: Bone, Growth Plate and Mineral Metabolism
Comparison of two automated bone age evaluation methods in pediatric patients with growth and puberty disorders
Lausanne, Switzerland
Sat 16 14:25
Rapid Free Communications 3: Pituitary, Neuroendocrinology and Puberty (1)
Hall 1
Chairs: Bradley Miller (Minnesota, USA) & Rachel Reynaud (Marseille, France)
Sat 16 14:25
RFC3.1
Rapid Free Communications 3: Pituitary, Neuroendocrinology and Puberty (1)
DNA Methylation profiles in girls with anorexia nervosa and amenorrhea: a pilot study
Naples, Italy
Sat 16 14:30
RFC3.2
Rapid Free Communications 3: Pituitary, Neuroendocrinology and Puberty (1)
Results from a targeted hypopituitarism gene panel in patients with variable congenital hypopituitarism identifies variants in known and novel candidate genes.
London, United Kingdom
Sat 16 14:35
RFC3.3
Rapid Free Communications 3: Pituitary, Neuroendocrinology and Puberty (1)
Analysis of the expression levels of spexin and kisspeptin in serum, ovarian tissue and white adipose tissue as related to pubertal status and metabolic surrogates of puberty in female albino Wistar rats
Istanbul, Turkey
Sat 16 14:40
RFC3.4
Rapid Free Communications 3: Pituitary, Neuroendocrinology and Puberty (1)
Longitudinal Changes in Serum DLK1 Concentrations During Pubertal Transition in Healthy Girls and in girls with Precocious Puberty during GnRHa treatment
Copenhagen, Denmark
Sat 16 14:45
RFC3.5
Rapid Free Communications 3: Pituitary, Neuroendocrinology and Puberty (1)
Long-Term Health Outcomes of Delayed Puberty in Males: A Comprehensive Population-Based Study
Örebro, Sweden
Sat 16 14:50
RFC3.6
Rapid Free Communications 3: Pituitary, Neuroendocrinology and Puberty (1)
Final Height and Endocrine Complications in Children with Pilocytic Astrocytomas: A Retrospective Study
Istanbul, Turkey
Sat 16 14:25
Rapid Free Communications 4: Adrenals and HPA Axis (1)
Hall 2H
Chairs: Evangelia Charmandari (London, UK) & Harshini Katugampola (London, UK)
Sat 16 14:25
RFC4.1
Rapid Free Communications 4: Adrenals and HPA Axis (1)
Screening for Adrenal Insufficiency in Children by Home Waking Salivary Cortisone testing
Liverpool, UK
Sat 16 14:30
RFC4.2
Rapid Free Communications 4: Adrenals and HPA Axis (1)
Salivary cortisol and cortisone is related to age
Liverpool, United Kingdon
Sat 16 14:35
RFC4.3
Rapid Free Communications 4: Adrenals and HPA Axis (1)
Differences and similarities in salivary diurnal adrenal hormones in monozygotic twins with intra-twin birthweight-differences
Bonn, Germany
Sat 16 14:40
RFC4.4
Rapid Free Communications 4: Adrenals and HPA Axis (1)
Serum cortisol correlates strongly with salivary cortisol and cortisone in girls and boys, and across all ages
Liverpool, United Kingdom
Sat 16 14:45
RFC4.5
Rapid Free Communications 4: Adrenals and HPA Axis (1)
Ontogenesis of the urinary steroid metabolome in infancy assessed by gas chromatography/mass spectrometry (GC-MS)
Gießen, Germany
Sat 16 14:50
RFC4.6
Rapid Free Communications 4: Adrenals and HPA Axis (1)
Machine Learning-Based Decision Tree Model for the Diagnosis of Congenital Disorders of Adrenal Steroidogenesis Using LC-MS/MS-based Plasma Steroid Hormone Profiles
Istanbul, Turkey
Sat 16 14:25
Rapid Free Communications 5: Growth and Syndromes
Hall 2G
Chair: Assunta Albanese (London, United Kingdom) and Aneta Gawlik (Katowice, Poland)
Sat 16 14:25
RFC5.1
Rapid Free Communications 5: Growth and Syndromes
ABOUT CARING FOR PATIENTS AND UNDERSTANDING THEIR PATHWAYS: 10 YEARS OF ‘THE ROTTERDAM CENTRE FOR ADULTS WITH RARE GENETIC SYNDROMES’
Rotterdam, The Netherlands
Sat 16 14:30
RFC5.2
Rapid Free Communications 5: Growth and Syndromes
The development and validation of Bone age-guided Interpretation of Growth (BIG), a web-based tool for the guidance of evaluation of children and adolescents with growth disorders.
kanpur, India
Sat 16 14:35
RFC5.3
Rapid Free Communications 5: Growth and Syndromes
Neuroradiological Findings in Noonan Syndrome: a multicentric Italian study
Genova, Italy
Sat 16 14:40
RFC5.4
Rapid Free Communications 5: Growth and Syndromes
Analysis of growth patterns in Klinefelter syndrome using the QEPS growth model
Gothenburg, Sweden
Sat 16 14:45
RFC5.5
Rapid Free Communications 5: Growth and Syndromes
Searching for associated dysmorphic and cardiac abnormalities in youth tall basketball players
Prague, Czech republic
Sat 16 14:50
RFC5.6
Rapid Free Communications 5: Growth and Syndromes
Pubertal induction in girls with Turner syndrome – retrospective data from the International TS registry
Katowice, Poland
Sat 16 14:55
Free Communications 1: Diabetes and Insulin
Hall 2J
Chairs: Catherine Peters (London, UK) & Ruben Willemsen (London, UK)
Sat 16 14:55
FC1.1
Free Communications 1: Diabetes and Insulin
Does Type 1 Diabetes Effect Left Ventricular Function in Children? Evaluation with Treadmill Exercise Stress Echocardiography
Izmir, Turkey
Sat 16 15:05
FC1.2
Free Communications 1: Diabetes and Insulin
EFFECT OF HYDROXYCHLOROQUINE THERAPY IN NEWLY DIAGNOSED TYPE 1 DIABETES: A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROL PILOT TRIAL
Chandigarh, India
Sat 16 15:15
FC1.3
Free Communications 1: Diabetes and Insulin
A Non-Invasive Diagnostic Tool for Early Detection of Microvascular Alterations in Children with Type 1 Diabetes Mellitus: Nail-Fold Capillaroscopy
Izmir, Turkey
Sat 16 15:25
FC1.4
Free Communications 1: Diabetes and Insulin
A personalized approach to classify the degree of liver insulin resistance in children with obesity
Hertogenbosch, The Netherlands
Sat 16 15:35
FC1.5
Free Communications 1: Diabetes and Insulin
The Side-Effects of Lanreotide in Children with Congenital Hyperinsulinism (CHI): A Decade-long Exploration
Basildon, United Kingdom
Sat 16 15:45
FC1.6
Free Communications 1: Diabetes and Insulin
Comprehensive rescreening of the known congenital hyperinsulinism genes provides a new genetic diagnosis for 18% of the Finnish cohort
Exeter, United Kingdom
Sat 16 14:55
Free Communications 2: Bone, Growth Plate and Mineral Metabolism
Hall 2K
Chair: Gabriele Hartmann (Vienna, Austria) and Renuka Ramakrishnan (Liverpool, United Kingdom)
Sat 16 14:55
FC2.1
Free Communications 2: Bone, Growth Plate and Mineral Metabolism
A highly selective FGFR3 inhibitor alleviates achondroplasia symptoms and restores chondrocyte growth in mice model
Shanghai, China
Shanghai, China
Shanghai, China
Shanghai, China
Shanghai, China
Sat 16 15:05
FC2.2
Free Communications 2: Bone, Growth Plate and Mineral Metabolism
Therapeutic Effects of Human Bone Marrow Mesenchymal Stem Cells Derived Exosomes on Glucocorticoid-Induced Osteoporosis: In Vitro Model
İstanbul, Turkey
Sat 16 15:15
FC2.3
Free Communications 2: Bone, Growth Plate and Mineral Metabolism
Molecular mechanism of FBN1 variants result to acromicric dysplasia by mechano-transduction
Hangzhou, China
Sat 16 15:25
FC2.4
Free Communications 2: Bone, Growth Plate and Mineral Metabolism
Analysis of baseline data from the SUNFLOWER longitudinal, observational cohort study of patients with XLH: relationship between various complications and QOL
Tottori, Japan
Sat 16 15:35
FC2.5
Free Communications 2: Bone, Growth Plate and Mineral Metabolism
Bone health in adolescents with cow’s milk allergy during infancy
Helsinki, Finland
Sat 16 15:45
FC2.6
Free Communications 2: Bone, Growth Plate and Mineral Metabolism
Expansion of the CrescNet Registry Achondroplasia Module: Real-World Demographic Data and Outcomes After up to 2 Years of Vosoritide Treatment
Magdeburg, Germany
Sat 16 14:55
Free Communications 3: Pituitary, Neuroendocrinology and Puberty (1)
Hall 1
Chairs: Bradley Miller (Minnesota, USA) & Rachel Reynaud (Marseille, France)
Sat 16 14:55
FC3.1
Free Communications 3: Pituitary, Neuroendocrinology and Puberty (1)
The Effects of Blue Light Exposure on the Epiphyseal Plate and IGF1 - IGFBP3 Expression in Rats
Ankara, Turkey
Sat 16 15:05
FC3.2
Free Communications 3: Pituitary, Neuroendocrinology and Puberty (1)
Disruption of the Wnt-antagonist APC in the pituitary stem cells is a driver of adamantinomatous craniopharyngioma
London, United Kingdom
Sat 16 15:15
FC3.3
Free Communications 3: Pituitary, Neuroendocrinology and Puberty (1)
Analysis of clinical factors affecting retinal ganglion cell complex thickness reduction in patients with childhood‑onset craniopharyngioma.
Warsaw, Poland
Sat 16 15:25
FC3.4
Free Communications 3: Pituitary, Neuroendocrinology and Puberty (1)
The spectrum of Endocrinopathies in Children with Ectopic Posterior Pituitary (EPP) correlates with the severity of associated hypothalamo-pituitary abnormalities on imaging: a decade long experience from two tertiary centers.
Basildon, United Kingdom
Sat 16 15:35
FC3.5
Free Communications 3: Pituitary, Neuroendocrinology and Puberty (1)
Screening for First Morning Voided (FMV) Urinary Gonadotropin (Gn) in Children with Normal and Precocious Puberty (PP): A Prospective, Multi-Center, Large-Sample based Study in China
Wuhan, China
Sat 16 15:45
FC3.6
Free Communications 3: Pituitary, Neuroendocrinology and Puberty (1)
Adolescent Acne: Association to Sex, Age, Pubertal Stage and Circulating Concentrations of Testosterone and DHT
Copenhagen, Denmark
Sat 16 14:55
Free Communications 4: Adrenals and HPA Axis (1)
Hall 2H
Chairs: Evangelia Charmandari (London, UK) & Harshini Katugampola (London, UK)
Sat 16 14:55
FC4.1
Free Communications 4: Adrenals and HPA Axis (1)
Real world data analysis of contemporary therapy and its association to anthropometric outcomes in 1500 patients with congenital adrenal hyperplasia (CAH).
Sheffield, United Kingdom
Sat 16 15:05
FC4.2
Free Communications 4: Adrenals and HPA Axis (1)
11-oxygenated androgens are abundantly produced by first and second-trimester foetal adrenal glands in ex vivo culture
Birmingham, United Kingdom
Sat 16 15:15
FC4.3
Free Communications 4: Adrenals and HPA Axis (1)
Plasma reference values for C19 oxy-steroids, 11-keto testosterone and 11-keto androstenedione in a paediatric cohort
Kiel, Germany
Sat 16 15:25
FC4.4
Free Communications 4: Adrenals and HPA Axis (1)
Crinecerfont, a Corticotropin-Releasing Factor Type 1 Receptor (CRF1) Antagonist, Reduced Excess Adrenal Androgens and Glucocorticoid Doses in Children and Adolescents with Classic Congenital Adrenal Hyperplasia: Results from CAHtalystTM Pediatric
Minneapolis, United States
Sat 16 15:35
FC4.5
Free Communications 4: Adrenals and HPA Axis (1)
3D printed, personalized hydrocortisone for hypocortisolemia.
Rotterdam, The Netherlands
Sat 16 15:45
FC4.6
Free Communications 4: Adrenals and HPA Axis (1)
Comparative Efficacy of Modified-Release versus Conventional Hydrocortisone Treatment in Adolescents and Young Adults with Congenital Adrenal Hyperplasia: A Retrospective Observational Study
Agios Nikolaos, Greece
Sat 16 14:55
Free Communications 5: Growth and Syndromes
Hall 2G
Chair: Assunta Albanese (London, United Kingdom) and Aneta Gawlik (Katowice, Poland)
Sat 16 14:55
FC5.1
Free Communications 5: Growth and Syndromes
A homozygous variant in ZSWIM6 causes short stature, microcephaly and developmental delay
Prague, Czech Republic
Sat 16 15:05
FC5.2
Free Communications 5: Growth and Syndromes
The pathogenesis of Noonan syndrome and associated growth restriction is modulated by NOC2L, a novel interactor of LZTR1 leading to impaired p53 signalling
London, United Kingdom
Sat 16 15:15
FC5.3
Free Communications 5: Growth and Syndromes
Gene expression of monosomy X during human development reveals potential mechanisms in Turner syndrome
London, United Kingdom
Sat 16 15:25
FC5.4
Free Communications 5: Growth and Syndromes
Predictors of short stature at age 6-7 years in Israeli children
Petach Tikva, Israel
Sat 16 15:35
FC5.5
Free Communications 5: Growth and Syndromes
Phase 2 Trial of Vosoritide Use in patients with Hypochondroplasia: Pharmacokinetic/ Pharmacodynamic analysis from 12 Month Data
Washington DC, United States of America (USA)
Sat 16 15:45
FC5.6
Free Communications 5: Growth and Syndromes
First line treatment evaluation in patients with severe primary insulin-like growth factor 1 deficiency (SPIGFD): Data from the Global Increlex® Registry
Linköping, Sweden
Sat 16 14:25
How Do I...1
Arena Plenary
Chairs: Veronica Mericq (Santiago, Chile) & Jo Blair (Liverpool, UK)
Sat 16 14:25
HDI1.1
How Do I...1
How do I...Use Bisphosphonates
Genoa, Italy
Sat 16 14:55
HDI1.2
How Do I...1
How do I...Handle GLP-1 analogue treatment in adolescents with obesity
Salzburg, Austria
Sat 16 15:25
HDI1.3
How Do I...1
How do I...Manage the infant with hypoglycaemia
Brussels, Belgium
Sat 16 15:55
Coffee, Posters & Exhibition
Exhibition Hall
Sat 16 16:15
Plenary 2 - Addressing Inequalities in Child Health. Lessons from the UK policy experiments in poverty and adversity
Arena Plenary
Chairs: Rasha Hamza (Cairo, Egypt) & Poonam Dharmaraj (Liverpool, UK)
Sat 16 16:15
PL2
Plenary 2 - Addressing Inequalities in Child Health. Lessons from the UK policy experiments in poverty and adversity
Addressing Inequalities in Child Health. Lessons from the UK policy experiments in poverty and adversity
Liverpool, UK
Sat 16 16:55
Meet The Expert 1.1
Hall 2G
Sat 16 16:55
MTE1.1
Meet The Expert 1.1
Genetic Testing in Hypogonadism
Paris, France
Sat 16 16:55
Meet The Expert 2.1
Hall 2K
Sat 16 16:55
MTE2.1
Meet The Expert 2.1
Management of Lipodystrophy
Cambridge, UK
Sat 16 16:55
Meet The Expert 3.1
Hall 2H
Sat 16 16:55
MTE3.1
Meet The Expert 3.1
Pharmacological treatment options for adolescents with Obesity
Rotterdam, The Netherlands
Sat 16 16:55
Meet The Expert 4.1
Hall 2J
Sat 16 16:55
MTE4.1
Meet The Expert 4.1
Closed loop in the very young
Luxembourg, Luxembourg
Sat 16 16:55
Novel Advances
Exhibition Hall C
Chairs: Irene Netchine (Paris, France) & Rod Mitchell (Edinburgh, United Kingdom)
Sat 16 16:55
NA1
Novel Advances
Relevance of single cell analysis and spatial transcriptomics for endocrine research to unravel new mechanisms?
London, UK
Sun 17 07:15
Registration Open
ACC Cityside Galleria
Sun 17 08:00
Plenary 3 - Adipogenic Hits on Kids
Arena Plenary
Chairs: Annette Grüters-Kieslich (Berlin, Germany) & Agnès Linglart (Paris, France)
Sun 17 08:00
PL3
Plenary 3 - Adipogenic Hits on Kids
Adipogenic Hits on Kids
Leipzig, Germany
Sun 17 08:35
Meet The Expert 5.1
Hall 2G
Sun 17 08:35
MTE5.1
Meet The Expert 5.1
Managing difficult menstrual periods
London, UK
Sun 17 08:35
Meet The Expert 6.1
Hall 2K
Sun 17 08:35
MTE6.1
Meet The Expert 6.1
Management of sodium and water regulation disorders
Leuven, Belgium
Sun 17 08:35
Meet The Expert 7.1
Hall 2H
Sun 17 08:35
MTE7.1
Meet The Expert 7.1
Diagnosis and Management of PCOS
Tel Aviv, Israel
Sun 17 08:35
Meet The Expert 8.1
Hall 2J
Sun 17 08:35
MTE8.1
Meet The Expert 8.1
The Diagnosis & Management of Rickets in the 21st Century
Dubai , UAE
Sun 17 08:35
Meet The Expert 2.2
Hall 1
Sun 17 08:35
MTE2.2
Meet The Expert 2.2
Management of Lipodystrophy
Cambridge, UK
Sun 17 08:30
Controvery: Should we restrict height in tall stature?
Exhibition Hall C
Chairs: Jan Maarten Wit (Leiden, the Netherlands) & Peter Simm (Melbourne, Australia)
Sun 17 08:30
C1.1
Controvery: Should we restrict height in tall stature?
Should we restrict height in tall stature? - FOR
Stockholm, Sweden
Sun 17 09:00
C1.2
Controvery: Should we restrict height in tall stature?
Should we restrict height in tall stature? - AGAINST
Pittsburgh, USA
Sun 17 09:30
ESPE-ESE Joint Symposium
Arena Plenary
Chairs: Anita Hokken-Koelega (Rotterdam, The Netherlands) & Jérôme Bertherat (Paris, France)
Sun 17 09:30
ES1.1
ESPE-ESE Joint Symposium
Endocrine disrupting effects of over-the-counter mild analgesics such as paracetamol in humans
Copenhagen, Denmark
Sun 17 10:00
ES1.2
ESPE-ESE Joint Symposium
Prenatal Exposure to Over-the-Counter Antifugal Drugs Affects Fetal Steroidogenesis and is Associated with Persistent Effects in Children
Copenhagen, Denmark
Sun 17 10:30
ES1.3
ESPE-ESE Joint Symposium
Effect of EDCs on the hypothalamic regulation of energy homeostasis and GnRH activity
Liège, Belgium
Sun 17 09:30
Rapid Free Communications 6: Fat, Metabolism and Obesity (1)
Hall 2G
Chairs: Cosimo Gianini (Chieti, Italy) & Violeta Iotova (Varna, Bulgaria)
Sun 17 09:30
RFC6.1
Rapid Free Communications 6: Fat, Metabolism and Obesity (1)
Frequency of genetic variants in a population with early-onset obesity: a single center experience
Naples, Italy
Sun 17 09:35
RFC6.2
Rapid Free Communications 6: Fat, Metabolism and Obesity (1)
Genetic Diagnostic Yield of Obesity
Leipzig, Germany
Sun 17 09:40
RFC6.3
Rapid Free Communications 6: Fat, Metabolism and Obesity (1)
Identification and clinical characterization of new patients with novel monogenic agouti-like obesity trait
Leipzig, Germany
Sun 17 09:45
RFC6.4
Rapid Free Communications 6: Fat, Metabolism and Obesity (1)
Investigation of GNAS Variations as Causes of Monogenic Obesity in Qatar: An Integrative Approach Utilizing In Silico, In Vivo, and In Vitro Studies
Doha, Qatar
Sun 17 09:50
RFC6.5
Rapid Free Communications 6: Fat, Metabolism and Obesity (1)
GRB10 METHYLATION IN UMBILICAL CORD ASSOCIATES POSTNATALLY WITH OBESITY IN HEALTHY CHILDREN
Girona, Spain
Sun 17 09:55
RFC6.6
Rapid Free Communications 6: Fat, Metabolism and Obesity (1)
POTENTIAL ROLE OF ASPG METHYLATION AS A BIOMARKER OF CHILDHOOD OBESITY
Girona, Spain
Sun 17 09:30
Rapid Free Communications 7: GH and IGFs
Hall 2K
Chairs: Maria Carolina Salerno (Naples, Italy) & TBC
Sun 17 09:30
RFC7.1
Rapid Free Communications 7: GH and IGFs
Understanding the molecular basis of short stature in Fanconi Anemia: Impact of pappalysins and stanniocalcins on IGF-I bioavailability
Toledo, Spain
Sun 17 09:35
RFC7.2
Rapid Free Communications 7: GH and IGFs
Time-Restricted Feeding Restored Growth Hormone Pulsatile Profile in LEAP-2 KO Mice with High Fat Diet
Jinan, China
Sun 17 09:40
RFC7.3
Rapid Free Communications 7: GH and IGFs
Incidence of false positive results of growth hormone stimulation tests in children with short stature – from theoretical background to clinical approach
Lodz, Poland
Sun 17 09:45
RFC7.4
Rapid Free Communications 7: GH and IGFs
Use of iSYS-IDS IGF1-Assay Normative Data as a STANDARD in the Diagnosis of Pediatric Growth Hormone Deficiency
ALGIERS, ALGERIA
Sun 17 09:50
RFC7.5
Rapid Free Communications 7: GH and IGFs
HEALTH-RELATED QUALITY OF LIFE AT MID-PUBERTY IN ADOLESCENTS WITH IDIOPATHIC ISOLATED GROWTH HORMONE DEFICIENCY
Rotterdam, The Netherlands
Sun 17 09:55
RFC7.6
Rapid Free Communications 7: GH and IGFs
Big data as a strategy in the development of population auxological studies
Vitoria, Spain
Sun 17 09:30
Rapid Free Communications 8: Adrenals and HPA Axis (2)
Hall 2H
Chairs: Tülay Güran (Istanbul, Turkey) & Anna Nordenstrom (Solna, Sweden)
Sun 17 09:30
RFC8.1
Rapid Free Communications 8: Adrenals and HPA Axis (2)
PREDICT – A randomized investigation of a reduced prenatal dexamethasone dose to reduce virilization in female fetuses with congenital adrenal hyperplasia
Berlin, Germany
Sun 17 09:35
RFC8.2
Rapid Free Communications 8: Adrenals and HPA Axis (2)
A Novel Peroxisomal Cause of Primary Adrenal İnsufficiency: Pseudo-neonatal Adrenoleukodystrophy Due to ACOX1 Mutations.
Istanbul, Turkey
Sun 17 09:40
RFC8.3
Rapid Free Communications 8: Adrenals and HPA Axis (2)
Multi-hit Model of Primary Adrenal Insufficiency in CPOX mutations
Istanbul, Turkey
Sun 17 09:45
RFC8.4
Rapid Free Communications 8: Adrenals and HPA Axis (2)
Rare Genetic Etiology of Primary Adrenal Insufficiency in Children; Clinical and Genetic Characterization Of a Large Sudanese Cohort
Khartoum, Sudan
Sun 17 09:50
RFC8.5
Rapid Free Communications 8: Adrenals and HPA Axis (2)
Mitochondrial Nicotinamide Nucleotide Transidrogenase (NNT) and NNT-AS1 impairment is associated with worse outcomes in patients with adrenocortical tumors
Ribeirão Preto, Brazil
Sun 17 09:55
RFC8.6
Rapid Free Communications 8: Adrenals and HPA Axis (2)
Prospective evaluation of urinary outcome after partial urogenital sinus mobilization (PUM) for toilet trained female patients with classic congenital adrenal hyperplasia (CAH).
Cairo, Egypt
Cairo, Egypt
Sun 17 09:30
Rapid Free Communications 9: Sex Endocrinology and Gonads
Hall 2J
Chairs: Sabah Alvi (Leeds, United Kingdom) & Sabine Hannema (Amsterdam, The Netherlands)
Sun 17 09:30
RFC9.1
Rapid Free Communications 9: Sex Endocrinology and Gonads
Prenatal Steroid profiling in 46,XY Disorders of sexual Development (DSD) : A 10 year Retrospective Cohort study
Bron, France
Sun 17 09:35
RFC9.2
Rapid Free Communications 9: Sex Endocrinology and Gonads
Effects of the modified release hydrocortisone preparation Efmody® on hormones, spermatogenesis and body weight in males with congenital adrenal hyperplasia
St.Gallen, Switzerland
Sun 17 09:40
RFC9.3
Rapid Free Communications 9: Sex Endocrinology and Gonads
Nanoencapsulated Curcumin-Piperine Complex: A Breakthrough in Targeting CYP17A1 for Managing Androgen Excess in Adolescents with PCOS.
Bern, Switzerland
Sun 17 09:45
RFC9.4
Rapid Free Communications 9: Sex Endocrinology and Gonads
Testicular function in prepubertal boys with haematological malignancies during and post chemotherapy: a prospective, longitudinal study
Buenos Aires, Argentina
Sun 17 09:50
RFC9.5
Rapid Free Communications 9: Sex Endocrinology and Gonads
Reevaluating Guidelines for Primary Ovarian Insufficiency Workup: Is It Time for a Change?
Ramat Gan, Israel
Sun 17 09:55
RFC9.6
Rapid Free Communications 9: Sex Endocrinology and Gonads
GnRHa TREATMENT OF CRYPTORCHIDISM ALTERS TESTICULAR SUMO GENE EXPRESSION
Liestal, Switzerland
Sun 17 09:30
Rapid Free Communications 10: Multisystem Endocrine Disorders
Hall 1
Chairs: Abdelhadi Habeb (Madinah, Saudi Arabia) & Leena Patel (Manchester, UK)
Sun 17 09:30
RFC10.1
Rapid Free Communications 10: Multisystem Endocrine Disorders
Long-Term Endocrine Outcomes of Acute Lymphoblastic Leukemia Treatment with Special Emphasis on the Gonadal Impact
Istanbul, Turkey
Sun 17 09:35
RFC10.2
Rapid Free Communications 10: Multisystem Endocrine Disorders
Ten-year follow up for Children with non-lethal form of Raine Syndrome: Single Center Experience in Oman
Muscat, Oman
Sun 17 09:40
RFC10.3
Rapid Free Communications 10: Multisystem Endocrine Disorders
Anthropometric changes in survivors of childhood acute lymphoblastic leukemia treated on the Italian Association of Pediatric Hematology and Oncology protocols without radiotherapy in the last two decades: preliminary data from an Italian tertiary center.
MODENA, ITALY
Sun 17 09:45
RFC10.4
Rapid Free Communications 10: Multisystem Endocrine Disorders
Manifestation of PTEN and MUTYH gene mutations: A Case Report
Kaunas, Lithuania
Sun 17 09:50
RFC10.5
Rapid Free Communications 10: Multisystem Endocrine Disorders
GAD-65 antibody positive autoimmune encephalitis with type III autoimmune polyendocrine syndrome: a rare pediatric case report
Suzhou, China
Sun 17 09:55
RFC10.6
Rapid Free Communications 10: Multisystem Endocrine Disorders
Different Faces of Carney Complex: Report of Three Cases
Istanbul, Turkey
Sun 17 10:00
Free Communications 6: Fat, Metabolism and Obesity (1)
Hall 2G
Chairs: Cosimo Gianini (Chieti, Italy) & Violeta Iotova (Varna, Bulgaria)
Sun 17 10:00
FC6.1
Free Communications 6: Fat, Metabolism and Obesity (1)
Corneal Nerve Loss and regeneration after GLP-1 Therapy in Children with Simple and Monogenic Obesity
Doha, Qatar
Sun 17 10:10
FC6.2
Free Communications 6: Fat, Metabolism and Obesity (1)
Frequency of Bardet-Biedl syndrome variants in a population with early-onset obesity
Madrid, Spain
Sun 17 10:20
FC6.3
Free Communications 6: Fat, Metabolism and Obesity (1)
SPISE is more strongly correlated with cardiometabolic factors in adolescents with obesity than HOMA-IR, and is related to the amount of body weight reduction under lifestyle intervention
Genoa, Italy
Sun 17 10:30
FC6.4
Free Communications 6: Fat, Metabolism and Obesity (1)
Relaxation of Food Control Parameters Based on Improvements in the Food Safe Zone Questionnaire Occurs with Reduction of Hyperphagia in Clinical Trials of Diazoxide Choline Extended Release (DCCR) in Participants with Prader-Willi Syndrome
London, United Kingdom
Sun 17 10:40
FC6.5
Free Communications 6: Fat, Metabolism and Obesity (1)
FIRST CROSS SECTIONAL ANALYSIS OF THE ECLIP REGISTRY
Ulm, Germany
Sun 17 10:50
FC6.6
Free Communications 6: Fat, Metabolism and Obesity (1)
Novel Melanocortin and Gut-peptide Dual Agonist for Obesity and Diabetes Treatment
Seattle, USA
Sun 17 10:00
Free Communications 7: GH and IGFs
Hall 2K
Chairs: Maria Carolina Salerno (Naples, Italy) & TBC
Sun 17 10:00
FC7.1
Free Communications 7: GH and IGFs
Clinical characteristics and response to growth hormone treatment in 27 children and adolescents with pathogenic NPR2 variants
Rotterdam, The Netherlands
Sun 17 10:10
FC7.2
Free Communications 7: GH and IGFs
Stratifying genetic etiology in children born small for gestational age with persistent short stature (SGA-SS): 5-year growth hormone (GH) treatment outcomes in genetic subgroups
Prague, Czech Republic
Sun 17 10:20
FC7.3
Free Communications 7: GH and IGFs
Growth hormone (GH) deficiency and subsequent replacement therapy trigger differential expression of specific miRNAs in males and females: not just a matter of height
Parma, Italy
Sun 17 10:30
FC7.4
Free Communications 7: GH and IGFs
Growth Hormone Response to Glucagon Stimulation Test in Transitional Age
Genova, Italy
Sun 17 10:40
FC7.5
Free Communications 7: GH and IGFs
Use of overnight GH sampling in the diagnosis of growth disorders in children: neuroimaging findings and response to treatment
London, United Kingdom
Sun 17 10:50
FC7.6
Free Communications 7: GH and IGFs
Growth, IGF-1 and IGFBP-3 Responses to Oral LUM-201 in OraGrowtH210 and OraGrowtH212 Trials in Pediatric Growth Hormone Deficiency (PGHD) over 12 to 24 Months on Treatment
Szczecin, Poland
Sun 17 10:00
Free Communications 8: Adrenals and HPA Axis (2)
Hall 2H
Chairs: Tülay Güran (Istanbul, Turkey) & Anna Nordenstrom (Solna, Sweden)
Sun 17 10:00
FC8.1
Free Communications 8: Adrenals and HPA Axis (2)
Quantitative proteomics of pediatric adrenocortical tumors provides insights into zone of origin and identifies overrepresented pathways
Augsburg, Germany
Sun 17 10:10
FC8.2
Free Communications 8: Adrenals and HPA Axis (2)
Detection and differentiation of adrenocortical tumors (ACTs) in children by gas chromatography-mass spectrometry (GC-MS) based urinary steroid metabotyping
Giessen, Germany
Sun 17 10:20
FC8.3
Free Communications 8: Adrenals and HPA Axis (2)
Insight into the role of TXNRD2 in steroidogenesis through a novel homozygous TXNRD2 splice variant
Brussels, Belgium
Sun 17 10:30
FC8.4
Free Communications 8: Adrenals and HPA Axis (2)
A deep intronic splice variant of CYP11B1 is the most common in Caucasian patients with 11-beta hydroxylase deficiency: functional, clinical and hormonal findings in 36 families
Bron, France
Sun 17 10:40
FC8.5
Free Communications 8: Adrenals and HPA Axis (2)
Free cortisol and free 21-deoxycortisol in the clinical evaluation of adrenal insufficiency in congenital adrenal hyperplasia
Nijmegen, Netherlands
Sun 17 10:50
FC8.6
Free Communications 8: Adrenals and HPA Axis (2)
Plasma concentrations of renin and ACTH in children and adolescents from the general population: new reference intervals according to sex, age, and pubertal stage
Copenhagen, Denmark
Sun 17 10:00
Free Communications 9: Sex Endocrinology and Gonads
Hall 2J
Chairs: Sabah Alvi (Leeds, United Kingdom) & Sabine Hannema (Amsterdam, The Netherlands)
Sun 17 10:00
FC9.1
Free Communications 9: Sex Endocrinology and Gonads
A tiered approach to exome sequencing analysis in early-onset Primary Ovarian Insufficiency
London, United Kingdom
Sun 17 10:10
FC9.2
Free Communications 9: Sex Endocrinology and Gonads
Unveiling DHT-driven Androgen Receptor target genes in genital skin fibroblasts
Kiel, Germany
Sun 17 10:20
FC9.3
Free Communications 9: Sex Endocrinology and Gonads
Prenatal exposure to paracetamol is associated with reduced uterine volume at infancy - A COPANA Cohort study of 302 healthy girls
Copenhagen, Denmark
Sun 17 10:30
FC9.4
Free Communications 9: Sex Endocrinology and Gonads
Prenatal exposure to paracetamol is associated with smaller testis volume and decreased levels of steroid metabolites during infancy in healthy males: A COPANA cohort study of 287 boys
Copenhagen, Denmark
Sun 17 10:40
FC9.5
Free Communications 9: Sex Endocrinology and Gonads
Sex hormones shape the skeleton: The impact of puberty suppression and gender affirming hormone therapy on skeletal dimensions in transgender individuals
Amsterdam, The Netherlands
Sun 17 10:50
FC9.6
Free Communications 9: Sex Endocrinology and Gonads
The Gender Identity Questionnaire for Children: a useful tool for gender identity detection in early life
Modena, Italy
Sun 17 10:00
Free Communications 10: Multisystem Endocrine Disorders
Hall 1
Chairs: Abdelhadi Habeb (Madinah, Saudi Arabia) & Leena Patel (Manchester, UK)
Sun 17 10:00
FC10.1
Free Communications 10: Multisystem Endocrine Disorders
Genetic screening and tumour surveillance program outcomes in rare paediatric hereditary endocrine tumour syndromes
London, United Kingdom
Sun 17 10:10
FC10.2
Free Communications 10: Multisystem Endocrine Disorders
Characterising the natural history of Multiple Endocrine Neoplasia 2B caused by M918TRET pathogenic variants in children and young people
London, United Kingdom
Sun 17 10:20
FC10.3
Free Communications 10: Multisystem Endocrine Disorders
Endocrine disorders in a wide cohort of children and adolescents affected by Neurofibromatosis type 1
Milan, Italy
Sun 17 10:30
FC10.4
Free Communications 10: Multisystem Endocrine Disorders
A novel de novo SAMD9 gene variant causing MIRAGE syndrome associated with steroid-resistant nephrotic syndrome in a 46,XY male.
ATHENS, GREECE
Sun 17 10:40
FC10.5
Free Communications 10: Multisystem Endocrine Disorders
Using sno-lncRNAs as potential markers for Prader-Willi syndrome diagnosis
Zhejiang, China
Sun 17 10:50
FC10.6
Free Communications 10: Multisystem Endocrine Disorders
Comprehensive analysis of disease spectrum and mortality in Sanjad-Sakati Syndrome: A Rare Disease Perspective
Riyadh, Saudi Arabia
Sun 17 11:00
Coffee, Posters & Exhibition
Exhibition Hall
Sun 17 11:30
Awards 2 - ESPE Research Award
Arena Plenary
Chair: Rasa Verkauskiene (Kaunas, Lithuania)
Sun 17 12:00
Plenary 4 - The importance of chronobiology for medicine – when time matters
Arena Plenary
Chairs: Peter Kühnen (Berlin, Germany) & Martine Cools (Ghent, Belgium)
Sun 17 12:00
PL4
Plenary 4 - The importance of chronobiology for medicine – when time matters
The importance of chronobiology for medicine – when time matters
Munich, Germany
Sun 17 12:30
Awards 3
Arena Plenary
Sun 17
Awards 3
ESPE International Outstanding Clinician Award
Rotterdam, The Netherlands
Sun 17
Awards 3
Outstanding Clinician Award
Rotterdam, The Netherlands
Sun 17
Awards 3
ESPE Hormone Research in Paediatrics Prizes
Rome, Italy
Sun 17
Awards 3
IFCAH-ESPE Award
Ghent, Belgium
Sun 17 13:00
Lunch, Posters & Exhibition
Exhibition Hall
Sun 17 14:30
Endo-ERN
Meeting Room 3
Sun 17 14:30
Endo-ERN
Introduction
Lübeck, Germany
Sun 17 14:35
Endo-ERN
Future of Registers for Rare Disease: the example E-REC
Rotterdam, The Netherlands
Sun 17 15:00
Endo-ERN
Genetic testing in rare forms of primary adrenal insufficiency
Sun 17 15:30
Endo-ERN
The patient perspective on new treatment options (example hypogonadotropic hypogonadism)
Hertfordshire, United Kingdom
Sun 17 14:30
Symposium 5 - Adrenal Disorders
Hall 2K
Chairs: Svetlana Lajic (Solna, Sweden) & Li Chan (London, UK)
Sun 17 14:30
S5.1
Symposium 5 - Adrenal Disorders
Innovations in pharmacotherapy of CAH
Michigan, USA
Sun 17 15:00
S5.2
Symposium 5 - Adrenal Disorders
Translational Clinical Applications of Complex Steroidobolome Data
Giessen, Germany
Sun 17 15:30
S5.3
Symposium 5 - Adrenal Disorders
Lessons from CAH service evaluation and real world data
Sheffield, UK
Sun 17 14:30
Symposium 6 - Novel Insights into Pituitary Disorders
Hall 1
Chairs: Roland Pfaeffle (Leipzig, Germany) & Cécile Brachet (Brussels, Belgium)
Sun 17 14:30
S6.1
Symposium 6 - Novel Insights into Pituitary Disorders
Molecular Basis of Congenital Hypopituitarism
Michigan, USA
Sun 17 15:00
S6.2
Symposium 6 - Novel Insights into Pituitary Disorders
New insights into Gonadotrope development
London, UK
Sun 17 15:30
S6.3
Symposium 6 - Novel Insights into Pituitary Disorders
Management of pituitary stalk thickening in children and young people
London, UK
Sun 17 14:30
Symposium 7 - Future Hope for skeletal disorders
Hall 2H
Chairs: Moira Cheung (London, UK) & Ola Nilsson (Stockholm, Sweden)
Sun 17 14:30
S7.1
Symposium 7 - Future Hope for skeletal disorders
Stem cells in skeletal development and growth
Texas, USA
Sun 17 15:00
S7.2
Symposium 7 - Future Hope for skeletal disorders
Genetic disorders of bone - historic perspectives and novel advances
London, UK
Sun 17 15:30
S7.3
Symposium 7 - Future Hope for skeletal disorders
Consensus statement on management of achondroplasia
Nesoddtangen, Norway
Sun 17 14:30
Symposium 8 - Improving treatment strategies in Obesity
Hall 2J
Chairs: Christian Roth & Feyza Darendelier (Istanbul, Turkey)
Sun 17 14:30
S8.1
Symposium 8 - Improving treatment strategies in Obesity
Pharmacotherapy of Obesity

Unknown speaker

Liverpool, United Kingdom
Sun 17 15:00
S8.2
Symposium 8 - Improving treatment strategies in Obesity
Impact of adolescent obesity on adult morbidity and mortality
Ramat Gan, Israel
Sun 17 15:30
S8.3
Symposium 8 - Improving treatment strategies in Obesity
Bariatic surgery: impact beyond weight
Boston, USA
Sun 17 14:30
Yearbook 2
Hall 2G
Chair: Christa Flück (Bern, Switzerland)
Sun 17 14:30
Yearbook 2
Antenatal and Neonatal Endocrinology
Montreal, Canada
Sun 17 14:42
Yearbook 2
Oncology and Chronic Disease
Rome, Italy
Sun 17 14:54
Yearbook 2
Type 1 Diabetes
Cambridge, UK
Sun 17 15:06
Yearbook 2
Obesity and Weight Regulation
Germany
Sun 17 15:18
Yearbook 2
The Year in Science & Medicine
Switzerland
Sun 17 16:10
Plenary 5 - MKRN3 and the initiation of puberty
Arena Plenary
Chairs: Anders Juul (Copenhagen, Denmark) & Rasa Verkauskiene (Kaunas, Lithuania)
Sun 17 16:10
PL5
Plenary 5 - MKRN3 and the initiation of puberty
MKRN3 and the initiation of puberty
Boston, USA
Sun 17 16:40
Coffee, Posters & Exhibition
Exhibition Hall
Sun 17 18:30
ESPE Annual Business Meeting
Arena Plenary
Mon 18 07:15
Registration Opens
ACC Cityside Galleria
Mon 18 08:00
Meet the Expert 3.2
Hall 2J
Mon 18 08:00
MTE3.2
Meet the Expert 3.2
Pharmacological treatment options for adolescents with Obesity
Rotterdam, The Netherlands
Mon 18 08:00
Meet The Expert 4.2
Hall 2H
Mon 18 08:00
MTE4.2
Meet The Expert 4.2
Closed loop in the very young
Luxembourg, Luxembourg
Mon 18 08:00
Meet The Expert 5.2
Hall 1
Mon 18 08:00
MTE 5.2
Meet The Expert 5.2
Managing difficult menstrual periods
London, UK
Mon 18 08:00
Meet The Expert 8.2
Hall 2K
Mon 18 08:00
MTE8.2
Meet The Expert 8.2
The Diagnosis & Management of Rickets in the 21st Century
Dubai , UAE
Mon 18 08:00
Yearbook 3
Hall 2G
Chair: Ken Ong (Cambridge, UK)
Mon 18 08:00
Yearbook 3
Bone, Growth Plate and Mineral Metabolism
Mon 18 08:12
Yearbook 3
DSD and gender incongruence
Istanbul, Turkey
Mon 18 08:24
Yearbook 3
Thyroid
Amsterdam, The Netherlands
Mon 18 08:36
Yearbook 3
Pituitary and Neuroendocrinology
London, UK
Mon 18 08:48
Yearbook 3
Editors' Choice
Cambridge, UK
Mon 18 09:00
How Do I...2
Arena Plenary
Chairs: Justin Davies (Southampton, UK) & Reiko Horikawa (Tokyo, Japan)
Mon 18 09:00
HDI2.1
How Do I...2
How do I...Manage Fertility Preservation in Young People with Klinefelter syndrome?
London, UK
Mon 18 09:30
HDI2.2
How Do I...2
How do I...Manage a child with Hypopituitarism
Marseille, France
Mon 18 10:00
HDI2.3
How Do I...2
How do I...Diagnose and manage pre-diabetes
Chieti, Italy
Mon 18 09:00
Rapid Free Communications 11: Fat, Metabolism and Obesity (2)
Hall 2G
Chairs: Liz Crowne (Bristol, United Kingdom) & Anuja Natarajan (Doncaster, UK)
Mon 18 09:00
RFC11.1
Rapid Free Communications 11: Fat, Metabolism and Obesity (2)
Assessing how the Edmonton Obesity Staging System for Pediatrics (EOSS-P) in childhood relates to later cardiometabolic health compared to other anthropometric measures of obesity
Montreal, Canada
Mon 18 09:05
RFC11.2
Rapid Free Communications 11: Fat, Metabolism and Obesity (2)
Is the Single Point Insulin Sensitivity Estimator (SPISE) index a reliable tool for children and adolescents with overweight/obesity?
Genoa, Italy
Mon 18 09:10
RFC11.3
Rapid Free Communications 11: Fat, Metabolism and Obesity (2)
Ultrasound evaluation of kidney and liver involvement in Bardet-Biedl syndrome
Essen, Germany
Mon 18 09:15
RFC11.4
Rapid Free Communications 11: Fat, Metabolism and Obesity (2)
Association of whole blood amino acid and acylcarnitine metabolome with anthropometry and IGF1 serum levels in healthy children and adolescents
Leipzig, Germany
Mon 18 09:20
RFC11.5
Rapid Free Communications 11: Fat, Metabolism and Obesity (2)
Hepatic lipogenesis increases FGF21 in children/adolescents with obesity.
Verona, Italy
Mon 18 09:25
RFC11.6
Rapid Free Communications 11: Fat, Metabolism and Obesity (2)
Pten knockout in osteoprogenitor cells leads to loss of adipose tissue
Leipzig, Germany
Mon 18 09:00
Rapid Free Communications 12: Thyroid
Hall 2K
Chairs: Marek Niedziela (Poznan, Poland) & Luisa De Sanctis (Turin, Italy)
Mon 18 09:00
RFC12.1
Rapid Free Communications 12: Thyroid
From neurology to endocrine: Misdiagnosed MCT8 deficiency
Bursa, Turkey
Mon 18 09:05
RFC12.2
Rapid Free Communications 12: Thyroid
Prevalence and etiology of thyroid disorders and Characteristic of thyroid function tests in preterm infants
Bangkok, Thailand
Mon 18 09:10
RFC12.3
Rapid Free Communications 12: Thyroid
Mechanisms and natural history of pituitary resistance to exogenous thyroxine in children with congenital hypothyroidism
Baku, Azerbaijan
Mon 18 09:15
RFC12.4
Rapid Free Communications 12: Thyroid
Establishing Outcomes and Management of Mild Neonatal Hyperthyrotropinaemia, a Retrospective Multi-Centre Review
Dublin, Ireland
Mon 18 09:20
RFC12.5
Rapid Free Communications 12: Thyroid
Use of the FT3/FT4 ratio as a predictor of relapse in autoimmune hyperthyroidism: retrospective study on a cohort of 80 pediatric patients
Milan, Italy
Milan , Italy
Italy
Mon 18 09:25
RFC12.6
Rapid Free Communications 12: Thyroid
Evaluation of thyroid nodules in children and adolescents by shear wave elastography (SWE)
Bialystok, Poland
Mon 18 09:00
Rapid Free Communications 13: Pituitary, Neuroendocrinology and Puberty (2)
Hall 2H
Chairs: Anne-Simone Parent (Liego, Belgium) & Hoong-Wei Gan (London, UK)
Mon 18 09:00
RFC13.1
Rapid Free Communications 13: Pituitary, Neuroendocrinology and Puberty (2)
MRI-based radiomics of the pituitary gland is highly predictive of CentralPrecocious Puberty in girls: pilot study
Parma, Italy
Mon 18 09:05
RFC13.2
Rapid Free Communications 13: Pituitary, Neuroendocrinology and Puberty (2)
Novel anatomical quantification of all hypothalamic, pituitary, and stalk components predicts the severity of neuroendocrine phenotypes.
London, United Kingdom
Mon 18 09:10
RFC13.3
Rapid Free Communications 13: Pituitary, Neuroendocrinology and Puberty (2)
Unstimulated copeptin and oxytocin concentrations correlate with hypothalamic volumes and posterior pituitary location in congenital and acquired salt-water imbalance disorders.
London, United Kingdom
Mon 18 09:15
RFC13.4
Rapid Free Communications 13: Pituitary, Neuroendocrinology and Puberty (2)
Investigation of Pituitary Function in Langerhans Cell Histiocytosis: A Comprehensive Analysis of Clinical and Radiological Findings
Istanbul, Turkey
Mon 18 09:20
RFC13.5
Rapid Free Communications 13: Pituitary, Neuroendocrinology and Puberty (2)
The Development and Validation of Bone-age guided Interpretation of Puberty, a web-based tool for guidance of pubertal disorders
Kanpur, India
Mon 18 09:25
RFC13.6
Rapid Free Communications 13: Pituitary, Neuroendocrinology and Puberty (2)
Hypogonadism hyperprolactinemia-related and its treatment in three patients with inherited disorders of biogenic amine metabolism
Florence, Italy
Mon 18 09:00
Rapid Free Communications 14: Fetal and Neonatal Endocrinology
Hall 2J
Chairs: Pratik Shah (London, UK) & Hussain Alsaffar (Wasit, Iraq)
Mon 18 09:00
RFC14.1
Rapid Free Communications 14: Fetal and Neonatal Endocrinology
The LIFE-MILCH project: preliminary data from the risk assessment model of exposure to Endocrine Disrupting Chemicals (EDCs) in mother-infant dyads during the first 3 months of life.
Reggio Emilia, Italy
Mon 18 09:05
RFC14.2
Rapid Free Communications 14: Fetal and Neonatal Endocrinology
Does gestational diabetes mellitus influence mitochondrial dynamics in offspring?
Istanbul, TURKEY
Mon 18 09:10
RFC14.3
Rapid Free Communications 14: Fetal and Neonatal Endocrinology
Complex Glycerol Kinase Deficiency: four new cases and a review of the literature
Jinan, China
Mon 18 09:15
RFC14.4
Rapid Free Communications 14: Fetal and Neonatal Endocrinology
Neurodevelopmental response to nifedipine treatment in an infant with Congenital Hyperinsulinism due to de novo gain-of-function CACNA1D variant.
Mumbai, India
Mon 18 09:20
RFC14.5
Rapid Free Communications 14: Fetal and Neonatal Endocrinology
The utility of ketones in screening for congenital hyperinsulinism: a retrospective evaluation.
Manchester, United Kingdom
Mon 18 09:25
RFC14.6
Rapid Free Communications 14: Fetal and Neonatal Endocrinology
Utility of Continuous Glucose Monitoring in hospital monitoring of patients with Hyperinsulinism
Manchester, United Kingdom
Mon 18 09:00
Rapid Free Communications 15: Late Breaking
Hall 1
Chairs: Ritika Kapoor (London, United Kingdom) & Xiao Ping Luo (Shanghai, China)
Mon 18 09:00
RFC15.1
Rapid Free Communications 15: Late Breaking
Altered expression of epigenetic regulators is associated with high infertility risk in patients diagnosed with cryptorchidism.
Liestal, Switzerland
Mon 18 09:05
RFC15.2
Rapid Free Communications 15: Late Breaking
Study on effects of poly- and perfluoroalkyl substances on hormones in girls with central precocious puberty
Shanghai, China
Mon 18 09:10
RFC15.3
Rapid Free Communications 15: Late Breaking
The different faces of acquired hypothalamic dysfunction.
Utrecht, Netherlands
Mon 18 09:15
RFC15.4
Rapid Free Communications 15: Late Breaking
Autoimmunity in children with type 1 diabetes in association with the COVID_19 pandemic - results from the prospective DPV Registry
Bern, Switzerland
Mon 18 09:20
RFC15.5
Rapid Free Communications 15: Late Breaking
Prevalence and management of modifiable cardiovascular risk factors among adolescents and young adults with type 1 diabetes – a cross-sectional analysis from the Diabetes Prospective Follow-Up Registry DPV
Duesseldorf, Germany
Mon 18 09:25
RFC15.6
Rapid Free Communications 15: Late Breaking
Macrophage switch and iron metabolism regulation by Burosumab in XLH pediatric patients: implications in inflammation and pain modulation.
Naples, Italy
Mon 18 09:30
Free Communications 11: Fat, Metabolism and Obesity (2)
Hall 2G
Chairs: Liz Crowne (Bristol, United Kingdom) & Anuja Natarajan (Doncaster, UK)
Mon 18 09:30
FC11.1
Free Communications 11: Fat, Metabolism and Obesity (2)
Frequency of rare syndromic diseases in a population with early-onset obesity
Rome, Italy
Mon 18 09:40
FC11.2
Free Communications 11: Fat, Metabolism and Obesity (2)
Frequency of rare non-syndromic diseases in a population with early-onset obesity
Madrid, Spain
Mon 18 09:50
FC11.3
Free Communications 11: Fat, Metabolism and Obesity (2)
Asprosin serum levels in subjects with Prader-Willi Syndrome: associations with hyperphagia, anthropometric, and metabolic parameters
Bari, Italy
Mon 18 10:00
FC11.4
Free Communications 11: Fat, Metabolism and Obesity (2)
Long-term Efficacy Results of Diazoxide Choline Extended-Release (DCCR) Tablets in Participants with Prader-Willi Syndrome from the Completed C601 (DESTINY PWS) and C602 Open Label Extension (OLE) Studies
London, UK
Mon 18 10:10
FC11.5
Free Communications 11: Fat, Metabolism and Obesity (2)
Complement 3 Alleviates Obesity Hypoventilation by Inhibiting Caspase-8/GSDME-Related Pyroptosis
Jinan, China
Jinan, China
Jinan, China
Mon 18 10:20
FC11.6
Free Communications 11: Fat, Metabolism and Obesity (2)
Poly- and Perfluoroalkyl substances (PFAS) levels and breastfeeding have opposite associations with growth and body composition at age 3 years
Rotterdam, The Netherlands
Mon 18 09:30
Free Communications 12: Thyroid
Hall 2K
Chairs: Marek Niedziela (Poznan, Poland) & Luisa De Sanctis (Turin, Italy)
Mon 18 09:30
FC12.1
Free Communications 12: Thyroid
Use of targeted Next-Generation Sequencing panel in patients with non-autoimmune hypothyroidism: the experience of an Italian Pediatric Endocrinology Center
Bologna, Italy
Mon 18 09:40
FC12.2
Free Communications 12: Thyroid
Molecular Characterization of Childhood Thyroid Nodules and Thyroid Cancer with DNA/RNA Next Generation Sequencing and Investigation of Phenotype-Genotype Correlation
Ankara, Turkey
Mon 18 09:50
FC12.3
Free Communications 12: Thyroid
Usefulness of application novel TurboTM TSAb bioassay in the monitoring of pediatric Graves’ patients
Białystok, Poland
Mon 18 10:00
FC12.4
Free Communications 12: Thyroid
Docosahexaenoic acid (DHA) is reduced and could be protective against Hashimoto’s thyroiditis in children with Down syndrome: a cross-sectional study
Piacenza, Italy
Mon 18 10:10
FC12.5
Free Communications 12: Thyroid
The Association between Plasma Thyroxine Levels and Attention-Deficit/Hyperactivity Disorder
Izmir, Turkey
Mon 18 10:20
FC12.6
Free Communications 12: Thyroid
The First Robust Bioavailability/Bioequivalence (BA/BE) Study of Thyromimetic Tiratricol, a Treatment in Development for MCT8 Deficiency.
Stockport, UK
Mon 18 09:30
Free Communications 13: Pituitary, Neuroendocrinology and Puberty (2)
Hall 2H
Chairs: Anne-Simone Parent (Liego, Belgium) & Hoong-Wei Gan (London, UK)
Mon 18 09:30
FC13.1
Free Communications 13: Pituitary, Neuroendocrinology and Puberty (2)
Defect in C-terminal alpha-amidation during Kisspeptin synthesis: a new mechanism of hypogonadotropic hypogonadism
Paris, France
Mon 18 09:40
FC13.2
Free Communications 13: Pituitary, Neuroendocrinology and Puberty (2)
Copy Number Variation (CNV) in Self-limited Delayed Puberty (SLDP)
London, UK
Mon 18 09:50
FC13.3
Free Communications 13: Pituitary, Neuroendocrinology and Puberty (2)
Effect of Precocious Puberty and GnRHa Treatment on Glucose Metabolism in Female Rats
Guangzhou, China
Mon 18 10:00
FC13.4
Free Communications 13: Pituitary, Neuroendocrinology and Puberty (2)
Relationship between the timing of the physical changes of puberty and total pubertal growth in healthy adolescents: new insights which can provide helpful clinical guidance
London, United Kingdom
Mon 18 10:10
FC13.5
Free Communications 13: Pituitary, Neuroendocrinology and Puberty (2)
Rising in body mass index during childhood in girls with idiopathic CPP : a 20-year experience in a tertiary Belgian centre.
Brussels, Belgium
Mon 18 10:20
FC13.6
Free Communications 13: Pituitary, Neuroendocrinology and Puberty (2)
Voice frequency in healthy children and adolescents: A biomarker of androgen action in puberty
Copenhagen, Denmark
Mon 18 09:30
Free Communications 14: Fetal and Neonatal Endocrinology
Hall 2J
Chairs: Pratik Shah (London, UK) & Hussain Alsaffar (Wasit, Iraq)
Mon 18 09:30
FC14.1
Free Communications 14: Fetal and Neonatal Endocrinology
Non-invasive prenatal testing can detect maternally and paternally inherited variants in the KCNJ11 and ABCC8 genes: implications for clinical management of neonatal diabetes during pregnancy and beyond
Exeter, United Kingdom
Mon 18 09:40
FC14.2
Free Communications 14: Fetal and Neonatal Endocrinology
Cord glucose: A normal reference and a potential of an ideal universal screening tool for pathological hyperinsulinism.
Odense, Denmark
Mon 18 09:50
FC14.3
Free Communications 14: Fetal and Neonatal Endocrinology
Reduction of Overnight Hypoglycemia in Congenital Hyperinsulinism: Results from the RZ358-606 (RIZE) Study
London, UK
Mon 18 10:00
FC14.4
Free Communications 14: Fetal and Neonatal Endocrinology
Efficacy and Safety across Subgroups in Children with Congenital Hyperinsulinism Treated with Dasiglucagon
Manchester, UK
Mon 18 10:10
FC14.5
Free Communications 14: Fetal and Neonatal Endocrinology
A novel 94bp deletion in the SLC16A1 promoter causes fasting and exercise-induced hyperinsulinaemic hypoglycaemia
Exeter, United Kingdom
Mon 18 10:20
FC14.6
Free Communications 14: Fetal and Neonatal Endocrinology
Patient and Carer Perspectives: A National Survey of Continuous Glucose Monitoring in Children with Congenital Hyperinsulinism in the UK
Cambridge, United Kingdom
Mon 18 09:30
Free Communications 15: Late Breaking
Hall 1
Chairs: Ritika Kapoor (London, United Kingdom) & Xiao Ping Luo (Shanghai, China)
Mon 18 09:30
FC15.1
Free Communications 15: Late Breaking
Response  to Daily and Weekly Recombinant Human Growth Hormone Treatment in Children Born Small for Gestational Age is Predicted More Accurately by Pre-treatment Blood Transcriptome than Clinical Variables
Manchester, United Kingdom
Mon 18 09:40
FC15.2
Free Communications 15: Late Breaking
Amount and Pattern Of Pulsatile GH Secretion Induced By The Oral Growth Hormone Secretagogue LUM-201 Is Related To Growth And IGF-1 Responses In Moderate Pediatric Growth Hormone Deficiency (PGHD)
Manchester, United Kingdom
Mon 18 09:50
FC15.3
Free Communications 15: Late Breaking
Assessment of actionable secondary genetic findings in a large cohort of children with short stature
Sao Paulo, Brazil
Mon 18 10:00
FC15.4
Free Communications 15: Late Breaking
Oral infigratinib for children with achondroplasia: Month 18 results from the PROPEL 2 study demonstrate safety and durability of treatment effect on linear growth with improved body proportionality
London, United Kingdom
Mon 18 10:10
FC15.5
Free Communications 15: Late Breaking
Presence of neuropathy in children and adolescents with type 1 diabetes evaluated with bedside modalities
Herlev, Denmark
Mon 18 10:20
FC15.6
Free Communications 15: Late Breaking
Pharmacodynamic Endpoints After Once-Weekly Somapacitan in Children With GHD: 3-year results from REAL4 phase 3 study
Minneapolis, USA
Mon 18 10:30
Coffee, Posters & Exhibition
Exhibition Hall
Mon 18 11:00
Plenary 6 - Pancreatic and islet plasticity in early life: implications for diabetes risk
Arena Plenary
Chairs: Indi Banerjee (Manchester, UK) & Zdeněk Sumnik (Prague, Czechia)
Mon 18 11:00
PL6
Plenary 6 - Pancreatic and islet plasticity in early life: implications for diabetes risk
Pancreatic and islet plasticity in early life: implications for diabetes risk
Tennessee, USA
Mon 18 11:30
Awards 4
Arena Plenary
Chair: Anita Hokken-Koelega (Rotterdam, The Netherlands)
Mon 18 11:30
Awards 4
Andrea Prader Prize
Mon 18 12:00
Awards 4
ESPE International Award
Mon 18 12:15
Plenary 7 - Genomics in Rare Diseases
Arena Plenary
Chairs: Martin Wabitsch (Ulm, Germany) & Senthil Senniappan (Liverpool, UK)
Mon 18 17:05
PL8
Plenary 7 - Genomics in Rare Diseases
Genomics in rare diseases
Cambridge, UK
Mon 18 12:45
Lunch, Posters & Exhibition
Exhibition Hall
Mon 18 14:15
Meet The Expert 1.2
Hall 2G
Mon 18 14:15
MTE1.2
Meet The Expert 1.2
Genetic Testing in Hypogonadism
Paris, France
Mon 18 14:15
Meet The Expert 6.2
Hall 2K
Mon 18 14:15
MTE6.2
Meet The Expert 6.2
Management of sodium and water regulation disorders
Leuven, Belgium
Mon 18 14:15
Meet The Expert 7.2
Hall 2H
Mon 18 14:15
MTE7.2
Meet The Expert 7.2
Diagnosis and Management of PCOS
Tel Aviv, Israel
Mon 18 14:15
Young Investigators Awards
Exhibition Hall C
Chair: Martine Cools (Ghent, Belgium)
Mon 18
Young Investigators Awards
ESPE Young Investigator Awards
Mon 18
Young Investigators Awards
Research Unit Lecture
Mon 18
Young Investigators Awards
Research Fellowship Lecture
Mon 18 15:10
Coffee, Posters & Exhibition
Exhibition Hall
Mon 18 15:30
Symposium 9 - Novel advances in paediatric thyroid disease
Hall 2J
Chairs: Paul Van Trotesenberg (Amsterdam, the Netherlands) & Malgorzata Wasniewska (Messina, Italy)
Mon 18 15:30
S9.1
Symposium 9 - Novel advances in paediatric thyroid disease
Challenges in congenital hypothyroidism: including genetics, newborn screening and treatment optimization
Paris, France
Mon 18 16:00
S9.2
Symposium 9 - Novel advances in paediatric thyroid disease
Pediatric thyroid cancer guidelines: challenges in stratifying care based on limited data
Philadelphia, USA
Mon 18 16:30
S9.3
Symposium 9 - Novel advances in paediatric thyroid disease
The pathophysiology of transient congenital hypothyroidism
Cambridge, UK
Mon 18 15:30
Symposium 10 - Challenges in the management of Prader Willi Syndrome
Hall 2H
Chairs: Evelien Gevers (London, UK) & Susanna Wiegand (Berlin, Germany)
Mon 18 15:30
S10.1
Symposium 10 - Challenges in the management of Prader Willi Syndrome
Hypothalamic dysfunction in PWS – research perspective
London, UK
Mon 18 16:00
S10.2
Symposium 10 - Challenges in the management of Prader Willi Syndrome
Long-term management and outcomes in PWS
Cambridge, UK
Mon 18 16:30
S10.3
Symposium 10 - Challenges in the management of Prader Willi Syndrome
Growth hormone treatment in adults with PWS
Stockholm, Sweden
Mon 18 15:30
Symposium 11 - Microbiota in type 1 diabetes
Hall 2G
Chairs: Francesco Chiarelli (Chieti, Italy) & Esko Wiltshire (Wellington, New Zealand)
Mon 18 15:30
S11.1
Symposium 11 - Microbiota in type 1 diabetes
Gut dysbiosis in type 1 diabetes
Helsinki, Finland
Mon 18 16:00
S11.2
Symposium 11 - Microbiota in type 1 diabetes
MAIT cells, an immune link between microbiota and type 1 diabetes
Paris, France
Mon 18 16:30
S11.3
Symposium 11 - Microbiota in type 1 diabetes
Diet and microbiota in type 1 diabetes
Chicago, USA
Mon 18 15:30
Symposium 12 - The impact of gonadotrophin dysregulation on neurocognition
Hall 2K
Chairs: Sasha Howard (London, UK) & Katharina Main (Copenhagen, Denmark)
Mon 18 15:30
S12.1
Symposium 12 - The impact of gonadotrophin dysregulation on neurocognition
The Role of MiniPuberty in Non-Reproductive Outcomes
Lille, France
Mon 18 16:00
S12.2
Symposium 12 - The impact of gonadotrophin dysregulation on neurocognition
Neurodevelopmental syndromes associated with Centra Precocious Puberty
São Paulo, Brazil
Mon 18 16:30
S12.3
Symposium 12 - The impact of gonadotrophin dysregulation on neurocognition
Studying the genetic interplay between GnRH deficiency and associated neurocognitive disorders by combining in silico, in vitro and in vivo tools.
Milan, Italy
Mon 18 17:05
Plenary 8 - Fat & Bone; where are we now?
Hall 1
Chairs: Anita Hokken-Koelega (Rotterdam, the Netherlands) & Stefano Cianfarani (Rome, Italy)
Mon 18 12:15
PL7
Plenary 8 - Fat & Bone; where are we now?
Fat & Bone: where are we now?
Maine, USA
Mon 18 17:35
ESPE Awards 5 - ESPE Meeting Host Poster Awards
Hall 1
Chair: Mehul Dattani (London, United Kingdom)
Mon 18 17:55
Closing Ceremony
Hall 1

0 result(s) found.

Please wait...

     
      - 
     
     
     


    Abstracts from this event
      Abstracts from other events


          Session starts at:
          Abstract time:
        Event:


        Read full abstract